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Background: In recent years iron has been related to diseases such as cancer, 
cardiovascular disease, metabolic syndrome (MetS), gestational diabetes and type 2 
diabetes mellitus (T2DM), through an increase in oxidative stress. 
 
Several studies have found an association between a high consumption of red and 
processed meat and the risk of T2DM. The intake of haem iron intake - an important 
component of meat – as well as body iron stores have also been associated with the risk 
of developing T2DM in U.S., Chinese, and northern European cohorts, however these 
relationships have not been studied in southern European populations. Although the 
potential mechanism that mediates these relationships is not well-established, iron plays 
a role in insulin resistance and β-cell dysfunction, which are two key events in the clinical 
development of T2DM. Osteocalcin (OC), a biomarker of bone metabolism, has recently 
been related to glucose homeostasis and iron metabolism. This relationship suggests a 
potential for mechanism for explaining iron-induced T2DM. 
 
Main objectives: To assess, prospectively, the effect of elevated dietary iron intake and 
body iron status on the onset of T2DM in an adult Mediterranean population and to 
evaluate the relationship between iron status and OC levels as a potential mechanism for 
explaining iron-induced T2DM. 
 
Material and methods: We conducted three studies on the PREDIMED (PREvención con 
DIeta MEDiterránea) cohort with data collected in men and women aged 55 to 80 from 
centres located in Reus-Tarragona, Pamplona and/or Barcelona. 
 
The first was an observational cohort study of 1,073 individuals (131 incident diabetics 
and 942 non-incidents diabetics) to assess the association between iron intake and 
T2DM. Several proportional hazard regression models were fitted and adjusted for socio-
demographic, anthropometric, lifestyle, and dietary variables. 
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Second was a cross-sectional study of 423 subjects, 250 normal glucose metabolism 
(NGM) subjects and 173 impaired fasting glucose (IFG) subjects, to assess the 
relationship between iron status and serum concentrations of total and uncarboxylated 
osteocalcin (OC). Several multiple linear regression were fitted. 
 
The third was a prospective nested case-control study of 459 participants (153 incident 
diabetics and 306 non-incidents diabetics) to evaluate the association between body iron 
status (measured as serum ferritin (SF), soluble transferrin receptor (sTfR) and the 
sTfR/ferritin ratio) and the risk of T2DM. A conditional logistic regression model was 
fitted and adjusted for socio-demographic, anthropometric, lifestyle, dietary and 
inflammation variables, as well as for MetS components. 
 
The methodology included the diagnosis of T2DM based on American Diabetes 
Association (ADA) criteria. Dietary intake was determined at baseline using a validated 
137-item, semi-quantitative food frequency questionnaire (FFQ). Socio-demographic, 
anthropometric, lifestyle, iron status, lipid profile, glucose metabolism, and inflammation 
data were collected at baseline. 
 
Results: In the first study we found that incident diabetics consumed more haem iron 
(3.9 ± 1.3 vs. 3.7 ± 1.3mg/day, P = 0.036), and less coffee (20.5 ± 30.9 vs. 31.5 ± 
47.5cc/day, P = 0.001) than non-incidents diabetics. We also found that elevated haem 
iron intake (HR = 1.30, 95% CI, 1.02-1.66, P = 0.037), and alcoholic beverage 
consumption (HR = 1.02, 95% CI, 1.01-1.04, P = 0.005), increased the risk of T2DM but 
that this risk decreased with high coffee consumption (HR = 0.93, 95% CI, 0.89-0.98, 
P=0.005). 
 
In the second study we observed that for every 50ng/mL increase in ferritin, total serum 
OC decreased significantly (by 2.5% [P = 0.004] in the whole sample and by 2.9% 
[P=0.010] in NGM subjects) but not in IFG subjects (2.2% [P = 0.080]). Otherwise, for 
every 1ng/mL increase in sTfR, total serum OC decreased by 13.0% (P = 0.038) and UOC 
decreased by 22.1% (P = 0.029) in the whole sample. In contrast, sTfR/ferritin ratio was 
not significantly associated with total OC or UOC. 
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In the third study, we found that incident diabetics had higher SF (127.6 ± 2.5 vs. 105.2 
± 2.5µg/L, P = 0.037), higher fasting insulin (36.5 ± 1.9 vs. 32.0 ± 1.8pmol/L, P = 0.022) 
and higher glucose  levels (mean: 6.1, interquartile range: 5.6-6.8 vs. 5.2, 4.8-5.5mmol/L, 
P <0.001), and higher HOMA-IR (homeostasis model assessment of insulin resistance) 
(1.4 ± 1.9 vs. 1.0 ± 1.8, P <0.001) than non-incident diabetics. We also observed that SF 
values >257 µg/L in males and >139µg/L in females increased the risk of T2DM (OR=3.6, 
95% CI, 1.3-9.9, P-trend = 0.014). We also found an association between low 
sTfR/ferritin ratio levels and the risk of T2DM (OR = 3.0, 95%CI, 1.1-8.4, P-trend = 0.042) 
but found no association with sTfR (OR = 1.3, 95% CI, 0.5-3.2, P-trend = 0.722). 
 
Conclusions: In an adult Mediterranean population at high cardiovascular risk, high 
dietary haem iron and body iron stores increase the risk of T2DM after adjustment for 
potential confounding variables. The relationship between sTfR and the risk of 
developing T2DM is not evident, while the relationship between iron status and serum 
OC levels is controversial. 
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Functions 
 
The essential role of iron in living organisms is demonstrated by the fact that this is the 
fourth most abundant element in the earth's crust, and the most plentiful transition 
element in organisms. Iron is an essential trace element required by all organisms except 
for a few species of bacteria (Chua et al., 2007). It is present in many metabolic and 
cellular processes, including molecular oxygen transport, electron transfer, key 
metabolic reactions and DNA synthesis (Hentze et al., 2004), making it a subject of much 
interest, especially because of its role in health and disease. 
 
These physiological and vital iron functions revolve around its ability to exist in two 
stable oxidation states, ferric (Fe+3) and ferrous (Fe+2) iron. This chemical property of 
iron underlies in its ability to participate in reduction-oxidation (electron transfer) 
reactions, and also leads to its potential toxicity. Thereby, iron can participate in the 
production of oxygen free-radicals, and these in turn can damage numerous biological 
molecules (e.g., membrane lipids, proteins, DNA). Mammals have thus developed 
complex regulatory mechanisms that control iron absorption, transport, storage and 
recycling (Gulec et al., 2014). 
 
Distribution and body iron content 
 
The amount of iron in the body depends on age, gender, nutrition, and general state of 
health. There are limited iron stores in the new-born and these gradually increase with 
age until adulthood. Body iron content is approximately 4.0g in men and 3.5g in women; 
55mg and44 mg per kilogram of body weight, respectively. In adults, most body iron is 
present in haemoglobin (60–70%) in circulating erythrocytes where it is essential for 
oxygen transport, and in muscle myoglobin (10%). The remaining body iron, around 20–
30%, is found mainly stored in reticuloendothelial system and the liver as ferritin and 
haemosiderin (figure 1). Approximately 1% is incorporated in the iron-containing 
enzymes and less than 0.2% of body iron is in the plasma transport pool. The major 
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content of ferritin is in the liver, 25% of body iron, two-thirds of this as ferritin and up to 
one-third as haemosiderin (Geissler and Singh, 2011). 
 
 
1.1 IRON METABOLISM 
 
1.1.1 Iron digestion and absorption 
 
1.1.1.1 Digestion process of food containing iron 
 
Approximately 20-30mg of iron is required daily for the de novo production of 
haemoglobin, 90%–95% of which is derived from iron that is recycled from senescent 
and effete erythrocytes by reticuloendothelial macrophages in the spleen (see figure 1). 
The normal diet contains 15-20mg of iron, and approximately 1–2mg of iron is absorbed 
in the proximal duodenum to replace iron losses from bleeding, desquamation of 
epithelial cells, sweating and urinary excretion (Steinbicker and Muckenthaler, 2013). 
Figure 1. Distribution of body iron. 
 
      Source: (Yun and Vincelette, 2015) 
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Iron is found in a large variety of foods (see table 1). It can be found in the diet in two 
forms: non-haem iron (inorganic iron), which is present in both plant foods and animal 
tissues, and haem iron (organic iron), which comes only from animal source foods. Meats, 
fish, and seafood are rich sources of haem iron, the remainder is non-haem. Moreover, 
iron in dairy foods, eggs, and all plant-based foods are entirely non-haem. It is estimated 
that the bioavailability of iron from a vegetarian diet is approximately 10 percent, rather 
than the 18 percent from a mixed Western diet. Hence, the requirement for iron is 1.8 
times higher for vegetarians (Otten et al., 2006).  
 
In Western countries, iron derived from haem sources make up two-thirds of the total 
iron absorbed, despite only constituting one-third of the iron ingested (West and Oates, 
2008). In this regard, different research studies have estimated that the bioavailability of 
haem iron may be 2- to 7-fold higher than non-haem iron (Bjorn Rasmussen et al., 1974) 
(Hurrell, 1997)(Ekman and Reizenstein, 1993) (Reizenstein, 1979). It is believed that 
25% of dietary haem iron intake is absorbed, and only 5–15% of non-haem iron 
(Rajpathak et al., 2009a). 
 
Non-haem iron digestion 
 
Non-haem iron is found in both animal and plant foods mainly as ferric iron. This iron 
form is highly insoluble, and produces insoluble non-absorbable complexes in alkaline 
environment. Thereby, the process of its absorption has to be preceded by the reduction 
of ferric ion (Fe+3) to ferrous ion (Fe+2) (Przybyszewska and Żekanowska, 2014). Gastric 
acid, ascorbic acid and other organic acids (Gulec et al., 2014) and sugars such as fructose 
(Christides and Sharp, 2013) contained in foods promote reduction and solubilisation of 
dietary ferric iron and thus improve its subsequent absorption. Interestingly, research 
has shown that the presence of an elevated gastric content increases the bioavailability 
of dietary iron more than in the sole presence of isolated hydrochloric acid (Sobala et al., 
1989). 
 
In addition, the bioavailability of non-haem iron can be impaired by pathological 
conditions of the alimentary tract, such as Helicobacter pylori infection and 
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inflammatory diseases. Also, the chronic use of proton pump inhibitors for gastric acid 
reflux also decrease non-haem iron absorption (Gulec et al., 2014). 
 
Table 1. Iron content in food (mg/100g). 
Meats  1-3 
Liver 13 
Lean meat 1.3 
Spanish cured ham 2.3 
Fish and seafood 0,4-2,7 
Lean fish 1 
Oily fish  1.1 
Seafood  2.5 
Eggs 2.2 
Dairy products 0,004-0,9 
Natural yoghurt 0.1 
Cheese 0.6 
Whole milk  0.04 
Legumes 5,5-8,2 
Lentil 8.2 
Chickpea 6.8 
Nuts 5-7,9 
Pistachio 7.2 
Cereals 0,8-2,1 
Bread 1.6 
Spaghetti 2.1 
Vegetables 0,3-3 
Tomato 0.7 
Potato 0.8 
Chard and Spinach  3 
Fruits 0,1-0,7 
Banana 0.6 
Orange 0.5 
strawberry  0.7 
Source:  Mataix et al., 2002 
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Haem iron digestion 
 
Haem consists of protoporphyrin IX with an iron atom bound in the centre, coordinated 
to the pyrrole rings. It acts as prosthetic group of haem-proteins such as haemoglobin, 
myoglobin, cytochromes, catalase, peroxidase, and nitric oxide synthase, and also 
participates in metabolic processes such as transcription, translation, and cellular 
differentiation (Furuyama et al., 2007). 
 
Haem iron from diet comes primarily from haemoglobin and myoglobin, thus it is only 
present in animal sources. The low pH in the stomach and the action of proteolytic 
enzymes in the stomach and small intestine release haem from these proteins (West and 
Oates, 2008). The haem released in the stomach is poorly absorbed, because pure haem 
is poorly soluble at the low gastric pH, but the availability of haem is unaffected by gastric 
secretion (West and Oates, 2008) (Hooda et al., 2014). The presence of protein increases 
the solubility of haem iron. Thus, it interaction with peptides produced from proteolytic 
digestion prevents the formation of insoluble haem polymers, which could reduce its 
bioavailability. Hence, the amino acids and peptides released from digestion of meat and 
by-products can enhance subsequent absorption of haem iron (West and Oates, 2008) 
(Hooda et al., 2014). 
 
1.1.1.2 Intestinal iron absorption 
 
Iron is absorbed actively in epithelial cells of the duodenum and first portion of the 
jejunum, decreasing in to the distal intestine (Przybyszewska and Żekanowska, 2014). 
The epithelium of the small intestine is organised into large numbers of self-renewing 
crypt-villus units. Villi are finger-like protrusions of the gut wall that project into the gut 
lumen to maximise available absorptive surface area. Crypts are home to a population of 
proliferating epithelial cells, which fuel the active self-renewal of the epithelium (Clevers, 
2013). Thus, the epithelium is composed of stem cells and transit amplifying cells, which 
differentiate into several types of mature intestinal epithelial cells and move upward 
along the side of the villi to be ejected when they reach the villi tips (Clevers, 2013). Six 
differentiated epithelial cell types are distinguished. The most populous cell on the villus 
is the absorptive enterocyte, a highly polarised columnar cell (Clevers, 2013). This cells 
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reach absorptive maturity during their migration from duodenal crypts towards the apex 
of the intestinal villus (Przybyszewska and Żekanowska, 2014). It is precisely in these 
mature cells where iron is absorbed, although the mechanism of absorption is different 
for haem and non-haem iron. 
 
Cells of gastrointestinal mucosa synthesise mucins, a glycoprotein that constitutes the 
main component of mucus. These molecules can bind ferric and ferrous iron and form 
soluble complexes, which can be directly absorbed from the duodenum (Przybyszewska 
and Żekanowska, 2014). The presence of alkaline pH in the duodenal content is a 
prerequisite for the absorption of iron ions by the mucin-integrin system. Acidification 
of the duodenal content changes the physicochemical properties of mucins, stimulating 
the formation of aggregates thereby causing the resultant loss of iron ion-binding 
capacity (Przybyszewska and Żekanowska, 2014). 
 
Iron in duodenum can be found as organic iron (haem), inorganic iron (non-haem), but 
also as ferroproteins, e.g. lactoferrin or phytoferritin. It has been seen in humans that 
ferritin from both, animal  and plant  sources (Davila-Hicks et al., 2004) (Lönnerdal et al., 
2006) (Lv et al., 2015), is absorbed, but the exact mechanism is not known yet. It has 
observed that ferritin, at least partially, survives digestion (Theil et al., 2012), and could 
be absorbed through a different mechanism from inorganic or organic iron (Theil et al., 
2012), possibly by endocytosis (San Martin et al., 2008). 
 
Non-haem iron absorption 
 
The non-haem iron absorption starts in apical membrane of differentiated enterocytes 
of the mid and upper zones of the villus of duodenal epithelium (Lane et al., 2015). The 
first step in this process is the reduction of non-haem iron, from ferric iron to ferrous 
iron, since non-haem iron is rapidly oxidised into its ferric form in the presence of 
dissolved oxygen. Importantly, there is also evidence that the reduction of non-haem iron 
in the extracellular environment may involve non-enzymatic ferrireduction driven by 
endogenous and secreted reductants, such as ascorbate (secreted or supplied in the diet) 
and/or superoxide (Lane et al., 2015). Congruently, duodenal cytochrome B (DCYTB) 
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appears to be regulated by iron, hypoxia, erythroid activity and by increased systemic 
iron requirements (McKie, 2008). 
 
Ferrous iron is then transported across the apical membrane of the enterocyte via 
divalent metal transporter 1 (DMT1), and possibly other divalent metal transporters, 
such as ZRT/IRT-like Protein (ZIP) 14 (Liuzzi et al., 2006). DMT1 is a 12-transmembrane 
domain protein, transports several divalent metals but operates mostly as a 
cotransporter of protons and ferrous iron (Brasselagnel et al., 2011). 
 
Ferrous iron absorbed can be guided to ferritin protein complex, to different intracellular 
compartments or to the basolateral membrane by means of an unknown mechanism. In 
basolateral membrane iron can be exported to the blood circulation by ferroportin 
(FPN), the only known mammalian iron exporter (see figure 2). This transporter is 
expressed not only in cells that absorb (enterocytes), but also in cells that store iron 
(hepatocytes and reticuloendothelial macrophages), consistent with its established roles 
in iron absorption and recycling (Gulec et al., 2014). 
 
FPN transcription has been shown to be regulated by iron deficiency (ID), hypoxia, 
transition metals, haem and inflammatory cytokines (Ward and Kaplan, 2012). It is 
noteworthy that not only non-haem, but also haem iron can induce FPN transcription 
(Marro et al., 2010). At the posttranslational level FPN expression is regulated via the 
small hepatic peptide hormone hepcidin that binds FPN to cause its internalization and 
proteolysis (De Domenico et al., 2007). However, it has seen that hepcidin also induces 
the proteasomal-mediated degradation of DMT1 by a signalling pathway that remains to 
be identified. This pathway seems more sensitive to changes in hepcidin concentration 
than the FPN (Brasselagnel et al., 2011). 
 
Beside FPN, a trans-membrane ferroxidase called hephaestin is located in the basolateral 
membrane and, in combination with plasma ceruloplasmin, helps to oxidise the exported 
ferrous iron back to ferric iron (Chen et al., 2004). This iron is then complexed to the 
major plasma iron transport protein, transferrin, for transport through the circulation 
and uptake by distal tissues (Lane et al., 2015). 
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       Figure 2. Iron absorption mechanisms in the intestinal enterocyte. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from (Hooda et al., 2014) 
 
Haem iron absorption 
 
Haem iron from diet comes primarily from haemoglobin and myoglobin, thus it is only 
present in animal sources. It is well established that haem is an efficient source of iron in 
the mammalian diet, markedly more effective than non-haem iron. Its major site of 
absorption in mammals is duodenal epithelium, through a different route from the 
absorption of non-haem iron. However, the identity of the putative haem transporter 
expressed by the proximal duodenal was unknown until recently when Shayeghi et al. 
proposed haem carrier protein 1 (HCP1) as a candidate protein (Shayeghi et al., 2005). 
HCP1 transports haem, and its analogues such as zinc protoporphyrin, from the gut 
lumen into intestinal epithelial cells. This protein was initially reported to be a pH-
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independent, low-affinity (Km ∼ 125μM), intestinal haem transporter (Shayeghi et al., 
2005). Subsequent studies suggested that it was most likely a high-affinity (Km= 1.67μM) 
proton-coupled folate transporter (PCFT) and not a physiologically relevant haem 
transporter (Qiu et al., 2006) (Umapathy et al., 2007) (Nakai et al., 2007), and Qiu et al. 
proposed to amend the name to PCFT/HCP1 (Qiu et al., 2006). Recent evidence have 
argued that PCFT/HCP1 receptor was involved in haem iron uptake and not just in the 
transport of folate (Laftah et al., 2009) (Le Blanc et al., 2012). Other different mechanisms 
have been proposed for haem uptake, such as via pinocytosis (Wyllie and Kaufman, 
1982), and via receptor-mediated endocytosis (Gräsbeck et al., 1979), but the exact 
mechanism still remains elusive. Irrespective of the exact mechanism, it has been seen 
that haem iron absorption from haemoglobin is saturable, with a daily maximum amount 
absorbed of 2 mg of iron (Pizarro et al., 2003). It has been suggested that the saturability 
of haem iron absorption might be a protective factor to avoid iron overload when iron 
intake is provided primarily by consumption of animal food. 
 
It has been observed that haem iron appears to be transported intact from the gut lumen 
into enterocytes (Shayeghi et al., 2005). Inside enterocytes, haem iron is mostly 
catabolised by the microsomal enzyme haem oxygenase-1 (HO-1) in biliverdin, carbon 
monoxide (CO) and free iron. It is likely that, after its disassembled by HO-1, the liberated 
iron enters the same storage and transport pathways taken by inorganic iron. Hence, free 
iron would form part of the labile iron pool (LIP), which is delivered either to ferritin and 
eliminated from the organism with exfoliated enterocytes, or to the basolateral side to 
be exported to the blood capillaries trough ferroportin. However, Mendiburo et al. 
observed that a fraction of haem iron can be transported out of the cells intact 
(Mendiburo et al., 2011). Supporting this hypothesis, a recent study in a rat model 
showed a differential tissue utilization of haem and non-haem iron, suggesting that some 
haem may be exported into the circulation in a form different from that of non-haem iron, 
i. e., as haem iron intact (Cao et al., 2014). 
 
The haem transport could be performed by a cell-surface membrane protein named 
Feline Leukaemia Virus subgroup C Receptor (FLVCR) (Quigley et al., 2004). This haem-
efflux protein is expressed in different cells and tissues, including the intestine, where it 
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appears to function as basolateral haem exporter to prevent toxicity within the 
enterocytes (Quigley et al., 2004). 
 
1.1.2 Iron transport 
 
Non-haem iron transport 
 
Transferrin 
 
Ferrous iron released into the circulation from enterocytes is oxidised to ferric iron by 
ferroxidases, such as, hephaestin and/or ceruloplasmin. In this process, ceruloplasmin, 
captures and oxidises two ferric ions. Following, ceruloplasmin binds to transferrin 
forming the ceruloplasmin–transferrin adduct. With transferrin and in the formed 
ceruloplasmin–transferrin adduct, two ferrous ions are transferred from ceruloplasmin 
to two C-lobes of two transferrins (Eid et al., 2014).  
 
Transferrin is the major extracellular iron binding protein, and the principal source of 
iron for tissues. It is a single chain bilobal protein with a molecular weight of 
approximately 80 kDa (Mizutani et al., 2012). Each lobe (termed N- and C-lobes) also has 
a single iron-binding site with an extremely high affinity for ferric iron (Kd = 10-23M) 
(Aisen et al., 1978). Despite this, the binding is reversible. The binding of ferric iron to 
transferrin requires carbonate as a synergistic anion (Harris, 2012) and causes the 
protein to undergo a conformation change from the “open” apotransferrin form to the 
“closed” holotransferrin form in which the ferric ions are buried deep within the each 
lobe (Mizutani et al., 2012). This acts to keep the iron in a soluble but redox inactive state 
so that it can be safely transported around the body. 
 
Transferrin is produced predominantly by the liver and is one of the most abundant 
proteins in the plasma, being present at 2–4mg/mL in humans (Anderson and Vulpe, 
2009). Under normal conditions, essentially all of the iron found in the circulation is 
bound to this protein, although it is typically only 30% saturated with iron (El Hage 
Chahine et al., 2012). This is possible because transferrin exists as four molecular forms: 
apotransferrin, monoferric A transferrin, monoferric B transferrin, and diferric 
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transferrin; but all transferrin bound iron can be considered physiologically as a single 
homogeneous pool  (Brissot et al., 2012). The additional iron binding capacity is thought 
to provide a buffer in the event of a sudden influx of iron into the circulation due to the 
iron absorbed from the diet, the iron recycled and released by reticuloendothelial 
macrophages, and the iron utilised by the bone marrow and other tissues. Despite this, 
the amount of iron in the circulation is maintained at a relatively constant level. Whether, 
circulating iron levels exceed the binding capacity of transferrin, highly toxic non-
transferrin bound iron (NTBI) can be formed. 
 
Non-transferrin bound iron 
 
Iron in the circulation exists in complex with three major proteins, transferrin, haem, and 
ferritin. Besides these plasma iron forms, another iron species, termed NTBI was 
originally identified by Hershko et al. (Hershko et al., 1978). NTBI is a heterogeneous 
group of potentially toxic iron complexes in plasma. The main form of NTBI could be 
ferric citrate, but albumin, which is present in high concentration in the plasma (close to 
40g/L), contains many negatively charged sites on its surface suitable for ferric iron 
binding (Brissot et al., 2012). Another special form of NTBI in plasma has been identified 
and it is defined by its ability to engage in redox cycling. This form has been termed labile 
plasma iron (LPI) (Cabantchik et al., 2005). Thereby, the exact nature of plasma NTBI 
remains to be determined. It is likely that different forms of plasma NTBI coexist and vary 
according to the degree of iron excess, to its duration, and to the aetiology. 
 
It is thought that NTBI play a major role in various pathological conditions that are 
dominated by iron overload. In humans, values of transferrin saturation >45% are 
consistent with iron overload (Hentze et al., 2010), which may even exceed 60%. Under 
these conditions, the levels of NTBI increase dramatically (up to 10–15 μM or higher) 
(Gkouvatsos et al., 2012). The liver is the most prominent site of NTBI deposition, 
although considerable amounts of NTBI accumulate in further tissues, such as pancreas 
and heart, leading to organ damage (Gkouvatsos et al., 2012). Cellular uptake of NTBI is 
mediated by several organ-specific transporters and receptors. NTBI-induced toxicity is 
the result of oxidative damage to various macromolecules by ROS (Brissot et al., 2012). 
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Haem iron transport 
 
Haemopexin 
 
Haem iron released into the portal circulation from enterocytes is likely caught by 
haemopexin in an equimolar way. This is a 57-kDa acute phase plasma glycoprotein 
produced by the liver with an extraordinarily high haem binding affinity (Kd 10-9 M). In 
plasma, haemopexin targets haem to the liver parenchymal cells for haem catabolism, 
iron storage, and re-distribution (Tolosano and Altruda, 2002), to the spleen (Cao et al., 
2014) and macrophages via the low density lipoprotein receptor-related protein/CD91 
(LRP/CD91) (Hvidberg et al., 2005). Its function is essential in iron homeostasis by 
recycling haem iron and against the deleterious effects of haem too. Thereby, free haem 
excess can cause cell damage and tissue injury since haem catalyses the formation of 
reactive oxygen species (ROS), resulting in oxidative stress (Chiabrando et al., 2014), and 
may also drive or amplify tissue inflammation (Lin et al., 2015). Both conditions might 
be suppressed by haemopexin, either through direct sequestering of free haem, or 
possibly indirectly through activation of HO-1 (Lin et al., 2015), since it is known that 
haemopexin mediates haem uptake and its degradation, through HO-1, to CO, bilirubin 
and iron (Sung et al., 2000). 
 
Albumin and other transporters 
 
In addition to haemopexin, haem can be attached with especially strong affinity to the 
most abundant protein in the blood serum (60% of the total protein content), albumin, 
allowing to store the haem in excess in blood serum (Guizado et al., 2012). However, 
during the first seconds after haem appearance in plasma, more than 80% of this 
powerful oxidiser binds to HDL and LDL, and only the remaining 20% binds to serum 
albumin and haemopexin. Serum albumin and haemopexin then slowly remove most of 
the haem from HDL and LDL (Ascenzi et al., 2005). Recently, a new haem binding protein 
with an affinity to haem comparable to that of albumin was discovered, α1- proteinase 
inhibitor (Karnaukhova et al., 2012). 
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Further, under pathological conditions, α1-microglobulin, a member of the superfamily 
of lipocalins, may cooperate to haem scavenging in extracellular fluid by binding and 
degrading haem (Ascenzi et al., 2005). 
 
1.1.3 Cellular uptake of iron 
 
Non-haem iron uptake 
 
Transferrin-dependent pathway 
 
Under physiological circumstances, the major iron uptake route utilised by most cells 
involves transferrin-bound iron and transferrin receptor (TfR) 1 (Hentze et al., 2010). 
Cells take up transferrin in proportion to the number of TfR1 located at the cell surface. 
This transmembrane glycoprotein forms a disulfide-bonded homodimer, which can bind 
one transferrin molecule at each of its subunits (Aisen, 2004). Interestingly, the iron 
status of transferrin impinges on its affinity for TfR1. Thereby, diferric transferrin binds 
with 30- and 500-fold higher affinity to TfR1, than monoferric and apotransferrin, 
respectively (Young et al., 1984). The holotransferrin/TfR1 complex is internalised by 
receptor-mediated endocytosis via clathrin-coated pits. Acidification of the endosome by 
a proton pump ATPase to pH 5.5 triggers a conformational change in transferrin 
resulting in the release of ferric iron (Klausner et al., 1983), while transferrin remains 
bound to TfR1. Before, ferric iron is reduced to ferrous iron by an endosomal 
ferrireductase, six transmembrane epithelial antigen of the prostate 3 (STEAP3) (Hentze 
et al., 2010), or by an novel mechanism involving cellular ascorbate (Lane and 
Richardson, 2014). Iron is then transported across the endosomal membrane to the 
cellular cytoplasm by DMT1 (Gunshin et al., 1997) or ZIP14 (Jenkitkasemwong et al., 
2012). This nascent cytosolic iron then becomes part of a poorly characterised chelatable 
or LIP and can be utilised for metabolism, stored in ferritin or released back to the 
extracellular space (Hentze et al., 2010). Finally, the apotransferrin/TfR1 complex 
returns to the cell membrane, where apotransferrin is recycled back to the bloodstream, 
available to recapture iron (see figure 3). 
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Figure 3. Cellular uptake of transferrin-bound iron. 
   Adapted from (Gkouvatsos et al., 2012) 
 
Non-transferrin-dependent pathway 
 
In iron overload states, such as hereditary haemochromatosis (HH), NTBI is thought to 
be a main contributor to tissue iron loading, but the molecular mechanisms remain 
poorly defined (Brissot et al., 2012). NTBI is accumulated in the circulation and 
transported to tissue parenchymal cells by transferrin-independent mechanisms 
(Brissot et al., 2012). Interestingly, as opposed to transferrin-dependent pathway, 
hepatocyte uptake of NTBI does not appear to be inhibited by increasing levels of liver 
iron (Baker et al., 1998). 
 
DMT1 was initially proposed to operate as a major NTBI transporter in the liver, which 
is the principal site of NTBI clearance (Trinder et al., 2000). A study conducted on human 
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hepatoma cells suggest a role for DMT1 in NTBI uptake (Shindo et al., 2006). Recently, it 
was proposed that ZIP14 transporter, also known as SLC39A14, has an important role in 
liver NTBI uptake based on that ZIP14 is most amply expressed in the liver, and that 
ZIP14 optimal pH is 7.5 (Liuzzi et al., 2006). In addition, a recent study found that in iron-
loaded rat liver, ZIP14 levels were up-regulated whereas DMT1 levels were markedly 
down-regulated, suggesting that ZIP14 plays more of a role than DMT1 in iron uptake 
(Nam et al., 2013). Interestingly, apart from its NTBI transporting activity, ZIP14 appears 
to also facilitate cellular assimilation of transferrin-bound iron in cells (Zhao et al., 2010). 
 
This iron uptake process may include cell surface reduction by ferrireductases such as 
DCYTB (McKie, 2008), or by effluxed reductants, such as ascorbate (Lane and 
Richardson, 2014). These enzymes reduce ferric NTBI to its ferrous state, which can be 
imported from the plasma membrane. 
 
Haem iron uptake 
 
Haemopexin pathway 
 
Free haem iron released into the circulation is caught by haemopexin, which targets 
haem to the liver parenchymal cells for haem catabolism, iron storage, and re-
distribution, and also to the spleen (Cao et al., 2014), and macrophages (Hvidberg et al., 
2005). Consistently, it has been found that the receptor responsible for capturing the 
haemopexin-haem complex, LRP/CD91, is expressed in a wide spectrum of cell types, 
including hepatocytes, macrophages, adipocytes, neurons and syncytiotrophoblasts 
(Moestrup et al., 1992). LRP/CD91 leads haemopexin-haem complexes to endocytosis 
and degradation of the haem iron (see figure 4), mainly in liver (Hvidberg et al., 2005). 
In this regard, it was shown in rats that more than 90% of intravenous-injected haem-
haemopexin was recovered in the liver within two hours (Potter et al., 1993) 
 
Uptake of haemopexin-haem complexes stimulates HO-1 transcription (Hvidberg et al., 
2005) in order to degrade haem in biliverdin, CO and free iron. Likely, the liberated iron 
from the endoplasmic reticulum enzyme HO-1 could be stored inside ferritin molecules. 
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Figure 4. Pathways for uptake of haemopexin-haem and haptoglobin-haemoglobin 
complexes. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
   Adapted from (Hvidberg et al., 2005) 
1.1.4 Iron stores 
 
The human body stores iron in the form of ferritin and haemosiderin in liver, spleen, 
marrow, duodenum, skeletal muscle and other anatomic areas. 
 
Ferritin 
 
Cellular iron in excess is stored as an iron oxide within ferritin core. This protein 
represents the most common and ancient molecule of iron homeostasis developed by 
organisms in the three domains of life (Archaea, Bacteria and Eukaryote). Its primary 
role is in iron sequestration in which it functions as a ferroxidase, converting Fe (+2) to 
Fe(+3). Thus, iron is internalised and sequestered in the ferritin mineral core, while a 
controlled release of the metal guarantees its availability for critical cellular processes 
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while protecting lipids, DNA, and proteins from the potentially toxic effects of iron. 
Thereby, storage and detoxification of iron represent the main functions of these 
molecules (Finazzi and Arosio, 2014). 
 
   Figure 5. Ferritin structure. 
 
 
 
 
 
 
 
 
 
Apoferritin, the iron-free form of the protein, forms a roughly spherical container of 
about 450 kd. within which ferric iron is stored as a ferrihydrite mineral in the 
holoferritin form. How iron is delivered to ferritin remains elusive, however, 
experimental evidence suggests the involvement of the cytosolic iron chaperone 
Poly(rC)-binding protein 1 (Shi et al., 2008). Channels in the ferritin shell may facilitate 
its entry and exit. The apoferritin shell in mammals is composed of 24 subunits with two 
functionally and genetically distinct ferritin types: light-ferritin (L-ferritin) and heavy-
ferritin (H-ferritin) (Knovich et al., 2009). In humans, their molecular masses are 19 and 
21 kDa, respectively. The heavy subunit is primarily responsible for the ferroxidase 
activity of the ferritin complex, whereas the light subunit facilitates the storage of iron 
into the ferritin core. The ratio of these subunits varies widely depending on tissue type, 
and can be modified by inflammatory and infectious conditions. Tissue ferritins vary 
from H-subunit rich (found mostly in the heart and kidney) to L-subunit rich (found 
predominantly in liver and spleen). The efficient storage of iron, up to 4500 iron atoms 
per ferritin, requires the cooperativity of both ferritin subunits (Alkhateeb and Connor, 
2010). 
 
Ferritin is also present extracellularly within the serum, where it serves as an important 
clinical marker of iron status. Despite its regular use in clinical medicine, the precise 
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source of serum ferritin (SF) has yet to be determined. It has been suggested that ferritin 
secretion may provide a mechanism to limit iron storage after a shift from high to low 
iron, and prior to activation of IRPs (Arosio et al., 2009). 
 
Haemosiderin 
 
Another form of stored iron in the cell is haemosiderin, insoluble degradation product of 
incomplete lysosomal breakdown of ferritin. In iron overloading conditions 
haemosiderin becomes the predominant iron storage protein. Under physiological 
conditions, haemosiderin is not an effective iron donor but plays a protective role. 
Subject to conditions such as inflammation and hypoxia it could become an iron donor 
promoting free radical production and tissue damage in iron overloaded cells (Tandara 
and Salamunic, 2012). 
 
Prolonged iron overload causes an accumulation of haemosiderin in the tissues, clinically 
manifested as haemosiderosis, and its severe form with damage of tissues 
haemochromatosis. 
 
1.1.5 Excretion and physiological losses 
 
Unlike most essential nutrients, no active excretory mechanisms exist for iron in humans. 
However, small amounts, around 1-2mg per day, are lost in healthy individuals via 
exfoliation of skin and gastrointestinal cells (1mg/day) and sweat (0.2-0.3mg/day), in 
urine (<0.1mg/day), hair, and bile. The losses are slightly more elevated in women of 
child-bearing age because of additional losses due to menstruation, pregnancy, and 
lactation (Geissler and Singh, 2011) (Gulec et al., 2014). Therefore, iron recycling, from 
senescent red blood cells by the reticuloendothelial cells in the spleen and the Kupffer 
cells in the liver, accounts for most of the iron homeostasis in human (Waldvogel-
Abramowski et al., 2014).  
 
Most iron retained in endothelial ferritin is likely lost via subsequent exfoliation of 
enterocytes into the gut lumen. Interestingly, a recent study described a protective role 
for ferritin H in the regulation of intestinal iron absorption during conditions of iron 
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overload. These authors showed that intestine-specific ferritin H deletion led to a twofold 
increase in iron absorption in iron-loaded mice, suggesting that ferritin H works to limit 
iron flux (Vanoaica et al., 2010). 
 
1.1.6 Regulatory proteins of iron metabolism 
 
A revolution occurred during the past decade in the comprehension of the physiology as 
well as in the pathophysiology of iron metabolism. Many proteins have been identified 
playing roles in iron homeostasis. Some of the most important are the following: 
 
Hepcidin 
 
Hepcidin (HEPatic bacteriCIDal proteIN) is a liver-derived 25 amino acid peptide 
identified as the systemic iron-regulatory hormone in 2000 (Krause et al., 2000) (Park et 
al., 2001). Chromosome 19 contains the hepcidin antimicrobial peptide (HAMP) gene, 
which codes for hepcidin. It codes for the 84 amino acid precursor, preprohepcidin, 
which subsequently undergoes two enzymatic cleavages in the hepatocyte cytoplasm 
and in the blood, to liberate the 25 amino acids containing the biologically active form 
(hepcidin25) (Kali et al., 2015). Its expression is induced when body iron stores are 
elevated, and during infection or inflammation, with the net result being lower serum 
iron levels. On the contrary, it is also known that ID, hypoxia and the erythropoietic 
demand, reduces hepcidin levels in order to increase iron availability for the production 
of red blood cells (Evstatiev and Gasche, 2012). 
 
The role of hepcidin in iron homeostasis is to control the level of iron efflux from three 
key cell-types into the circulation: a) iron efflux into the portal circulation from duodenal 
enterocytes in dietary iron absorption; b) the release of recycled iron from macrophages; 
and c) iron release from hepatocytes (Lane et al., 2015). Hepcidin reduces the non-haem 
iron absorption from the intestinal enterocytes by binding to the only known cellular 
non-haem iron exporter, FPN (De Domenico et al., 2007), and possibly by inducing the 
proteasomal-mediated degradation of the brush-border membrane receptor, DMT1  
(Brasselagnel et al., 2011). In addition, Cao et al. observed that hepcidin expression has 
also an impact in the variation of haem  absorption (59%), although had a greater relative 
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impact on non-haem iron absorption (63%)  (Cao et al., 2014). The hepcidin-ferroportin 
interaction also explains the regulation of reticuloendothelial recycling of iron, by 
decreasing iron efflux into the plasma following the phagocytic turnover of effete 
erythrocytes, and the iron release from hepatocytes (Lane et al., 2015). 
 
Hepcidin expression is regulated by a cohort of proteins, including the HH protein called 
HFE, TfR2, and hemojuvelin (HJV), that can sense the circulating levels of iron and relay 
these messages through signal transduction pathways to the nucleus to regulate hepcidin 
transcription. Disruption of any one of these proteins results in inappropriate regulation 
of hepcidin expression and consequently causes either iron overload or ID (Zhang, 2010). 
In recent years, the bone morphogenetic protein-transcription factors SMAD (BMP–
SMAD) pathway has been demonstrated as the predominant pathway responsible for 
regulating HAMP in response to iron (Rishi et al., 2015). It has been seen that in 
hepatocytes, BMP6 levels correlate with iron stores (Corradini et al., 2011), but a more 
complicated regulation of BMP6 was suggested (Enns et al., 2013) (Feng et al., 2012). In 
fact, the ‘iron sensing’ role of the liver could be a function of multiple cell types, especially 
the liver sinusoidal endothelial cells  (LSECs) and hepatic stellate cells  (HSCs) but also 
hepatocytes, which may sense the iron levels and respond by releasing BMP6 (Enns et 
al., 2013). This initiates a cascade of events in hepatocytes leading to the production of 
hepcidin. This intercellular crosstalk seems to be one of the mechanisms mediating 
BMP6 upregulation in response to iron, but the actual molecular pathways underlying 
the production of BMP6 in response to either serum iron or liver iron stores still remain 
to be identified (Rishi et al., 2015). 
 
HFE 
 
The HFE gene was discovered in 1996 and belongs to the major histocompatibility 
complex 1 family (Feder et al., 1996). The most common form of HH, type I or also called 
classical haemochromatosis, arises from mutations in HFE. This gene encodes the HFE 
protein, which is believed could interact with TfR2 in order to sense the iron levels. 
 
Early studies linked the HFE protein to iron metabolism by identifying an interaction 
with TFR1 (Feder et al., 1998). With increasing levels of holotransferrin, HFE is displaced 
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from the HFE–TFR1 complex, a step thought to be important for initiating a signalling 
cascade that results hepcidin transcription (Schmidt et al., 2008). According to this 
model, HFE association with TfR1 is inversely proportional to transferrin-iron 
saturation. If serum holotransferrin levels increase, HFE is displaced from TfR1 to allow 
its interaction with TfR2, linkage stabilised by holotransferrin binding. The 
holotransferrin/HFE/TfR2 complex then stimulates hepcidin expression through an 
incompletely understood pathway, which requires functional HJV (D’Alessio et al., 2012). 
It has been proposed that the complex potentiates BMP and/or Mitogen-activated 
protein kinases (MAPK) pathway signalling (Gao et al., 2009) (Ramey et al., 2009) but 
further work is needed to delineate the molecular interactions involved in this process 
(Ganz and Nemeth, 2012). 
 
Transferrin receptor 2 
 
TfR2 is a type II transmembrane glycoprotein, member of the TfR family and homologous 
to TFR1. Its expression is restricted to the hepatocytes and erythroid precursors. The 
stabilization of TfR2 by holotransferrin and its ability to bind HFE led to the current 
model in which liver TfR2, in conjunction with HFE, represents a sensor of circulating 
iron and activates hepcidin in response to elevated transferrin saturation (Silvestri et al., 
2014). 
 
In humans inactivating mutations of TfR2 lead to haemochromatosis type 3, a rare 
recessive disorder characterised by iron overload and low hepcidin levels (Nemeth et al., 
2005). 
 
Hemojuvelin 
 
Hemojuvelin, encoded by the HJV gene and also called HFE2, is a membrane protein 
responsible for the iron overload condition known as juvenile haemochromatosis, a 
severe form of hereditary disease (Silvestri et al., 2007). One insight into the 
pathogenesis of juvenile haemochromatosis is that patients have low to undetectable 
urinary hepcidin levels, suggesting that HJV is a positive regulator of hepcidin (Dunn et 
al., 2007). 
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It has been reported that HFE, HJV, TfR2 and HAMP genes are closely related, but the 
precise underlying mechanisms were not revealed (Steele et al., 2005). A recent study 
found a direct biochemical evidence that HJV, TfR2 and HFE form a protein complex, and 
that HJV competes for HFE/TfR1 interaction with similar efficiency as TfR2. These data 
also directly implicate the BMP co-receptor, HJV, and possibly HJV/BMP/SMAD 
signalling in HFE/TfR2-dependent hepcidin regulation (D’Alessio et al., 2012). 
 
Proteins involved in the intracellular iron balance 
 
Cellular iron metabolism is controlled by iron regulatory proteins (IRP) 1 and IRP2 
(Anderson et al., 2012). In iron-deficient cells, both IRPs interact with iron-responsive 
elements (IREs), a stem-loop structure, in the 5’-untranslated region (UTR) of the ferritin 
H- and L-chain, as well as FPN, transcripts in order to inhibit their translation. In contrast 
to ferritin and FPN, IRPs binding to the IRE in the 3’-UTR region of the TfR1 and DMT1 
mRNAs prevent their degradation, and, thereby, cells increase the iron uptake. In cells 
with elevated iron levels, the translation of ferritin and FPN increase, while TfR1 and 
DMT1 translation is reduced (see figure 6), in order to decrease free iron levels within 
the cell (Anderson et al., 2012). 
 
The humoral regulation by hepcidin and cell-autonomous local control by the IRP/IRE 
systems intersect at the level of enterocytes, and both must function properly for 
adequate regulation of key iron absorption molecules in the duodenum (Anderson et al., 
2012). 
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Figure 6. The role of iron regulatory proteins in iron homeostasis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Adapted from (Torti and Torti, 2013) 
 
One obvious point of intersection between the cellular IRP/IRE system and the systemic 
regulator hepcidin is FPN. The presence of an IRE in the 5’-UTR of the mRNA encoding 
the hepcidin target, FPN, would predict FPN translation to be inhibited when enterocytes 
are iron deprived, which seems inconsistent with the observed augmentation of 
duodenal FPN levels in ID (McKie et al., 2000). This apparent contradiction has been 
explained by the expression of intestinal FPN mRNA isoforms that lack the 5’-UTR IRE 
and thus evade translational repression by the IRPs (Zhang et al., 2009). In contrast to 
FPN, IRPs would exert a positive effect on DMT1 mRNA expression via its 3’-UTR IRE. 
Inhibition of FPN-mediated iron export by hepcidin would increase iron levels within 
Ferritin, 
FPN 
Ferritin, 
FPN 
DMT1, 
TfR1 
DMT1, 
TfR1 
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enterocytes, reducing IRP activity, and thus decrease DMT1 mRNA levels, and thereby, 
intestinal iron absorption. However, a study in mice with intestinal IRP deficiency found 
that they retain their ability to upregulate DMT1 upon stimulation of erythroid iron 
requirements (Anderson et al., 2012). Further research is warranted in order to elucidate 
this topic. 
 
Moreover, HIF2α expression in enterocytes mediates the transcriptional upregulation of 
DMT1 in the duodenum of mice fed an iron-deficient diet (Taylor et al., 2011). How 
exactly changes in body iron needs are conveyed to the HIF2α pathway in intestinal 
epithelial cells remains incompletely understood. Additional research is also required in 
order to clarify this issue. 
 
1.1.7 Dietary factors 
 
The composition of a diet has important effects on iron bioavailability, particularly with 
regard to non-haem iron. A recent systematic review and meta-analysis showed a large 
variation in non-haem iron absorption (0.7-22.9%) according to the iron status, but also 
according to the dietary content of enhancers and inhibitors of iron absorption (Collings 
et al., 2013). 
 
It is well known that haem-iron absorption is relatively unaffected by other dietary 
factors that are common inhibitors of non-haem iron and other mineral absorption, such 
as phytates. However, recent evidence suggests that certain dietary factors may play an 
important role on haem-iron bioavailability. 
 
1.1.7.1 Enhancers of iron absorption 
 
Ascorbic acid/ascorbate/vitamin C 
 
Accumulating evidence strongly suggests an ability of dietary ascorbate to enhance non-
haem iron absorption in the gut in a dose-dependent manner (Cook and Reddy, 2001). 
The enhancing effect is largely due to its ability to reduce ferric to ferrous iron, but is also 
due to the possibility of forming a soluble complex with ferric ion (López and Martos, 
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2004). Ascorbic acid will overcome the negative effects on iron absorption of all 
inhibitors, which include phytate (Hallberg et al., 1989), polyphenols (Siegenberg et al., 
1991) (Kim et al., 2011b), and dairy calcium and proteins (Stekel et al., 1986). Cooking, 
industrial processing, and storage degrade ascorbic acid and remove its enhancing effect 
on iron absorption (Teucher et al., 2004). 
 
In addition to the known ability of dietary ascorbic acid to enhance non-haem iron 
absorption in the gut, ascorbic acid can also modulate cellular iron metabolism; iron 
transport, by increasing transferrin-dependent and non-transferrin-dependent iron 
uptake; and iron stores, stimulating ferritin synthesis, inhibiting lysosomal ferritin 
degradation, and decreasing cellular iron efflux (Lane and Richardson, 2014). 
 
Besides of non-haem iron, a recent experimental study in Caco-2 cells found that ascorbic 
acid markedly enhanced haem iron transport across the cell monolayer without altering 
the apical uptake of haem, indicating that ascorbic acid may affect cellular or basolateral 
events that increase haem-derived free iron export (Ma et al., 2011). This study also 
showed that the addition of 100μmol/L ascorbic acid completely reversed the inhibitory 
action of dietary polyphenols on haem iron absorption when the polyphenolic 
compounds were added at 0.46mg/L concentrations. When the concentrations of 
polyphenols were increased above 4.6mg/L, ascorbic acid was not able to counteract the 
inhibitory action of polyphenols on haem iron absorption, although the inhibition was 
reduced. However, ascorbic acid failed to have any positive effect on haem iron 
absorption when the polyphenols were added at a high (but still within physiological) 
level of 46mg/L. These results imply that, while the inhibitory effect of low 
concentrations of bioactive polyphenols on haem iron absorption can be easily 
counteracted by ascorbic acid, the inhibitory action of high concentrations of 
polyphenolic compounds cannot be offset by regular consumption of dietary ascorbic 
acid (Ma et al., 2011). Further research is required to confirm these observations. 
 
“Meat factor” 
 
The enhancing effect of meat and fish on non-haem iron absorption is well documented. 
For instance, in a 5 days study an intake of 60g of pork meat resulted in an increased 
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fractional non-haem iron absorption. Total iron absorption was significantly increased 
from meat diets compared to the non-meat diets, resulting in a 50–70% increase in total 
iron absorption (Bach Kristensen et al., 2005). 
 
However, the identification of the meat component, ‘‘meat factor’’, involved in this effect 
remains elusive. Several candidates have been proposed such as some amino acids 
(Martinez-Torres and Layrisse, 1970), peptides (Hurrell et al., 2006), the L-a-
glycerophosphocholine (Armah et al., 2008), and  some glycosaminoglycans (Huh et al., 
2004) (Laparra et al., 2009). 
 
Alcohol 
 
Although alcohol consumption does not directly affect iron absorption, it has been shown 
its indirect action. Consumption of up to two alcoholic drinks/day or more was 
associated with an increase in the risk of iron overload (Ioannou et al., 2004). In this 
sense, low amounts of alcohol consumption increased serum iron and ferritin levels and, 
therefore, body iron stores (Whitfield et al., 2001). It seems that the acute or chronic 
alcohol exposure suppresses the expression of hepcidin in the liver, leading to a higher 
iron absorption (Bridle et al., 2006) (Harrison-Findik et al., 2006) (Ohtake et al., 2007) 
(Flanagan et al., 2007) (Harrison-Findik, 2007)  (Harrison-Findik et al., 2007) (Harrison-
Findik, 2009). Furthermore, it has been found that the intestinal iron absorption 
increases two-fold in chronic alcoholics, possibly secondary to changes in the intestinal 
permeability (Duane et al., 1992). 
 
Other enhancers of iron absorption 
 
Organic acids 
 
Although less well studied than ascorbic acid, several other organic acids, such as citric, 
malic and tartaric acids, appear to have comparable enhancing effects on non-haem iron 
absorption (Lynch, 1997). 
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Vitamin A/β-carotenes 
 
The influence of vitamin A on non-haem iron absorption remains largely unknown. While 
some earlier reports found that vitamin A improved iron absorption (García-Casal et al., 
1998), subsequent studies did not confirm this findings (García-Casal et al., 2000) 
(Walczyk et al., 2003) (Chen et al., 2014).  
 
Regarding β-carotenes, some reports observed an increased non-haem iron absorption 
in presence of β-carotene (García-Casal et al., 1998) (García-Casal et al., 2000) (García-
Casal and Leets, 2014), by a mechanism not yet elucidated. 
 
Sugars 
 
It has been suggested that sugars, such as fructose, could increase iron bioavailability in 
human (Christides and Sharp, 2013). These results are consistent with a previous works 
conducted in rodent animal models in which iron-fructose solutions increased gut iron 
absorption (Pollack et al., 1964). Further studies are warranted to examine these issues. 
 
1.1.7.2 Inhibitors of iron absorption 
 
Phytate/phytic acid 
 
Phytate, myo-inositol hexakisphosphate, is a component of cereals that inhibits iron 
absorption (Andrews et al., 2014). The negative effect of phytate on iron absorption has 
been shown to be dose dependent and starts at very low concentrations of 2–10mg/meal 
(Hallberg et al., 1989). Heat treatment, milling, soaking, germination, and fermentation, 
can remove or degrade phytate and thereby improve iron absorption (Hurrell, 2004). 
 
Fibre 
 
Traditionally a negative effect on mineral absorption has been attributed to fibre due to 
its capacity to bind cations. In this sense, an in vitro study has demonstrated that soluble 
fibre, such as pectin, carrageenan and xanthan gum, presented a great response for 
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binding cations (Debon and Tester, 2001). However, other experiments with pectin and 
guar gum in human and animal models (Torre et al., 1991) have concluded that soluble 
dietary fibre does not have a significant effect on mineral bioavailability. These 
discrepancies in the role of fibre on mineral availability have been also reported by 
recent papers. Thus, an experimental study showed that soluble fibre pectin did not 
cause a reduction in intestinal iron absorption (Feltrin et al., 2009). However, a 
subsequent published study found a slight decrease in iron uptake (Andrews et al., 2014). 
 
Otherwise, fructo-oligosaccharides, a component of the dietary fibre fraction found in 
trace amounts as natural components in fruits, vegetables, barley, garlic, honey, onion, 
and chicory, effectively enhances the mineral absorption rate, such as iron, and 
counteracts the deleterious effects of phytic acid (Wang et al., 2010b). 
 
Calcium  
 
Dietary calcium is known to reduce the bioavailability of non-haem iron. Many studies 
observed a reduction of 50-60% on iron absorption at doses of 300-600mg calcium 
(Hallberg et al., 1991) (Benkhedda et al., 2010). This effect seems to have a direct dose-
dependent relationship (Hallberg et al., 1991), although the molecular basis of this 
interaction is not completely understood. Calcium is a low-affinity non-competitive 
inhibitor of DMT1, explaining in part the effect of high dietary calcium on non-haem iron 
bioavailability  (Shawki and Mackenzie, 2010). In addition, it was seen that calcium 
reduces iron bioavailability by decreasing DMT1 expression at the apical cell membrane, 
thereby downregulating non-haem iron transport into the cell (Thompson et al., 2010). 
 
Other divalent minerals, such as zinc (Olivares et al., 2007a) (Olivares et al., 2012) and 
magnesium (Wallace et al., 1998), may decrease iron absorption through the DMT1. 
However, this data was not confirmed in subsequent studies (Snyder and Clark, 1999) 
(Olivares et al., 2007b). 
 
Calcium also has been shown to have negative effects on haem iron absorption, in 
addition to non-haem (Hallberg et al., 1991) (Hallberg et al., 1993). The same amount of 
calcium, around 165 g, also significantly reduced about 50-60% haem iron absorption. 
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The observed marked inhibitory effect on iron absorption of calcium in amounts 
frequently encountered in normal meals has important nutritional implications 
(Hallberg et al., 1991).  
 
Polyphenols 
 
Other dose-dependent common inhibitors of non-haem iron absorption are polyphenols 
(Morock et al., 1983) (Kim et al., 2011b). Epidemiological studies showed that 
polyphenolic-containing beverages such as black tea, coffee and cocoa, are potent 
inhibitors of non-haem iron absorption (Hurrell et al., 1999). Hurrell et al. report that the 
polyphenolic content typical in a cup of instant coffee reduces iron absorption from a test 
meal by 60% to 90% (Hurrell et al., 1999). Among elderly participants in the 
Framingham Heart Study, each 236mL/wk (1 cup per week) of coffee consumed was 
associated with 1% lower SF concentrations (Fleming et al., 1998). 
 
It was observed that polyphenols, such as chlorogenic acid (Hurrell et al., 1999), the main 
phenolic compound in coffee; tannic acid (Jaramillo et al., 2015), present also in coffee, 
tea, cocoa and wine; quercetin (Lesjak et al., 2014), the most abundant dietary flavonoid 
in onions, tea and apples; and other, decreases the fasting bioavailability of non-haem 
iron. In addition, experiments in the Caco-2 cells (derived from colon cancer cells) have 
shown that a molar ratio 1:0.1 of iron:tannic acid produced a 92% inhibition of iron 
uptake, indicating that tannic acid may be a potent inhibitor (Glahn et al., 2002). 
 
The exact mechanism implicated in the polyphenol dependent iron bioavailability 
remains elusive, but authors suggested that these compounds enhance apical iron uptake 
partially by reducing ferric to ferrous ion and by increasing the uptake of polyphenol-
iron complexes via an energy-independent pathway, and decrease the basolateral iron 
release  (Kim et al., 2011b). 
 
Besides of non-haem iron, an early study indicated that haem iron absorption decreased 
due to the consumption of tea in humans (Disler et al., 1975), and this finding was 
confirmed by Ma et al. in a subsequent study (Ma et al., 2010). The same research group 
found that green tea catechin, (-)-epigallocatechin-3-gallate and grape seed extract, 
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inhibit haem iron absorption in a dose-dependent manner in human intestinal cells (Ma 
et al., 2011). They suggested that haem iron inhibition affects transport across the 
enterocyte by decreasing basolateral iron export, possibly by forming non-transportable 
complexes with iron in the cell. However, the precise mechanism by which bioactive 
dietary polyphenolic compounds inhibit haem iron absorption remains to be elucidated. 
 
Animal and vegetal protein 
 
In vitro model (Caco-2 cell line) found that animal and vegetable protein in general 
decreased haem iron uptake (Villarroel et al., 2011). This study showed that intact haem 
uptake was higher than haem plus albumin or digested haem plus albumin, but lower 
than digested haem. In addition, haem iron uptake decreased in the presence of all 
legume extracts. Previously, casein in milk has already been shown to reduce haem iron 
bioavailability (Hallberg et al., 1993). However, the results were not consistent, since 
pure animal (collagen and casein) and vegetable (zein and glutelin) proteins increased 
hemin iron uptake, a by-product from haem. 
 
1.1.8 Biological factors 
 
Body iron levels are principally controlled by modulation of iron absorption in the 
duodenum and proximal jejunum, which allows absorption to be precisely matched to 
body iron needs. In addition to body iron levels, absorption is also accurately regulated 
by hypoxia, erythropoiesis, pregnancy, and in the suckling period (Gulec et al., 2014). 
 
Stores regulator 
 
Iron absorption is stimulated when body iron stores decrease, and conversely, at high 
iron levels absorption is reduced. In this sense, a study observed that both iron status 
and modifiers of dietary iron absorption have a large effect on percentage absorption, 
with absorption values ranging from 13.9% to 23.0% when SF concentrations were 
6µg/L. However, with higher iron status, absorption was very much reduced, ranging 
from 1.8% to 3.0% with a SF concentration of 100mg/L (Collings et al., 2013). 
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Erythroid regulator 
 
Although overall physiological requirements for iron have influence in iron absorption, 
iron demand to support haemoglobin production in developing erythrocytes in the bone 
marrow is the strongest stimulator of this process, since it requires large amounts of iron. 
Iron absorption thus increases when the erythropoietic rate is high, resulting from blood 
loss or acute haemolysis, and decreases in the reverse situations (Gulec et al., 2014). 
 
Hypoxia 
 
Iron absorption also increases in response to tissue hypoxia. While in part this may relate 
to changes in the erythropoietic rate, a component of the response relates specifically to 
oxygen levels (Raja et al., 1988). In this regard, it has been found that iron absorption 
increased during hypoxia previously to increase of erythrocytes production (Hathorn, 
1971), demonstrating that hypoxia exerts a direct effect on the gut. Consistent with this 
observation, iron regulatory molecules in the liver and genes encoding iron transporters 
in the duodenum respond directly to hypoxia (Peyssonnaux et al., 2007). 
 
Pregnancy and suckling period 
 
Iron absorption also increases during pregnancy. During gestation, iron requirements 
are high due to expansion of the maternal erythroid mass and the iron needed by the 
developing foetus. The cause probably relates to both a reduction in maternal iron stores 
and a relative tissue hypoxia. Moreover, during the perinatal and neonatal periods, iron 
requirements of humans are high, and iron absorption from breast milk is very efficient. 
The high iron absorption of neonates appears to be predominantly due to active 
transport mechanisms, as occur in adults, but the relative permeability of the neonatal 
epithelium, which allows passive absorption of solutes, likely contributes to greater 
absorption of iron (Gulec et al., 2014). 
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1.2 IRON INTAKE AND IRON STATUS IN POPULATION 
 
1.2.1 Dietary iron intake recommendations 
 
Intake recommendations for iron are provided in the Dietary Reference Intakes (DRIs) 
developed by the Food and Nutrition Board (FNB) at the Institute of Medicine (IOM) of 
the National Academies (Institute of Medicine et al., 2001). DRI is the general term for a 
set of reference values used for planning and assessing nutrient intakes of healthy people 
(see figure 7). These values, which vary by age and gender, include: 
 
Figure 7. Relationship between individual intake and risk of adverse effects due to 
insufficient or excessive intake. 
 
Adapted from (Arija et al., 2015) 
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 Recommended Dietary Allowance (RDA): average daily level of intake sufficient to 
meet the nutrient requirements of nearly all (97%–98%) healthy individuals. 
 
 Adequate Intake (AI): established when evidence is insufficient to develop an RDA; 
intake at this level is assumed to ensure nutritional adequacy. 
 
 Estimated Average Requirement (EAR): average daily level of intake estimated to 
meet the requirements of 50% of healthy individuals. It is usually used to assess the 
adequacy of nutrient intakes in population groups but not individuals. 
 
 Tolerable Upper Intake Level (UL): maximum daily intake unlikely to cause adverse 
health effects. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Dietary reference intakes (DRIs) for iron by life stage 
group (mg/day). 
  EARa RDAb AIc ULd 
  Males Females Males Females     
0 - 6 months     0.27 40 
7 - 12 months 6.9 6.9 11 11  40 
1 - 3 years 3.0 3.0 7 7  40 
4 - 8 years 4.1 4.1 10 10  40 
9- 13 years 5.9 5.7 8 8  40 
14 - 18 years 7.7 7.9 11 15  45 
19 - 30 years 6.0 8.1 8 18  45 
31 - 50 years 6.0 8.1 8 18  45 
51 - 70 years 6.0 5.0 8 8  45 
> 70 years 6.0 5.0 8 8   45 
Pregnancy       
≤ 18 years  23  27  45 
19 - 50 years   22   27   45 
Lactation       
≤ 18 years  7  10  45 
19 - 50 years   6.5   9   45 
aEAR: Estimated Average Requirement 
bRDA: Recommended Dietary Allowance 
cAI: Adequate Intake 
dUL: Tolerable Upper Intake Level. Unless otherwise specified, the UL represents total 
intake from food, water and supplements 
Source: Institute of Medicine 2001 
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When adequate information is available, each nutrient has a set of DRIs. A nutrient has 
either an EAR and a RDA or an AI. When an EAR for the nutrient cannot be determined 
(therefore, neither can the RDA), then an AI is set for the nutrient. In addition, many 
nutrients have a UL (Institute of Medicine et al., 2001). 
 
In order to prevent ID, RDAs were taken as a reference. Table 2 lists the current iron 
RDAs for non-vegetarians. The RDAs for vegetarians are 1.8 times higher than non-
vegetarian people who eat meat, due to lower iron bioavailability in plant based food 
regarding animal foods. 
 
In 1985, Moreiras et al. established the first values of recommended intakes for Spanish 
population, and its last update was in 2009 (see table 3)  (Moreiras et al., 2009). 
Recommended Intakes (RIs) are reference standards for intake of energy and nutrients 
such as iron in order to maintain the health of virtually all healthy individuals in 
population. They are estimated for groups of age, gender, and physiological condition of 
pregnancy and lactation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Reference Intakes (RIs) for 
Iron in Spanish Population (mg/day). 
  RDAa 
  Males Females 
Age Group   
0 - 5 months 7 7 
6 months - 1 year 7 7 
2 - 3 years 7 7 
4 - 5 years 9 9 
6- 9 years 9 9 
10 - 12 years 12 18 
13 - 15 years 15 18 
16 - 19 years 15 18 
20 - 39 years 10 18 
40 - 49 years 10 18 
50 - 59 years 10 10 
> 60 years 10 10 
Pregnancy (2nd half)  18 
Lactation   18 
aRDA: Recommended Dietary Allowance 
Source: Moreiras et al. 2009 
UNIVERSITAT ROVIRA I VIRGILI 
IRON EXCESS AND RISK OF TYPE 2 DIABETES MELLITUS IN A PROSPECTIVE COHORT OF MEDITERRANEAN POPULATION 
José Cándido Fernández Cao 
Introduction 
51 
 
Iron recommendations in children, men and women are similar in both, Spanish RIs and 
DRIs of IOM but there is an important difference in pregnancy, and perinatal stage. Thus, 
iron DRIs for pregnant women are 27mg/day, much higher than IRs (18mg/day). 
Regarding lactation, iron DRIs are between 9 and 10mg/day, while IRs are 18mg/day. In 
addition, DRIs for the first months of new-born are 0.27mg/day versus 7mg/day in RIs. 
 
1.2.2 Methods for assessing dietary intake 
 
Several methods for assessing dietary intake allow examining the food consumption, 
energy and nutrient intake in collective or individual level. These methods provide us 
with important information about the frequency of food consumption and/or the 
quantity of food, energy and nutrient intake. Therefore, it enables us to identify 
inadequate diets and nutritional status, to assess and monitor nutritional health, and to 
examine trends and changes in dietary patterns of the population. Dietary food 
information could be obtained in three levels (table 4) (del Pozo de la Calle et al., 2015): 
 
 
 
 
 
 
Table 4. Methods for assessing dietary intake. 
  Method Find out differences between 
National 
surveys 
Food Balance Sheets Countries and regions worldwide 
Family surveys 
Household budget surveys 
Country, locality, seasonal, 
household Household surveys: shopping 
basket 
Individual 
surveys 
The weighing method Geographics, seasonal and 
demographics subgroup and 
individuals 
Food frequency questionnaire 
24-hour recall 
Diet history 
Temporary and demographics 
subgroup and individuals 
Source: del Pozo de la Calle et al. 2015 
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 National level: using the Food Balance Sheet based on data provided by the Ministry 
of Agriculture. This method allows knowing the food availability in a country. 
 
 Familiar level: by household budget surveys or family record or diary. 
 
 Individual level: using dietary survey from which cross-section information is 
obtained to assess dietary intake (Gibson, 2005). A wide variety of dietary survey 
methods exists, the most used are: food frequency questionnaire (FFQ), 24-hour 
recall, food record, diet history, screener and brief assessment methods. 
 
Food Frequency Questionnaire 
 
FFQ is a dietary assessment tool that is highly used in epidemiological studies to examine 
the relation between dietary intake and disease or health outcomes. It is a retrospective 
and direct method to estimated food consumption by which global dietary information 
is obtained from a certain period of time (i.e. last 3 months or last year). Briefly, this 
method consists in asking how often and how much food items are consumed over a 
reference period (Martin and Gorgojo, 2007). This method enables to classify the 
participants that show a high or low consumption of certain food (Martin and Gorgojo, 
2007). Actually, FFQs may be designed to focus on whole diet or on particular group of 
foods or nutrients such as iron. Also, sometimes they are designed to be administered to 
specific population groups such as elderly (Huybrechts et al., 2007). 
 
This method can be self-administered, on paper or web-based, or interview administered 
(face-to-face or by telephone). More complete data may be collected if the FFQ is 
administered by an interviewer; although self-administered questionnaires may reduce 
respondent bias (Pérez Rodrigo et al., 2015). 
 
There are three types of FFQ: 
 
 Qualitative FFQs are those that only ask about frequency of food consumption, not 
about the size of consumed portions. 
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 Semi-quantitative FFQs include standard portions or reference portion sizes for each 
item and respondents are asked how often they consume the specified portion of a 
particular food item. 
 
 Quantitative FFQs ask respondents to estimate either in grams or household 
measures the size of the portions consumed (Pérez Rodrigo et al., 2015). 
 
The FFQ shows several strengths. They assess food consumption over a wide period and 
enable us to estimate the usual intake. These questionnaires are highly cost-effective, 
easy and fast administration since they have a standard format; therefore, they are 
widespread used in large epidemiological cohort studies. This method implies low 
respondent load compared to other methods, and this increases the cooperation and 
participation. Moreover, being a retrospective method, the habitual consumption is not 
influenced. They show a considerable validity and accuracy to estimate the dietary intake 
(Arija, 2014). Furthermore, FFQ requires less nutrition knowledge in data entry 
compared to other food consumption assessment methods and therefore do not require 
trained professionals (Pérez Rodrigo et al., 2015). 
Despite these advantages, several drawbacks exist. Firstly, there is high complexity in 
designing these questionnaires or their validation, which involve systematic errors and 
biases in dietary intake estimates (Pérez Rodrigo et al., 2015). It could produce 
inaccuracies in the result from an incomplete listing of all possible foods and from errors 
in frequency and usual portion size estimations. However, a comprehensive and 
complete list of all foods cannot be included since the length of questionnaire influence 
on accuracy of the dietary report, for instance, over-estimation increases. Other 
limitation is the inaccuracies in the dietary report due to respondent memory. In 
addition, respondent should have a relatively high degree of literacy and numeracy skills 
are required if self-administered.  
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24-hour dietary recall 
 
The 24-hour dietary recall method is one of the most widely used methods in nutrition 
epidemiology. It is an open interview, retrospective and quantitative method that 
examines the food consumption of the previous 24 hours. This method consists in a 
direct interview and currently can also be self-administered using computer 
programmes (Salvador et al., 2015). The estimated average interview time is about 20 to 
30 minutes. 
 
The method consists of describing and quantifying the consumption of foods and 
beverages consumed in the previous 24 hours, from the first intake in the morning until 
the last intakes at night (Beaton et al., 1983). The information should describe the type 
of food and its characteristics, the amount consumed, method of preparation, sauces 
used, dressings or condiments to add, or accompanied food, as well as the time and place 
of consumption. 
 
The method requires several support tools such as examples of dishes, volumes and 
household measures, drawings or photographic models or three dimensional 
representations. Contribution of novel technologies could be helpful to obtain an 
accurate assessment of food consumption (Salvador et al., 2015). This method involves 
professional trained interviewers who should have dietetic and nutrition knowledge and 
be familiarised with the eating habit of the study population to be able to estimate and 
record accurate information of daily food consumption. Also, the interviewer should 
attempt not to influence on the interviewee answers (Salvador et al., 2015). Once the 
food consumption information is recorded, this should be analysed with a database to 
obtain grams of food, nutrients and energy intake per day using food composition tables. 
 
One single 24-hour dietary recall does not typically estimate usual intake. A minimum of 
two or five days of 24-hour dietary recalls is needed to examine usual dietary intake. In 
common practice two or three days of 24-hour recall are used and they must be carried 
out on non-consecutive days including a weekend day (Serra-Majem et al., 2006) (Martin 
and Gorgojo, 2007). This period of time involved acute dietary information without 
diminishing the participation. Otherwise, 24-hour recall during more days (i.e. 7 days) 
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could reduce the participation. Also, it is better to administer in different periods of time 
of the year so as to examine seasonal variation (Arija, 2014). 
 
The 24-hour recall is easy and quick method with low cost and high precision. Response 
rate is high since its administration does not require so much time and could be 
administered to low literacy population. Moreover, the habitual food consumption of the 
participant is not altered since it is a retrospective method. Serial recalls can estimate 
the usual intake at the individual as well as the community levels (Serra-Majem et al., 
2006)(Martin and Gorgojo, 2007) (Shim et al., 2014). 
 
Nevertheless, this method show several limitations. Thus, it depends on the recent 
memory of the interviewee. Therefore, 24-hour recall is not recommended for the elderly 
or children less than 12 years. In addition, the accuracy of this method is influenced by 
the capacity of interviewee to refer food information. For instance, women and 
individuals who follow a diet tend to specify more exactly the dietary information than 
men or individuals who not follow a diet. Moreover, the “Flat slope syndrome” is 
described as the tendency to overestimate low intakes and underestimate high intakes. 
Underestimated intake is often in the elderly, children, and obese people or with 
unhealthy eating habits (for instance alcohol or fat excess intake) (Salvador et al., 2015). 
 
Dietary record 
 
The dietary record is a prospective and quantitative method in which the subject records 
all the foods and beverages consumed and its amounts over a specific period of time, 
usually between 3-7 days (Thompson and Byers, 1994). 
 
This method usually record detailed information about portion size, food preparation 
methods, ingredients of mixed dishes and recipes, and even the brand name of 
commercial products. Therefore, the participant should be specifically trained to be able 
to describe adequately these items. At the end of the recorded period, a trained 
interviewer should review the dietary record with the participant, in order to clarify any 
doubts or ask by possible forgotten foods consumed (Ortega et al., 2015). There are two 
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main types: dietary record by household measures or by estimation, and dietary record 
by weight. 
 
In dietary record by household measures or by estimation, the participants have to 
record all food consumption. The portion sizes could be estimated by household 
measures (plates, spoon, bowls, cups, and glasses), in reference to standard household 
measures, using three-dimensional food models or photographs. This is an easy, cost-
effective method and it represents a little load to the participant. Therefore, it obtains a 
high degree of adherence and participation (Ortega et al., 2015). 
 
In weighed dietary record, the amount of food consumed should be precisely measured 
by a kitchen weighing scale standardised, in order to diminish the bias. The food 
consumed should be weighted before eating and after eating (the food rest) and the 
participant should estimate the food eat-out-home. Thus, it is obtained the real quantity 
food consumed. Moreover, this methods show two derivations: 
 
 Weighed dietary record with interviewer in which the interviewer is who weights 
and records food consumption. This method is useful for institutionalised population 
or low literacy population. It could be combined with a 24 hour dietary recall to 
know the out-of-home dietary intake. Both methods, by weight and by weight with 
interviewer, show a high accuracy. However, they require a high level of cooperation 
from the participants, which could diminish the participation. 
 
 Weighted dietary record with chemical analysis in which the methodology is similar 
to the method of record by weight, but the food composition is obtained chemically. 
This method requires that respondent keeps up a portion of food which will be 
chemically analysed. This method presents the highest validity and accuracy, for this 
reason, it is considered the gold standard method in empirical researches. However, 
the limitations are the high complexity of the technic, high economic cost and high 
level of participation of the respondent (Arija, 2014). 
 
Generally, the main advantage of all these dietary record methods are their potential to 
collect accurate quantitative information. Because of the quality of its data, it is 
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considered the gold standard of the dietary methods. In addition, this method does not 
depend on the memory of the participant and is more accurate, since the amount of 
consumed food is recorded when eaten. The optimal number of days to collect data that 
are more reliable depends largely on the nutrient or the sample size. Traditionally the 
most common dietary record monitors the diet for seven consecutive days. This period 
allows to collect information about the diet minimizing bias related to the day of the 
week. Ideally, it is needed a long enough period of time to provide accuracy information 
of dietary (a minimum of 3 days is required) but without diminishing the participation 
and compliance (periods of no more than 4 consecutive days) (Arija, 2014) (Ortega et al., 
2015). 
In addition, other limitations are that these methods require that interviewers and 
participants are well trained and a high cooperation and literate of the participants. This 
could influence on the participation of some population groups (people with low literacy, 
immigrants with low language skills, children, elderly and people with writing 
difficulties) (Ortega et al., 2015). Another limitation is that this method can alter food 
consumption of the participants, as participants are more conscious about the food and 
the amount they consume, since their diet will be analysed (Kristjansdottir et al., 2006). 
 
Diet history 
 
The Diet History is a retrospective and quantitative method to describe food and usual 
nutrient intake during a relatively long period. It consists in a long interview that can 
take from one to two hours and requires a highly qualified interviewer in nutrition. The 
diet history method assesses quantitatively the global food intake of an individual for a 
certain period of time, habits in relation to food consumption, distribution and usual 
composition of meals throughout the day (Nelson, M, Bingham, 1997) (Martin and 
Gorgojo, 2007). Some authors considered that the complete method usually consists of: 
 
 An interview recalls estimating the habitual food consumption in the different eating 
occasions in a day. Often a 24-hour recall is included. 
 
 A FFQ to verify information to assess the overall pattern of food intake. 
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 A three day dietary record with estimated portion sizes of the foods and beverages 
consumed. 
 
Nevertheless, the method has several limitations that should be considered. For instance, 
this method entails a great effort of memory, a high participation and cooperation of the 
participant and a large duration to implement it. Furthermore, diet history method tends 
to overestimate intake. Otherwise, as it is focused on evaluation of usual patterns, 
exceptional intakes are underestimated.  The diet history is a complex, large and costly 
method that require highly well trained personnel, and there is not a standard protocol 
of complete diet history, for this reason, it is not applicable in large scale population 
studies. Therefore, currently the main application of the diet history method is in clinical 
practice (Morán Fagúndez et al., 2015). 
 
Screener and brief assessment methods 
 
Brief assessment tools are easy, self-administered and qualitative questionnaires. From 
the brief questionnaire, scores are obtained and are usually categorised according to 
levels. Usually, these tools ask about frequency of consumption or about dietary habits, 
thus they are useful to identify individuals with a very low or high intake and identify 
risk of malnutrition or inadequate consumption patterns for specific food groups (Pérez-
Rodrigo et al., 2015). 
 
These methods do not require a trained professional nor depend on the memory of the 
participant (Green and Watson, 2005), thereby, there is a high participation rate and 
cooperation. Recently these new brief assessment and self-evaluation tools are used by 
health professionals in primary health care, in community intervention to early 
screening and health promotion (Pérez-Rodrigo et al., 2015). 
 
A literature review conducted in 2005 identified 71 brief dietary assessment tools (Green 
and Watson, 2005) used in adults. Most of them included some anthropometry and 
sociocultural aspects related to food behaviour or biomarkers, and more complex 
anthropometrical measurements. Some specific instruments for adults are Dietary Risk 
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Assessment, Mediterranean Diet Adherence Screener (MEDAS), Dietary Intervention 
Care (DINE), Determine, Mini-Nutritional Assessment (MNA). 
 
Valid dietary assessment tools are needed to facilitate dietary counselling in high-risk 
populations. Nutrition advice for adults and underserved groups often occurs in clinical 
settings with time and resource limitations, dietary assessment tools for this setting 
should be brief (Gans et al., 2003). The Dietary Risk Assessment is a tool developed for 
non–dietetics-trained Health professionals, such as nurses and physicians, who provide 
dietary advice to underserved patients. Dietary Risk Assessment response options are 
arranged in three columns. The left column indicates the most healthful dietary practices, 
whereas responses in the right or middle columns indicate less healthful practices 
(Richardson et al., 2011). 
 
A more standardised protocol about application procedures and advice to provide users 
according to the scoring. Many have not assessed the validity and reliability of the 
method and often not investigated the sensitivity, specificity and acceptability of these 
tools. In the PREvención con DIeta MEDiterránea (PREDIMED) trial 14-point 
Mediterranean Diet Adherence Screener (MEDAS) was validated and used to identify 
subjects’ adherence to the intervention diet, a Mediterranean dietary pattern (Schröder 
et al., 2011). 
 
Dietary Intervention in Primary Care (DINE) is a 19-item questionnaire developed for 
use in interview-administered. It measures an individual’s intake of total fat and dietary 
fibre, categorised as low, medium or high. Specific foods are included which account for 
70% of the fat and fibre in a typical United Kingdom diet. The tool has been validated 
with good correlation with a validated four-day semi-weighed food diary. An 
experienced interviewer can complete it in 5–10 minutes (Richardson et al., 2011). 
 
Web-based tailored interventions aimed to modify food behaviour, physical activity and 
other lifestyles in adults have also used screeners of brief instruments (Broekhuizen et 
al., 2012). 
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Several screening tools focused on malnutrition targeted to be used in old adults have 
been validated. These vary depending on the type of population in question, the 
availability of personnel trained in nutrition, and the possibility of automation, etc. The 
most commonly used include the Malnutrition Screening Tool (MST), the Nutritional Risk 
Screening (NRS-2002) method, the Malnutrition Universal screening Tool (MUST), and 
the first part of the Mini-Nutritional Assessment (MNA) method. Nutritional screening 
allows the identification of subjects at risk of under-nutrition, as well as those who need 
a more exhaustive study and a nutritional diagnosis (Campos del Portillo et al., 2015). 
 
1.2.3 Dietary iron intake in population: Epidemiological studies 
 
The Spanish National Survey of Dietary Intake (ENIDE) was the first survey done in 
throughout the Spanish territory based on a methodology of analysis of individual 
consumption, through surveys (AECOSAN, 2011). It was conducted by The Spanish 
Agency for Consumer Affairs, Food Safety and Nutrition (AECOSAN) in a sample of 3000 
(1,500 women and 1,500 men) representative adult subjects between 2009 and 2010. 
The overall aim was to know, through a national study, the food consumption in Spain, 
and more specifically: to determine patterns of dietary intake in the Spanish population 
by age and gender; to obtain data to help complete the assessment of nutritional status; 
and to assess the intake of macro and micronutrients. The estimated micronutrient 
intake was based on the BEDCA Spanish Database Food Composition. 
 
The dietary iron of Spanish population is provided, to a greater extent, by the group of 
legumes, seeds, nuts and by-products (23%), followed by fish (19%) and meats (16%). 
It is also important the contribution of cereals and by-products (11%), and eggs and by-
products (10%) to the dietary iron intake (AECOSAN, 2011) (see figure 8). 
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Figure 8. Contribution (%) to daily iron intake of different food groups. 
 
Adapted from ENIDE 2011 
 
Data showed higher iron intake in men (16.1 ± 6.45mg/day) than in women (13.7 ± 
6.21mg/day), in agreement with previous surveys carried out in different regions of 
Spain, such as, Catalonia (14.5 ± 4.5 vs. 13.5 ± 3.8mg/day, P <0.001) (Bondia-Pons et al., 
2007), Comunidad de Madrid (15.6 ± 6.1 vs. 13.7 ± 5.6mg/day, P <0.001) (ENUCAM, 
2014) or Communidad Valenciana (18.0 ± 6.5 vs. 14.9 ± 7.0mg/day, P <0.001) (Vioque, 
2003). According with this, women of child-bearing age, with increased iron demand, do 
not reach the recommended values for this mineral (less than 80% of RDAs) established 
by Moreiras et al. for Spanish population (Moreiras et al., 2009). However, men consume 
an average of 60% over the RDAs, and postmenopausal women reach the 
recommendations in ENIDE sample (AECOSAN, 2011) (see table 5). In agreement with 
ENIDE data, the Food Consumption Survey, conducted for over 20 years by the Spanish 
Ministry of Agriculture, Food and Environment (MAGRAMA), showed that men aged 20 
to 59 years have a better compliance with the recommendations for iron than women. 
Data since 2000 to 2008 showed that men consume between 35 and 60 over the RDAs 
(Moreiras et al., 2009), while women do not reach the recommended values for iron  
(between 25 and 10% below the RDAs) (del Pozo de Calle et al., 2012). 
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The ENIDE survey observed (AECOSAN, 2011) that more than 95% of men older than 20 
years had an elevated intake of iron (5th percentile = 12mg/day) regarding Spanish RIs 
(10mg/day) (Moreiras et al., 2009) and RDAs of IOM (8mg/day) (Institute of Medicine et 
al., 2001). However, less than 25% of adult women of child-bearing age (75th percentile 
= 16-17mg/day) complied with the Spanish (Moreiras et al., 2009) and IOM (Institute of 
Medicine et al., 2001) recommendations (see table 6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In addition to the ENIDE survey (AECOSAN, 2011), the Health Department of the 
Autonomous Government of Catalonia has included as one of their objectives in the 
Health Policy for Catalonia, the making of periodic nutritional surveys for monitoring the 
nutritional status in a representative sample aged 10 to 75 years of the Catalan 
population (ENCAT). Serra-Majem et al. analysed the trends in energy and nutrient 
intakes derived from the last two Nutritional Surveys carried out in 1992-93 (ENCAT 
1992-93) and 2002-03 (ENCAT 2002-03) (Serra-Majem et al., 1996) (Serra Majem et al., 
2006). 
 
Table 5. Daily intake of total iron by gender and age. 
Age (years) 
Total Iron 
Intakea (mg) 
RI's             
(Morerias 2011) 
% 
adequacy 
MEN 
18-24 (n = 300) 15.9 ± 7.0 10 164 
25-44 (n = 656) 16.1 ± 6.3 10 161 
45-64 (n = 663) 16.2 ± 6.4 10b 163 
Total  (n = 1,589) 16.1 ± 6.5     
WOMEN 
18-24 (n = 324) 12.5 ± 4.7 18 72 
25-44 (n = 731) 14.1 ± 7.1 18 78 
45-64 (n = 674) 13.8 ± 5.9 10b 139 
Total  (n = 1,734) 13.7 ± 6.2     
RI's (Recommended Intakes) based on RDA (Recommended Dietary Allowance) 
a Mean ± standard deviation 
b RDA for adults older than 50 
 
Adapted from ENIDE 2011 
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Regarding iron consumption, a decrease was observed in its daily intake from 1992-93 
to 2002-03 (Serra-Majem et al., 1996) (Serra Majem et al., 2006). This decline was due to 
the reduction in the consumption of meat, and fish. Therefore, the risk of inadequate iron 
intake increased in the ENCAT-2002-03 in the group of women. Consistently, data from 
ENIDE survey showed that women of child-bearing age did not reach the recommended 
values, although the iron intake was higher in both, men and women groups (see table 
6), than the last ENCAT survey in 2002-03. 
      Figure 9. Evolution of daily intake of iron (mg/day) in Spanish population. 
 
 
 
 
 
 
 
 
 
 
Adapted from the Spanish Ministry of Agriculture, Food and Environment (MAGRAMA)(del Pozo de Calle et al., 
2012) 
Table 6. Total iron intake in Spanish population between 18 and 64 years. 
Age (years) 
18-24 25-44 45-64 
Males Females Males Females Males Females 
(n= 260) (n= 260) (n= 619) (n= 620) (n= 619) (n= 620) 
  IRON INTAKE (mg/day) 
P5 12 11 12 11 12 11 
P25 14 13 14 13 14 13 
P50 16 14 16 15 16 15 
P75 18 16 18 17 18 16 
P95 21 18 21 20 21 19 
EAR (IOM 1997) 6 8.1 6 8.1 6 5 
Percentage of subjects 
having intakes below the 
EAR values 
0 0 0 0.2 0 0 
EAR: average daily level of intake estimated to meet the requirements of 50% of healthy individuals 
Adapted from ENIDE 2011 
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1.2.4 Biochemical methods for assessing iron status 
 
Chemical analysis of a liver biopsy is the “gold standard” for quantifying iron stores. 
However, the need for a relatively large volume of tissue (4 mg net weight) as well as risk 
of this invasive procedure (haemorrhage occurs in about 0.5% of cases) has made this 
less appealing to most clinicians and patients (Knovich et al., 2009). Moreover, bone-
marrow examination is the gold standard for the diagnosis of ID, particularly when 
performed and reviewed under standardised conditions by experienced investigators. 
However, marrow examinations are not performed routinely in clinical practice; 
furthermore, they are expensive, uncomfortable, and require technical expertise 
(Zimmermann, 2008). Therefore, biochemical parameters related to iron metabolism are 
usually used in epidemiological studies in order to accurately measured total body iron 
stores. The most used of them are the following: 
 
Ferritin 
 
The iron storage protein, ferritin, is mainly found in the liver and spleen and other 
tissues, but also extracellularly within the serum at trace levels. It is suggested that 
ferritin may enter the circulation either via secretion of ferritin by cells or through the 
release of ferritin from damaged cells (Worwood, 1990), in proportion to the 
intracellular levels. Both mechanisms probably contribute to plasma levels, which serve 
as an important clinical marker of iron status. Actually, in the absence of inflammation 
and/or chronic disease, SF is considered as the best single indicator in assessing body 
iron stores, except liver or bone marrow biopsy as we noted above, due to its less 
invasive assessment and high specificity (Ren and Walczyk, 2014). 
 
The acute phase response is a systemic reaction to local or systemic infection, 
inflammation, tissue damage, cancer and in general, immune disturbances (Wang et al., 
2010a). Ferritin is widely recognised as an acute phase reactant, and an important role 
for ferritin during these conditions is to restrict the availability of iron by sequestration 
into the cavity of the ferritin protein shell. This function is presumed to have developed 
as a defence mechanism to restrict serum iron from utilization by pathogens and 
tumours (Ganz and Nemeth, 2009) (Weinberg and Miklossy, 2008). 
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In healthy individuals, SF is directly proportional to iron stores, thereby, 1µg/L of SF 
corresponds to 8–10 mg body iron or 120 mg storage iron/kg body weight (Cook, 2005). 
Normal ranges set by the World Health Organization (WHO) are 15–150mg/L for adult 
women and 15–200 mg/L for adult males (World Health Organization and Centers for 
Disease Control and Prevention, 2004). While SF concentration below the normal range 
(<12–15μg/L) is highly specific for diagnosis of ID (Worwood, 1979), high SF 
concentration is not necessarily indicative of iron overload, because its serum 
concentration increases sharply under inflammatory conditions, as discussed previously 
(Wang et al., 2010a). Here, the serum concentration of the soluble transferrin receptor 
(sTfR), its ratio relative to SF concentration, or a combination of both is of higher 
diagnostic value. Anyway, ferritin outperforms other biomarkers of iron status, such as 
transferrin saturation, mean cell volume, and red cell zinc protoporphyrin levels in terms 
of sensitivity and specificity at any level (Zähringer et al., 1975). 
 
sTfR 
 
The transferrin receptor (TfR) is a transmembrane glycoprotein key for iron metabolism, 
because it is involved in the process of cellular uptake of iron. Its expression is 
determined by the cellular demand for iron. Its truncated form, sTfR, is located in serum 
in proportion to the transmembrane protein and, therefore, to cell iron demands 
(Speeckaert et al., 2010). In addition, sTfR represents a significant advanced in the 
evaluation of body iron status, especially since inflammation processes do not alter it. 
These are the reasons because it is believed that represents a good biomarker in the 
evaluation of body-iron status (Désidéri-Vaillant et al., 2011), 
 
Further, sTfR concentration appears to be a specific indicator of iron-deficient 
erythropoiesis, since around 80 % of TfR in the body is found on erythroid precursors. 
Therefore, in conditions such as normal expansion of the erythroid mass during growth 
(Olivares et al., 2000), as well as diseases common in developing countries, including 
thalassemia, megaloblastic anaemia due to folate deficiency, or haemolysis due to 
malaria, may increase erythropoiesis and sTfR independent of iron status (Worwood, 
2002). 
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sTfR/ferritin ratio 
 
Cook et al. have demonstrated that in healthy subjects the concentration of stored iron 
may be estimated from the ratio of sTfR/ferritin (Cook et al., 2003). The logarithm of this 
ratio is directly proportional to the amount of stored iron in iron-replete subjects and the 
tissue iron deficit in ID. Thereby, sTfR/ferritin ratio appears to be a good marker of iron 
stores (Malope et al., 2001), especially useful in population studies since it is sensitive 
not only to elevated, but also decreased, levels of iron stores (Skikne, 2008). For instance, 
in elderly subjects, the ratio may be more sensitive than other laboratory tests for ID 
(Rimon et al., 2002). Although, it has been indicated that sTfR/ferritin ratio has no clear 
advantage over SF alone (Mei et al., 2005), a study assessing ID in the US population 
(NHANES) (Cogswell et al., 2009) reported that it appeared to be less affected by 
inflammation than ferritin alone. 
 
Serum iron 
 
The normal plasma iron concentration ranges between 50–120μg/dL. The thresholds 
used to classify individuals as iron deficient typically range from 50–60μg/dL (World 
Health Organization and Centers for Disease Control and Prevention, 2004), however 
natural variation in measurements may lead to misclassification. Serum iron has very 
limited value in assessing ID or chronic excess in population studies because 
concentrations within an individual are affected by other influences such as diurnal and 
post-prandial variations, and concentrations are rapidly reduced following infection or 
inflammation as part of the acute phase reaction (World Health Organization and Centers 
for Disease Control and Prevention, 2004). 
 
Transferrin 
 
The globular protein, transferrin, is the specific transport protein for iron in the plasma 
pool. The concentration of transferrin increases during ID and decreases with protein 
deficiency, so it is sensitive to several factors. The concentration of this transport protein 
reflects iron status only when iron stores are exhausted and when the plasma iron 
concentration is <40–60μg/dl, so it does not diagnose ID prior to ineffective 
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erythropoiesis (World Health Organization and Centers for Disease Control and 
Prevention, 2004). 
 
Total iron binding capacity 
 
A proxy measure of transferrin is the measurement of the total iron binding capacity 
(TIBC). The TIBC is not as subject to rapid changes in concentration as the plasma iron 
concentration, so it is inherently more stable as an indicator of iron status. The TIBC by 
itself is not often used as a measure of iron status because it appears not to change until 
iron stores are depleted (World Health Organization and Centers for Disease Control and 
Prevention, 2004). 
 
Transferrin saturation 
 
Transferrin saturation is a widely used screening test for ID, and is calculated by dividing 
the serum iron by the TIBC. Although relatively inexpensive, its use is limited by diurnal 
variation in serum iron and the many clinical disorders that influence transferrin levels 
(Cook, 2005). Thereby, in addition to ferritin, transferrin saturation also has some acute-
phase reactivity insofar as transferrin may be elevated in the setting of inflammation, 
which would lower the transferrin saturation if circulating iron is constant (Wish, 2006). 
 
Clinical studies have demonstrated that a transferrin saturation of <15% is insufficient 
to meet normal daily requirements for erythropoiesis (World Health Organization and 
Centers for Disease Control and Prevention, 2004). Otherwise, transferrin saturation 
values higher than 50% appear in iron overload conditions (Wish, 2006).  
 
Haemoglobin 
 
Haemoglobin is a widely used screening test for ID, but used alone has low specificity 
and sensitivity. Its sensitivity is low because individuals with baseline haemoglobin 
values in the upper range of normal need to lose 20–30% of their body iron before their 
haemoglobin falls below the cut-off for anaemia (Cook, 2005). Its specificity is low 
because there are many causes of anaemia other than ID. Cut-off criteria differ with the 
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age and gender of the individual, between laboratories, and there are ethnic differences 
in normal haemoglobin (Johnson-Spear and Yip, 1994). 
 
Mean corpuscular volume and reticulocyte Haemoglobin content 
 
The mean corpuscular volume (MCV) is a reliable, but relatively late indicator of ID. 
However, false normal values can occur when the MCV is increased or in thalassemia 
(Zimmermann, 2008). 
 
The reticulocyte haemoglobin content has been proposed as a sensitive indicator that 
falls within days of the onset of iron-deficient erythropoiesis (Mast et al., 2002). For both 
reticulocyte haemoglobin content and MCV, low specificity limits their clinical utility 
(Thomas and Thomas, 2002). 
 
Red cell zinc protoporphyrin, erythrocyte protoporphyrin and zinc protoporphyrin 
 
The absence of iron in the bone-marrow causes that zinc replaces it during formation of 
the protoporphyrin ring, previous step to the synthesis of haemoglobin. The normal ratio 
of iron to zinc in protoporphyrin is about 30,000:1, but a lack of iron available to 
ferrochetalase during the early stages of iron deficient erythropoiesis results in a 
measurable increase in the concentration of zinc protoporphyrin (World Health 
Organization and Centers for Disease Control and Prevention, 2004). When there is 
enough iron the reactions are as follows: 
 
Protoporphyrin + Ferrous iron   Ferrous protoporphyrin 
 
Ferrous protoporphyrin + Globin  Haemoglobin 
 
When there is a lack of iron then zinc replaces iron in a very small but measurable 
proportion of molecules: 
 
Protoporphyrin + Zinc  Zinc protoporphyrin 
 
Zinc protoporphyrin + Globin  Zinc protoporphyrin-globin 
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Typically free erythrocyte protoporphyrin is less than 5% of the total. Its measurements 
are nearly identical to the zinc protoporphyrin. In turn, both erythrocyte protoporphyrin 
and zinc protoporphyrin should be interchangeable with red cell zinc protoporphyrin 
(World Health Organization and Centers for Disease Control and Prevention, 2004). 
 
Zinc protoporphyrin has a high sensitivity in diagnosing ID (Labbé et al., 1999) (Labbé 
and Dewanji, 2004). A healthy normal individual will have an erythrocyte 
protoporphyrin concentration of less than 40–50μg/dL of red cells. Coincident with a fall 
in transferrin saturation below 15%, the concentration of erythrocyte protoporphyrin 
increases rapidly to more than 70–100μg/dL. With a prolonged or severe deficit in iron, 
the erythrocyte protoporphyrin concentration may reach as high as 200μg/dL (World 
Health Organization and Centers for Disease Control and Prevention, 2004). However, 
the specificity of zinc protoporphyrin in identifying ID may be limited, because it can be 
increased by lead poisoning, anaemia of chronic disease, chronic infections and 
inflammation, haemolytic anaemias, or haemoglobinopathies (Labbé and Dewanji, 2004) 
(Graham et al., 1996) (Hastka et al., 1993). Direct comparisons between studies of zinc 
protoporphyrin are difficult because of interassay variation. Zinc protoporphyrin is a 
useful screening test in field surveys, particularly in children, where uncomplicated ID is 
the primary cause of anaemia. Because of the difficulty in automating the assay, zinc 
protoporphyrin has been not widely adopted by clinical laboratories (Zimmermann, 
2008). 
 
1.2.5 Iron status in population: Epidemiological studies 
 
Adequate iron status implies presence of normal erythropoiesis, and iron dependent 
functions that are not limited by iron supply, as well as a small contingency reserve of 
iron storage to supply other physiological functions. 
 
Iron deficiency 
 
ID is a state in which there is insufficient iron to maintain the normal physiological 
function of tissues such as blood, brain, and muscles (World Health Organization, 2008). 
Haemoglobin determination has been the most widely used screening method for the 
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diagnosis of ID, but when used as the only laboratory measurement it has serious 
limitations because of its low specificity and sensitivity. The low haemoglobin specificity 
for identifying ID is due to the numerous causes of anaemia other than ID that are seen 
both clinically and in population surveys (Cook, 2005). For the diagnosis of ID bone-
marrow examination is the gold standard. However, marrow examinations are not 
performed routinely in clinical practice, since they are expensive, uncomfortable, and 
require technical expertise (Zimmermann, 2008). SF is considered a useful indicator of 
iron stores, despite its concentration rises during inflammation. Thus, the customary 
thresholds to indicate ID is of  <15ng/mL, and <30ng/mL in the presence of infection 
(World Health Organization, 2011a). 
 
In addition to ID, iron depletion is the state in which iron storage is absent or nearly 
absent but the tissues that need iron are able to maintain normal physiological functions. 
Moreover, a functional iron deficiency appears when iron stores are present, but the 
normal physiological systems for transporting iron to target tissues are impaired. This 
occurs most commonly because of cytokines released during inflammation states and 
infectious diseases, and appears to be mediated by hepcidin (World Health Organization, 
2008). 
 
Anaemia 
 
Anaemia is a public health problem that affects populations in developed and developing 
countries. Further, it is one of the most prevalent nutritional deficiency diseases 
worldwide. Although the primary cause is ID, it is seldom present in isolation. Anaemia 
frequently coexists with a number of other causes, such as malaria, parasitic infection, 
nutritional deficiencies, and haemoglobinopathies. WHO defines anaemia as blood 
haemoglobin values of less than 7.7mmol/L (13g/dL) in men and 7.4mmol/L (12g/dL) 
in women, and estimates that about two billion people are anaemic (World Health 
Organization, 2008). The severity of anaemia is based on the patient’s 
haemoglobin/haematocrit level (Johnson-Wimbley and Graham, 2011). 
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Iron deficiency anaemia 
 
Iron deficiency anaemia (IDA) is a form of anaemia due to the lack of sufficient iron to 
form normal red blood cells. The diagnosis of IDA requires evidence that iron stores are 
fully depleted. Isolated or uncomplicated IDA in the absence of other diseases that 
influence measurements of iron status is seen most often in infants and preschool 
children (due to rapid growth), in pregnant women (due to the iron demands of the 
foetus), and in patients with excessive uterine or gastrointestinal blood loss. The key 
laboratory measurement for its identification is the SF; a concentration below 30mg/L is 
diagnostic of IDA in patients with anaemia (Cook, 2005). As noted above, ID is the most 
common cause of anaemia in the world. 
 
IDA is characterised by microcytic, hypochromic erythrocytes and low iron stores. The 
MCV is the measure of the average red blood cell volume and mean corpuscular 
haemoglobin concentration is the measure of the concentration of haemoglobin in a 
given volume of packed red blood cells. The normal reference ranges for MCV is 80-100fL 
and mean corpuscular haemoglobin concentration is 320-360g/L (Johnson-Wimbley 
and Graham, 2011). 
 
Although ID is a problem mainly in developing countries, it is also well known to affect 
large fractions of populations in the industrialised world. In 2009, Sánchez et al. found 
that the risk of ID, among men and women between 25 to 60 years old in southern Spain, 
was 12.7%, and 2.1% for IDA (Sánchez et al., 2009). In this study, individuals were 
considered to have ID if at least two of the following indicators were abnormal: plasma 
iron, TIBC, transferrin saturation and MCV; and iron-deficient anaemia if they had below-
normal values for haemoglobin, MCV, mean cell hemoglobin and mean corpuscular 
haemoglobin concentration. The percentage of women with ID and IDA was higher than 
the corresponding percentages in men, according to the highest iron intake observed in 
men (16.1 ± 6.45mg/day) regarding women (13.7 ± 6.21mg/day) in ENIDE survey 
(AECOSAN, 2011). Data only for women younger than 45 years (women of child-bearing 
age) showed that the prevalence of anaemia increased to 13.8%. This prevalence is 
higher than in other European countries, such as, Northern Ireland (13.5%), United 
Kingdom (9.0%), Sweden (6.6 - 7.4%), France (4.4%), Norway (4.1%) and Denmark 
UNIVERSITAT ROVIRA I VIRGILI 
IRON EXCESS AND RISK OF TYPE 2 DIABETES MELLITUS IN A PROSPECTIVE COHORT OF MEDITERRANEAN POPULATION 
José Cándido Fernández Cao 
Introduction 
72 
 
(2.8%) (Hercberg et al., 2001), but lower than the global prevalence showed by WHO in 
2011 in the same group of women of child-bearing age (World Health Organization, 
2011b).  
 
Iron overload 
 
Iron overload (see section 1.3) occurs when excess iron accumulates in the body. It can 
be caused by increased absorption of dietary iron or by parenteral iron loading (repeated 
blood transfusions). The thresholds suggested for a SF concentration during iron 
overload have varied widely. WHO concluded that thresholds of >200μg/L for men and 
>150μg/L for women were appropriate (World Health Organization, 2001). 
 
A study carried out by Altés et al. in 2004 in the northwest of Spain, showed high iron 
overload  prevalence (9.3%) in the whole sample, 14.7% in men and 3.8% in women 
between 18 and 74 years old (Altés et al., 2004). In that study, iron overload was defined 
as ferritin levels above 200mg/L in women and 300mg/L in men. They also observed 
higher prevalence of iron overload in elderly subjects. Thus, 11.7% of young men (<50 
years) and 20.4% of those over 50 years presented iron overload. In women, it is 
noteworthy that only 1.2% of young women had iron overload, but the prevalence 
increased until 9.4% among women above 50 years. Interestingly, 1.6% of the general 
population, 2.5% of young men and 3.9% of those over 50 years had ferritin levels 
greater than 500mg/L (Altés et al., 2004). A previous study carried out in southern Spain 
among 176 postmenopausal women and 125 men between 40 and 93 years, and without 
evidence of diseases related to iron metabolism, also found higher prevalence of iron 
overload in men than in women (Vidal Miñana and Farré Rovira, 2002). Using the same 
criteria to determine iron overload, a study conducted in 1757 blood donors from Mexico 
City found a lower prevalence in men (12%) and higher in women (4.8%) than previous 
Spanish population, and as noted Altés et al., the prevalence increased in parallel with 
increasing age (from 15.6 to 29.9% for men and from 3.5 to 9.6%, for women) (Baptista-
González et al., 2005).  
 
The percentage of subjects with iron overload in a Danish male general population 
(13.5%) was slightly lower than that from northwest of Spain. Moreover, the Danish 
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study showed that the percentage of men having elevated SF ≥300μg/L increased 
gradually with age (Pedersen and Milman, 2009) as noted in earlier studies. Previous 
Danish studies reported a significantly increase in the prevalence of iron overload (from 
11.3% to 18.9%) in men (Milman et al., 2002) and in postmenopausal women (from 2.4 
to 5.5%), but not in premenopausal women (Milman et al., 2003), from 1984 to 1994. In 
addition, they also observed a significant rise in the prevalence of iron overload with age. 
 
Recently, Aranda et al. conducted a study in order to describe iron genetic mutations, 
dietetic and lifestyle factors, as well as, iron status in a general Mediterranean 
population. A total of 815 healthy Caucasian subjects (425 female, 390 males) between 
18 and 75 years were randomly selected from the local government census of three 
communities in the Mediterranean region of Tarragona (Spain). Results showed an 
important percentage of subjects (26.7% of males and 8.7% of females) with elevated 
iron status, measured as transferrin saturation >45%. When the biomarker used was SF, 
and according with iron overload criteria of WHO, i.e. >200ng/mL in males and 
>150ng/mL in females (World Health Organization, 2001), the percentage of subjects 
with elevated iron status was reduced to 19.7% in males and 4.0% in females (Aranda et 
al., 2010). Women with SF >200ng/mL represented 2.4% of the sample, quite lower than 
previous study carried out by Altés et al. in northwest Spanish population (3.8%) (Altés 
et al., 2004). The transferrin saturation mean of this population was 39.3 ± 18.5%, and 
SF was 106.9 ± 2.1ng/mL. 
 
Iron overload may be originated by various pathological conditions. The main causes 
found in a sample of Spanish population with iron overload were severe alterations of 
the HFE gene, hepatitis C virus infection, and dysmetabolic syndrome with iron overload 
(Altes et al., 2003). 
 
1.3 IRON OVERLOAD 
 
As it was reported previously, iron overload occurs when excess iron accumulates in the 
body. WHO suggested that a thresholds of SF >200μg/L for men and >150μg/L for 
women, were appropriate for iron overload (World Health Organization, 2001). 
However, there are other clinical conditions, in which SF levels reach 1,000μg/L. 
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1.3.1 Causal factors for iron overload 
 
Some genetic (primary) and acquired (secondary) disorders can cause iron overload. 
Haemochromatosis is one of the most common genetic disorders that results in iron 
overload. It is caused by a series of mutations that affect multiple regulatory proteins at 
various points along the pathway of hepcidin and iron regulation due to mutations in the 
HFE and non-HFE (FPN, TfR, HJV) genes (Ekanayake et al., 2015). Normal HFE is required 
for iron stimulation of hepcidin. The HFE alteration results in a reduced expression of 
hepcidin and hence iron absorption is inappropriately high for a given body iron load 
(Nemeth et al., 2005). 
 
1.3.1.1 Primary iron overload 
 
Haemochromatosis type I, also named classical haemochromatosis (see table 7), is an 
autosomal recessive disorder that occurs in approximately five per 1,000 Caucasians of 
northern European descent (Pietrangelo, 2010). Most commonly, the disease occurs due 
to two missense mutations (C282Y and H63D) in the haemochromatosis gene (HFE) 
located on the short arm (p) of chromosome 6 (Yun and Vincelette, 2015). The 
prevalence of the most common mutations in HH, C282Y homozygote and C282Y/wild 
type heterozygote, are 1 in 150–300 and 1 in 10 in general population, respectively 
(Allen et al., 2008). Of note is that genetic disorders, such as HH, in southern Europe are 
quite different from those in the USA, China and northern Europe. Thereby, while in 
Northern Europe the prevalence of the C282Y polymorphism in HFE gene is 5-10% and 
of H63D polymorphism is 10-20%, in southern Europe the prevalence is 1-5% and >20%, 
respectively (Kucinskas et al., 2012). In Spain, the prevalence of the main mutation 
(H63D, C282Y and S65C) reaches 46% in certain regions (Aranda et al., 2007). 
 
Haemochromatosis type IIA, juvenile haemochromatosis, is the most severe form of HH. 
This form of haemochromatosis is due to mutations in genes encoding HJV protein 
(Papanikolaou et al., 2004), which results in a reduced activation of hepcidin 
(Camaschella and Poggiali, 2009). Haemochromatosis type IIB is due to mutations of 
hepcidin, affecting the cysteine fingers or producing a null gene product (Camaschella 
and Poggiali, 2009). Mutations in TfR2 cause the form of hereditary haemochromatosis 
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type III. Although the function of TfR2 is not completely understood, it is believed to bind 
to sense transferrin in hepatocytes by binding to HFE. Therefore, dysfunction of TfR2 
results in reduced hepcidin production (Camaschella and Poggiali, 2009). 
 
Haemochromatosis type IV is the only autosomal dominant form of the disease interfering 
with FPN function  (Camaschella and Poggiali, 2009). As expected, the phenotype in 
affected patients is similar to that in patients with classic HH, but with normal or 
elevated, rather than low, hepcidin levels (Papanikolaou et al., 2005). This can result in 
IDA due to a reduced circulating iron and is associated with reduced end-organ damage 
and reduced need for venesection (Camaschella and Poggiali, 2009). 
 
There are other genetic disorders more rare, such as aceruloplasminaemia, 
atransferrinaemia or neonatal iron overload, which have also been associated with iron 
overload (Siah et al., 2006). 
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Table 7. Characteristics of hereditary haemochromatosis. 
Types 
Gene 
affected 
Protein 
affected 
Prevalence Penetrance Function Resulting phenotype Severity 
Haemochromatosis 
type I  (Classical 
haemochromatosis) 
HFE HFE 
Most common 
form worldwide. 
Varies by race 
Autosomal 
recessive: 2–28 % 
penetrance 
Hepcidin 
regulation 
Parenchymal iron 
overload, liver disease 
Mild 
Haemochromatosis 
type IIA 
HJV Hemojuvelin Rare 
Autosomal 
recessive 
Hepcidin 
regulation 
Severe parenchymal 
iron overload 
Severe 
Haemochromatosis 
type IIB 
HAMP Hepcidin Very rare 
Autosomal 
recessive 
Regulating the 
export of iron 
from enterocytes, 
macrophages, and 
hepatocytes 
Severe parenchymal 
iron overload 
Severe 
Haemochromatosis 
type III 
TfR2 
Transferrin 
receptor 2 
Rare 
Autosomal 
recessive 
Hepcidin 
regulation 
Parenchymal iron 
overload, liver disease 
Intermediate 
Haemochromatosis 
type IV 
SLC40A1 Ferroportin Rare 
Autosomal 
dominant 
Exporter of non-
haem iron 
Parenchymal and 
reticuloendothelial 
iron overload in the 
liver 
Mild 
HJV (HemoJuVelin), HAMP (Hepcidin AntiMicrobial Peptide), TfR2 (Transferrin Receptor 2). 
Adapted from (Yun and Vincelette, 2015)  
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1.3.1.2 Secondary iron overload 
 
Most of secondary iron overload disorders are characterised by some degree of 
ineffective erythropoiesis, that is, apoptosis of certain erythroid precursors, failure of 
erythroid maturation, and secondary expansion of erythropoiesis. Hepcidin is down-
regulated by signalling molecules associated with these events, and the consequent 
anaemia, hypoxia, or both. Therefore, the down-regulation of hepcidin persists despite 
iron overload (Nemeth and Ganz, 2006). Erythrocyte transfusions contribute 
substantially to the iron burden in patients with these disorders (Brittenham, 2011). 
 
Transfusional iron overload: Thalassemia 
 
Around 15 million people have clinically apparent α- or β-thalassemia worldwide. In 
patients with severe forms of thalassemia, iron overload is a major cause of illness, 
whether or not they receive regular transfusions (Hershko, 2010). Therapeutic option in 
thalassemia is recurrent blood transfusion. Therefore, these patients requires 
continuous periodic assessment of iron overload to prevent long term complications. 
Thalassemia major patients undergoing regular blood transfusion are predisposed to 
iron overload, which can affect endocrine organs such as heart, pancreas, liver, etc. (L N 
et al., 2015). 
 
Dietary iron overload 
 
It has been described in sub-Saharan Africa an iron overload as a result from the 
ingestion of large amounts of iron derived from traditional home brewed beer fermented 
in non-galvanised steel drums. However, only a small percentage of these beer drinkers 
get this condition. Evidence suggests that genetic predispositions, other than HFE gene, 
may be involved, but the exact putative locus has not been identified  (Siah et al., 2006). 
 
Currently, it is not believed that a high dietary iron intake could cause iron overload 
without coexisting genetic disorder. 
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Other causes of iron overload 
 
Congenital sideroblastics anaemias are heterogeneous disorders of haem synthesis. In 
these conditions, iron accumulates in mitochondria, producing the characteristic ring 
sideroblasts. The treatment of secondary iron overload consists in phlebotomy, 
chelation, or both (Fleming and Ponka, 2012). 
 
Myelodysplastic syndromes and aplastic anaemias are disorders also associated with 
iron overload, particularly when exacerbated by multiple erythrocyte transfusions. 
These conditions are characterised by an ineffective haematopoiesis and peripheral 
cytopenias (Mahesh et al., 2008). 
 
Friedreich’s ataxia is an inherited neurodegenerative disease with an alteration in the 
first intron of the Friedreich’s ataxia (FRDA) gene. It is a classic disorder associated with 
mitochondrial iron accumulation (Rivaud-Pechoux et al., 1998). 
 
Hepatitis C virus infection is associated with an accumulation of iron in the liver 
parenchyma. Thus, many patients with chronic hepatitis C virus infection often have 
elevated serum iron, transferrin saturation, and ferritin levels (Boujaoude et al., 2000). 
 
1.3.2 Iron and oxidative stress theory 
 
Iron has the ability to accept and donate electrons easily, rising from an oxidised state 
(ferric iron) to a reduced state (ferrous iron). This capability makes it physiologically 
essential, but also biochemically dangerous, since it can participate in redox reactions 
that lead to generation of ROS. ROS, such as hydroxyl radical, increases the oxidative 
stress, a condition that it is believed to be involved in numerous pathological disorders 
(Schulze and Hu, 2005) (Drews et al., 2010). 
 
In the Haber-Weiss reaction hydroxyl radicals are generated in the presence of hydrogen 
peroxide and iron ions (Lipinski, 2011). The first step involves reduction of ferric into 
ferrous ion: 
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In the Fenton reaction, ferrous iron fosters the generation of hydroxyl radicals from 
hydrogen peroxide to generate ferric iron, hydroxide and hydroxyl radicals. 
 
 
 
 
 
 
 
Thereafter, ferric iron is reduced by the superoxide radical to produce ferrous iron. The 
Haber–Weiss reaction uses iron to catalyse the generation of hydroxyl radicals from 
hydrogen peroxide and superoxide radical (Papanikolaou and Pantopoulos, 2005). 
 
 
 
 
 
 
In addition, iron also reacts directly with organic molecules to generate peroxyl (ROO˙), 
alkoxyl (RO˙), thiyl (RS˙) or thiyl-peroxyl (RSOO˙) radicals, and ferrous iron can be 
oxidised by oxygen generating the superoxide radical (Papanikolaou and Pantopoulos, 
2005). 
 
Therefore, iron excess can cause damage to various tissues through increasing oxidative 
stress by the ROS generated, resulting in the onset of  disease (Tiedge et al., 1997). 
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1.3.3 Diseases associated with iron overload 
 
Cancer 
 
It has been suggested that iron is a risk factor for cancer mainly due to its pro-oxidant 
activity, which can lead to oxidative DNA damage. A recent systematic review and meta-
analysis found that elevated haem iron intake is associated with the risk of cancer. This 
relationship was observed in colorectal, and colon cancer meta-analysis, but not with 
breast and lung cancer (Fonseca-Nunes et al., 2014). Epidemiological studies show that 
red and processed meat intake is associated with an increased risk of colorectal cancer. 
Haem iron, heterocyclic amines, and endogenous N-nitroso compounds are proposed to 
explain this effect, but their relative contribution is unknown. Recently, a study among 
rats found that haem iron increased the number of preneoplastic lesions, but dietary 
heterocyclic amines and N-nitroso compounds had no effect on carcinogenesis. Authors 
suggested that haem iron could initiate carcinogenesis through lipid peroxidation 
(Bastide et al., 2015). 
 
Regarding the relationship between body iron status and cancer risk remains 
inconclusive. A recent meta-analysis showed an unexpected inverse association between 
iron overload and the risk of developing colorectal cancer (Fonseca-Nunes et al., 2014). 
Otherwise, in patients with iron overload, iron excess is deposited predominantly in the 
liver, pancreas, and heart. As the primary site for body iron storage, the liver is usually 
the first organ affected, which is clinically manifested as fibrosis, cirrhosis, and 
hepatocellular carcinoma (Batts, 2007). 
 
Neurodegenerative diseases 
 
Accumulation of iron is often detected in the brains of people suffering from 
neurodegenerative diseases such as Parkinson (Bartzokis et al., 1999), Alzheimer’s 
(Bartzokis et al., 1994), and Huntington’s (Jurgens et al., 2010). These disorders can 
result from both defects in iron metabolism or iron accumulation in specific brain regions 
(Batista-Nascimento et al., 2012). However, remains to be determined whether iron 
contributes to the progression of these diseases.  
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Alzheimer’s disease 
 
Alzheimer’s disease is the most common cause of age-related neurodegeneration. This 
disease is characterised by the accumulation of aggregates of insoluble amyloid-β 
protein, and neurofibrillary tangles consisting of precipitates/aggregates of 
hyperphosphorylated tau protein, which result in the progressive loss of memory, 
speech, task performance, and recognition of people and objects (Ross and Poirier, 
2004). Iron has been associated with Alzheimer’s disease, but the mechanism that 
mediates this relationship is not well-established. Iron accumulation has been observed 
in and around the amyloid senile plaques and neurofibrillary tangles (Smith et al., 1997). 
Other studies have also suggested that high iron toxicity may be due to the propensity of 
ferrous iron to generate ROS (Jomova and Valko, 2011). 
 
Parkinson’s Disease 
 
Parkinson’s Disease is a progressive disorder that manifests as tremor at rest, 
bradykinesia, gait abnormalities, rigidity, postural dysfunction, and loss of balance 
(Jankovic, 2008). It is the most prevalent neurodegenerative disorder, after Alzheimer’s 
disease, affecting about 2% of people over 65 years old. Parkinson’s Disease is 
characterised by the loss of the substantia nigra dopaminergic neurons (Irizarry et al., 
1998) and the deposition of intracellular inclusion bodies known as Lewy bodies. Several 
studies have confirmed an increase of iron in the substantia nigra of most severe cases 
of Parkinson’s Disease (Hirsch et al., 1991). Anyway, there is a general agreement that 
total nigral iron levels increase in Parkinson’s Disease, possibly leading to nigrostriatal 
dopamine neuron degeneration as a result of its ability to produce ROS and cause lipid 
peroxidation (Jomova et al., 2010). 
 
Osteoporosis 
 
Many lines of evidence indicated that iron overload affects bone tissue causing both 
osteopenia and osteoporosis (Weinberg, 2006), and a high prevalence of fractures 
(Vogiatzi et al., 2009a). It has been suggested that elevated intracellular iron 
concentrations has a deleterious effect on differentiation, proliferation, and activity of 
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osteoblasts, which synthesise osteocalcin (OC) (Yamasaki and Hagiwara, 2009), 
probably through increased oxidative stress (Zhao et al., 2012). 
 
Cardiovascular disease 
 
Ever since the relationship between iron and cardiovascular disease was proposed by 
Jerome Sullivan in 1981 (Sullivan, 1981), many studies have attempted to confirm this 
hypothesis. However, the role of iron stores in CVD remains largely unknown. The 
disparity in results could be due to different iron biomarkers used in the studies (Muñoz-
Bravo et al., 2013). Studies are needed to clarify the true effect of iron status on CVD.  
 
Nevertheless, a recent meta-analysis showed that higher dietary haem iron intake was 
associated with an increased risk of CVD, whereas no association was found between 
CVD and non-haem iron intake or total iron intake (Fang et al., 2014). 
 
Metabolic syndrome (MetS) 
 
A recent meta-analysis showed that increased ferritin concentrations was positively 
associated with MetS (Abril-Ulloa et al., 2014). Oxidative stress could be the potential 
mechanism explaining iron-induced MetS (Lipinski, 2011). 
 
Type 2 diabetes mellitus 
 
Several prospective (Salonen et al., 1998) (Lee et al., 2004) (Jiang et al., 2004a) 
(Rajpathak et al., 2006) and cross-sectional (Luan de et al., 2008) studies have found  an 
association between haem iron and risk of T2DM. Moreover, the direct association 
between haem iron intake before pregnancy and/or during the early period of pregnancy 
and the risk of gestational diabetes was also reported in the Nurse’s Health Study (NHS) 
II (Bowers et al., 2011) and the U.S. Omega cohort (Qiu et al., 2011). It has been 
speculated that the increase of iron stores could play a role in the production of ROS, such 
as hydroxyl radicals, leading tissue damage (Lipinski, 2011). 
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2.1 GLUCOSE METABOLISM 
 
A fundamental mechanism for the maintenance of glucose homeostasis is the rapid 
action of insulin to stimulate glucose uptake and metabolism in peripheral tissues. 
Skeletal muscle is the primary site of glucose disposal in the insulin-stimulated state. The 
ability of insulin to increase glucose transport in skeletal muscle, and other peripheral 
tissues, is elicited by the translocation of glucose transporter 4 (GLUT4), the major 
insulin regulated GLUT, from intracellular vesicles to the plasma membrane and 
transverse tubules (Choi and Kim, 2010). 
 
In normal subjects, the blood glucose level normally ranges between 90 and 120mg/dL. 
After a meal, this may go up to 250–300mg/dL. Meanwhile, the fasting insulin level 
remains at 15μU/mL and after the intake of food, it may go up to 40μU/mL. This increase 
in insulin secretion is responsible for the post-prandial decrease in glucose, which 
reaches the normal level after about 2 hours. Removal of this excess glucose by insulin 
occurs due to glucose uptake and storage in insulin target cells such as skeletal muscle 
cells, hepatocytes and adipocytes. About 75% of this glucose is stored in skeletal muscle 
cells; therefore, it is the major target cell of insulin, while the rest is stored in the liver 
and adipocytes (Bhattacharya et al., 2007). 
 
Pancreatic islet β-cell 
 
Insulin secretion from pancreatic islet β‑cells is stimulated by glucose metabolism. When 
blood glucose is elevated beyond the Km of GLUT2, glucose is rapidly taken up by the β-
cell via this transporter. Glucose is phosphorylated via glucokinase, which is the rate-
limiting step of β-cell glucose metabolism. Further, glucose degradation leads to 
formation of pyruvate, which is then guided to the tricarboxylic acid cycle in the 
mitochondria. The formation of ATP leads to a rise the ATP/ADP ratio, resulting in 
closure of ATP-sensitive K+ channels. The closure of the potassium channels will alter the 
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membrane potential and open calcium channels, which triggers the release of preformed 
insulin-containing granules, plasma membrane depolarization, activation of voltage-
gated calcium channels and calcium-mediated stimulation of granule exocytosis 
(Stumvoll et al., 2005) (Muoio and Newgard, 2008). 
 
Insulin receptor and signalling 
 
Insulin is a potent anabolic hormone (figure 10), which exerts a variety of effects on many 
types of cells. The main metabolic actions of insulin are, among others (Højlund, 2014): 
 
 to stimulate glucose uptake in skeletal muscle and fat 
 to promote glycogen synthesis in skeletal muscle and liver 
 to suppress hepatic glucose production 
 to inhibit lipolysis in adipocytes 
 
Figure 10. Insulin functions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from (Stumvoll et al., 2005) 
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The action of insulin is initiated through its binding with the target cell surface receptor, 
the insulin receptor. The insulin receptor is a heterotetramer consisting of two α 
subunits and two β subunits that are linked by disulphide bonds. Insulin binds to the 
extracellular α subunit and transduces signals across the plasma membrane, which 
activates the intracellular tyrosine kinase C terminal domain of the β subunit. Binding of 
insulin to insulin receptor effects a series of intramolecular transphosphorylation 
reactions. Although insulin receptor are present on the surface of virtually all cells, their 
expression in classical insulin target tissues, i.e. muscle, liver and fat, is extremely high 
(Brunetti et al., 2001). Autophosphorylation of the insulin receptor tyrosine residue 
stimulates the catalytic activity of receptor tyrosine kinase, which recruits insulin 
receptor substrate (IRS) proteins (IRS-1 and IRS-2) (Rosen, 1987) (Pessin and Saltiel, 
2000). Phosphorylation of IRS1 and IRS2 leads to their association with the 
phosphatidylinositol 3-kinase (PI3K), which activates Akt/PKB. Akt/PKB plays an 
important role by linking GLUT4, the insulin-dependent GLUT protein, to the insulin 
signalling pathway. It activates GLUT4 which moves to the cell surface to transport 
glucose into the cell (Pessin et al., 1999) (Martin et al., 2000) (Kupriyanova and Kandror, 
1999). 
 
 
2.2 DEFINITION AND CLASSIFICATION OF DIABETES MELLITUS 
 
Diabetes is a chronic disease that occurs when the body cannot produce enough insulin 
or cannot use insulin effectively (Harris, M Zimmet, 2003). According to the American 
Diabetes Association (ADA), diabetes mellitus is “a group of metabolic diseases 
characterised by hyperglycaemia resulting from defects in insulin secretion, insulin 
action, or both. The chronic hyperglycaemia of diabetes is associated with long-term 
damage, dysfunction, and failure of various organs, especially the eyes, kidneys, nerves, 
heart, and blood vessels” (American Diabetes Association, 2013). Long-term 
complications of diabetes include retinopathy with potential loss of vision; nephropathy 
leading to renal failure; peripheral neuropathy with risk of foot ulcers, amputations, and 
Charcot joints; and autonomic neuropathy causing gastrointestinal, genitourinary, and 
cardiovascular symptoms and sexual dysfunction. Patients with diabetes have an 
increased incidence of atherosclerotic cardiovascular, peripheral arterial and 
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cerebrovascular disease. Also, hypertension and abnormalities of lipoprotein 
metabolism are often found in people with diabetes (American Diabetes Association, 
2013). 
 
According to ADA, there are four main groups of diabetes mellitus: type 1 diabetes 
mellitus (T1DM), T2DM, gestational diabetes mellitus (GDM), and “specific types due to 
other causes” (American Diabetes Association, 2014). 
 
Type 1 diabetes mellitus 
 
This form of diabetes, previously encompassed by the terms insulin-dependent diabetes 
or juvenile-onset diabetes, accounts for 5–10% of diabetes. T1DM is caused by an 
absolute deficiency of insulin secretion, brought about by a cellular-mediated 
autoimmune destruction of the β-cells of the pancreas (American Diabetes Association, 
2015). 
 
Some forms of T1DM, denominated idiopathic diabetes, have unknown aetiologies. These 
patients have permanent insulinopenia and are prone to ketoacidosis, but have no 
evidence of autoimmunity. Although only a minority of patients with T1DM fall into this 
category, of those who do, most are of African or Asian ancestry. 
 
Type 2 diabetes mellitus 
 
T2DM, previously referred to as non–insulin-dependent diabetes or adult onset diabetes, 
accounts for around 90–95% of all diabetes. The cause of T2DM is a combination of 
resistance to insulin action and an inadequate compensatory insulin secretory response 
(American Diabetes Association, 2015). 
 
Although the specific aetiologies are not completely understood, most patients are obese, 
and obesity itself causes some degree of IR. Autoimmune destruction of β-cells does not 
occur in this patients, thereby, at least initially, and often throughout their lifetime, these 
individuals do not need insulin treatment to survive (American Diabetes Association, 
2015). 
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This form of diabetes frequently goes undiagnosed for many years because the 
hyperglycaemia develops gradually and at earlier stages is often not severe enough for 
the patient to notice any of the classic symptoms of diabetes (American Diabetes 
Association, 2015). 
 
Gestational diabetes mellitus 
 
For many years, GDM was defined as any degree of glucose intolerance that was first 
recognised during pregnancy (Group, 1979), regardless of whether the condition may 
have predated the pregnancy or persisted after the pregnancy. This definition facilitated 
a uniform strategy for detection and classification of GDM, but it was limited by 
imprecision because there are pregnant women with undiagnosed type 2 diabetes. 
Therefore, ADA proposes that women with diabetes in the first trimester should receive 
a diagnostic of T2DM. GDM is diabetes diagnosed in the second or third trimester of 
pregnancy that is not clearly overt diabetes (American Diabetes Association, 2014). 
 
GDM can lead to serious health risks to the mother and her infant and increase the risk 
for developing type 2 diabetes later in life. 
 
Specific types due to other causes 
 
This group includes monogenic diabetes syndromes, such as neonatal diabetes and 
maturity-onset diabetes of the young (MODY), diseases of the exocrine pancreas, such as 
cystic fibrosis, and drug- or chemical-induced diabetes, such as in the treatment of 
HIV/AIDS or after organ transplantation (American Diabetes Association, 2015). 
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2.3 PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS: KEY 
MECHANISMS IN THE ONSET OF TYPE 2 DIABETES MELLITUS 
 
T2DM is characterised mainly, by a progressive failure of pancreatic β-cell function 
and/or IR. Once insulin over-secretion can no longer compensate for the degree of IR, 
hyperglycaemia becomes clinically significant and deterioration of residual β-cell 
reserve accelerates. 
 
2.3.1 Insulin resistance 
 
The concept of insulin resistance (IR) was proposed as early as 1936 (Himsworth, 1936) 
to describe diabetic patients requiring high doses of insulin. IR is said to be present when 
the biological effects of insulin are less than expected for both glucose disposal in skeletal 
muscle and suppression of endogenous glucose production primarily in the liver 
(Dinneen et al., 1992). Thus, endogenous glucose production is accelerated in patients 
with T2DM or impaired fasting glucose (IFG) (Weyer et al., 1999) (Meyer et al., 1998). 
Because this increase occurs in the presence of hyperinsulinaemia, at least in the early 
and intermediate disease stages, hepatic insulin resistance is the driving force of 
hyperglycaemia of T2DM (Stumvoll et al., 2005). 
 
IR is strongly associated with obesity and physical inactivity, and several mechanisms 
mediating this interaction have been identified. A number of circulating hormones, 
cytokines, and metabolic fuels, such as non-esterified fatty acids (NEFA) originate in the 
adipocyte and modulate insulin action. An increased mass of stored triglyceride, 
especially in visceral or deep subcutaneous adipose depots, leads to large adipocytes that 
are themselves resistant to the ability of insulin to suppress lipolysis. This results in 
increased release and circulating levels of NEFA and glycerol, both of which aggravate IR 
in skeletal muscle and liver (Boden, 1997). Thus, increased intramyocellular lipids are 
associated with skeletal muscle IR (Machann et al., 2004). In addition to the increased 
concentrations of NEFA, inflammatory cytokines, such as tumour necrosis factor α 
(TNFα) and interleukin 6, released by expanded visceral adipose tissue, also adversely 
affect the insulin signalling cascade (Rajala and Scherer, 2003) (Ravussin and Smith, 
2002). 
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In states of IR, one or more of the following molecular mechanisms to block insulin 
signalling are likely to be involved. The normal phosphorylation of the receptor and the 
IRS proteins may be counteracted by dephosphorylation of these by cellular protein-
tyrosine phosphatases and by protein phosphorylation on serine and threonine residues, 
which often occur together (Zick, 2001). In addition, serine/threonine phosphorylation 
of IRS1 may reduce its ability to act as a substrate for the tyrosine kinase activity of the 
IR and inhibits its coupling to its major downstream effector systems. Signal 
downregulation can also occur through internalisation and loss of the insulin receptor 
from the cell surface and degradation of IRS proteins (Zhande et al., 2002).  
 
2.3.2 Insulin deficiency 
 
β-cell dysfunction is a critical component in the T2DM pathogenesis. Generally, 
normoglycaemia is maintained by the balanced interplay between insulin action and 
insulin secretion. Importantly, the normal pancreatic β-cell can adapt to changes in 
insulin action, i.e., a decrease in insulin action is accompanied by up-regulation of insulin 
secretion (and vice versa) (Stumvoll et al., 2005). However, at the same time, 
concentrations of blood glucose at fasting and 2 hours after glucose load will increase 
mildly (Stumvoll et al., 2003). This increase may well be small, but over time becomes 
damaging, because of glucose toxicity, and in itself a cause for β-cell dysfunction. Thus, 
even with unlimited β-cell reserve, IR paves the way for hyperglycaemia and T2DM 
(Stumvoll et al., 2005). 
 
The notion that hyperglycaemia itself can decrease insulin secretion has led to the 
concept of glucose toxicity, which implies the development of irreversible damage to 
cellular components of insulin production over time (Robertson et al., 2003) (Yki-
Järvinen, 1992). Indeed, deterioration of insulin secretion over time is the usual course 
in most patients, and many patients will end with more or less severe insulin deficiency 
after about 10 years of diabetes (Wallace and Matthews, 2002). In β-cell, oxidative 
glucose metabolism will always lead to production of ROS, normally detoxified by 
catalase and superoxide dismutase. β-cell are equipped with a low amount of these 
proteins and also of the redox-regulating enzyme glutathione peroxidase (Robertson et 
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al., 2003). Hyperglycaemia has been proposed to lead to large amounts of ROS in β-cell, 
with subsequent damage to cellular components (Stumvoll et al., 2005). 
 
Lipotoxicity 
 
More recently, the concept of lipotoxicity involving the β-cell has been put forward. Fatty 
acids lead to enhanced insulin secretion in acute studies, but after 24 hours, they actually 
inhibit insulin secretion. In the presence of glucose, fatty acid oxidation in β-cell is 
inhibited and accumulation of long-chain acyl coenzyme A occurs (Robertson et al., 
2004).  Long-chain acyl coenzyme A itself can diminish the insulin secretory process by 
opening β-cell potassium channels. A second mechanism might be increased expression 
of uncoupling protein-2, which would lead to reduced ATP formation and, hence, 
decreased insulin secretion. A third mechanism might involve apoptosis of β-cell, 
possibly via fatty acid or triglyceride-induced ceramide synthesis or generation of nitric 
oxide. (Stumvoll et al., 2005) 
 
 
2.4 RISK FACTORS FOR TYPE 2 DIABETES MELLITUS 
 
T2DM is a multifactorial disease that increases with age, obesity, and lack of physical 
activity. It occurs more frequently in women with prior GDM and in individuals with 
hypertension or dyslipidaemia, and its prevalence varies in different racial/ethnic 
subgroups. It is often associated with a strong genetic predisposition, more so than is the 
autoimmune form of T1DM. However, the genetics of this form of diabetes are complex 
and not fully defined (American Diabetes Association, 2015).  The risk factors of T2DM 
may be classified as modifiable and non-modifiable risk factors, depending on whether 
it is possible to prevent them or not. 
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2.4.1 Modifiable risk factors 
 
Overweight and obesity 
 
WHO defines overweight and obesity as an abnormal or excessive fat accumulation that 
may impair health (World Health Organization, 2014). WHO classifies overweight and 
obesity in adults through Body mass index (BMI), a simple index of weight-for-height 
that is commonly used. BMI is defined as a person's weight in kilograms divided by the 
square of height in meters (kg/m2). Thereby, BMI ≥25kg/m2 is defined as overweight, 
and a BMI ≥30kg/m2 is defined as obesity. Both, overweight and obesity, affect a large 
part of adults in developed countries and are increasing rapidly in developing countries. 
 
Overweight and obesity are pushing the global diabetes epidemic. In 2014, more than 1.9 
billion adults, over 18 years, were overweight. Of these over 600 million were obese 
(World Health Organization, 2014). The severity of T2DM is also closely linked with BMI. 
Obese people have seven times greater risk of T2DM than those of healthy weight, while 
overweight people have a threefold increase the risk of T2DM (Abdullah et al., 2010). 
Duration of obesity has also been found to increase risk of developing T2DM, with greater 
risk in people who have been obese for longer periods of time (Abdullah et al., 2011). In 
addition, severity of obesity has shown to increase the risk of T2DM. Obese people with 
BMI ≥40 kg/m2 were at an even greater risk of T2DM, when compared to obese people 
with a lower BMI (30- 39.9 kg/m2) (Vinciguerra et al., 2013). Whilst it is known that body 
fat distribution is an important determinant of increased risk of diabetes, the precise 
mechanism of association remains unclear. 
 
Dietary habits 
 
Excessive caloric intake is a major driving force behind growing obesity and T2DM, but 
diet quality also has independent effects (Hu, 2011). A considerable body of evidence 
shows the negative effects of an unhealthy diet on T2DM. The NHS showed that the 
quality of fats and carbohydrates play an important role in the development of diabetes, 
independent of BMI and other risk factors. Thus, higher dietary glycaemic load and trans 
fat are associated with increased diabetes risk, whilst greater consumption of cereal fibre 
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and polyunsaturated fat are associated with decreased risk (Hu et al., 2001). A meta-
analysis also showed that a 2 serving/day increment in whole-grain intake was 
associated with a 21% lower risk of diabetes (de Munter et al., 2007). 
 
Globalization have spurred nutrition transitions in many countries. This nutritional shift 
involves increased consumption of animal products and energy-dense foods, decreased 
fibre, and more frequent intake of fast foods. Thus, higher consumption of sugar-
sweetened beverages (SSB) increases also the risk T2DM even while taking into account 
the body weight. Recent meta-analyses found that individuals in the highest SSB intake 
(most often 1–2 servings/day) had between 18% (Imamura et al., 2015)  and 26% (Malik 
et al., 2010) greater risk of developing the disease than those in the lowest SSB intake, 
13% after adjusted by adiposity (Imamura et al., 2015). A high consumption of SSBs, with 
large quantities of rapidly absorbable carbohydrates, results in a high dietary glycaemic 
load that drives to quick increases in blood glucose and insulin levels. A high glycaemic 
load diet may lead to pancreatic β-cell exhaustion in the long run, which has been 
implicated in increased risk of T2DM (Hu and Willett, 2002). Fructose, an important 
sugar in SSBs, is preferentially metabolised to lipid in the liver, leading to increased 
hepatic de novo lipogenesis, dyslipidaemia, IR (Stanhope and Havel, 2010), and it may 
also promote visceral adiposity (Stanhope et al., 2009), risk factors related to the 
development of T2DM. Other foods with a high glycaemic index or glycaemic load, such 
as white rice, has also associated with increased risk of T2DM (Villegas et al., 2007), 
whereas consumption of brown rice, a whole grain, protected against the disease (Sun et 
al., 2010). 
 
Moderate alcohol consumption is also associated with reduced risk of diabetes. Thus, a 
meta-analysis found a U-shaped relationship, with a 30% reduced risk of the disease 
among those consuming 6-48g/day of alcohol compared with heavy drinkers or 
abstainers (Koppes et al., 2005). The risk of diabetes among those who consumed three 
or more drinks/day was similar to that of abstainers. Moderate alcohol consumption 
improves insulin sensitivity, increases HDL-cholesterol and adiponectin, and the anti-
inflammatory effect of alcohol. On the contrary, heavy alcohol intake has multiple 
deleterious metabolic effects, including excess caloric intake and obesity, increased 
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triglyceride levels, pancreatitis, disturbance of carbohydrate and glucose metabolism, 
and impairment of liver function (Koppes et al., 2005). 
 
Other foods, such as fruit  and vegetables (Wu et al., 2015), specially green leafy 
vegetable, (Cooper et al., 2012) caffeinated and decaffeinated coffee (Ding et al., 2014) 
and tea (Yang et al., 2014) in a dose–response way, among other, have shown their 
protective effect against the development of T2DM. 
 
In addition, the overall dietary pattern seems to have an even more important role than 
foods separately regarding disease. Thereby, several dietary patterns have been related 
to diabetes risk. The western dietary pattern, strongly related to inflammatory markers, 
is characterised by high intakes of SSBs, refined grains, and red and processed meat, but 
low consumption of wine, coffee, cruciferous vegetables, and yellow vegetables. As 
expected, this pro-inflammatory pattern was strongly associated with an increased risk 
of diabetes (Schulze et al., 2005), suggesting that chronic inflammation may mediate the 
association between a Western dietary pattern and risk of T2DM. Moreover, 
Mediterranean diet is akin to the prudent diet, but has a higher total fat content, because 
it contains sizeable amounts of MUFA in the form of olive oil. In addition, it has alcohol 
(red wine) in moderation, high amounts of vegetables, fruits, legumes, whole grains, fish, 
poultry and low-fat dairy products. Because of that, it has emerged as another 
recognizable and healthy pattern approach to disease prevention (Salas-Salvadó et al., 
2011). Thereby, a Mediterranean diet enriched with extra-virgin olive oil but without 
energy restrictions, has been related to a 40% less risk of T2DM among persons with 
high cardiovascular risk (Salas-Salvadó et al., 2014). Several other studies have seen this 
association between Mediterranean pattern and risk of T2DM (Salas-Salvado et al., 2011) 
(Romaguera et al., 2011). 
 
Sedentary lifestyle 
 
Numerous epidemiologic studies show that increased physical activity reduces risk of 
diabetes, whereas sedentary behaviours increase risk. Thus, each 2-hour/day increment 
of time spent watching television (TV) was associated with a 14% increase in diabetes 
risk (Hu et al., 2003), whilst each 2-hour/day increment of standing or walking around 
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at home was associated with a 12% reduction in risk. Moreover, each 1-hour/day 
increment of brisk walking reduced the risk by 34%. 
 
Among sedentary behaviours (TV watching, sitting at work, and other sitting), prolonged 
TV watching was associated with the highest risk. Watching TV typically takes the place 
of physical activity, thereby reducing energy expended, and it is also associated with 
greater food and total energy intake. In addition, people who spend more time watching 
TV tend to have unhealthy eating patterns characterised by increased consumption of 
snacks, sugary beverages, and fast foods. (Hu et al., 2003). 
 
Smoking 
 
Cigarette smoking is an independent risk factor for T2DM (Cho et al., 2009). A meta-
analysis found a dose-response relationship between the number of cigarettes smoked 
and the diabetes risk. In addition, current smokers had a 45% increased risk of 
developing T2DM compared with non-smokers (Willi et al., 2007). Though underlying 
causes of how cigarette consumption increases the risk of T2DM is not entirely clear, 
several possible biological mechanisms have been proposed. First, although smokers 
tend to be leaner than non-smokers, smoking has been associated with increased risk of 
central obesity or abdominal fat (Barrett-Connor and Khaw, 1989) (Shimokata et al., 
1989), an established risk factor for IR and T2DM. The accumulation of visceral adipose 
tissue among smokers may be because of increased plasma cortisol levels induced by 
stimulation of sympathetic nervous system activity (Grassi et al., 1992). Moreover, 
smoking has anti-estrogenic effects in women and decreases plasma testosterone in men 
(Meikle et al., 1988), which may also promote abdominal fat accumulation and IR (Hu, 
2011). Second, nicotine exposure can cause β-cell dysfunction and increase β-cell 
apoptosis, as it was shown in animal models (Bruin et al., 2008). Smoking showed 
synergistic interaction with the status of low insulin secretion and high IR for developing 
diabetes (Cho et al., 2009). Finally, other studies indicated that smoking increases free 
radical oxidative damage and oxidative stress (Burke and FitzGerald, 2003), contributing 
to the development of T2DM (Paolisso et al., 1993) (Luo et al., 2015). 
 
UNIVERSITAT ROVIRA I VIRGILI 
IRON EXCESS AND RISK OF TYPE 2 DIABETES MELLITUS IN A PROSPECTIVE COHORT OF MEDITERRANEAN POPULATION 
José Cándido Fernández Cao 
Introduction 
95 
 
Furthermore, a recent meta-analyses showed that passive smoking is a risk factor of 
T2DM even in those who were not themselves active smokers (Wei et al., 2015). 
 
2.4.2 Non-modifiable risk factors 
 
Family history of diabetes 
 
Family history of diabetes is a well-known risk factor for the development of T2DM. Both 
genetic and common environmental exposures shared within the family may influence 
this risk factor of T2DM. In a recent study in adults from Shanghai, individuals with a 
family history of diabetes were 1.29 times more likely to develop T2DM than those 
without (Wang et al., 2014). Studies have also observed that maternal history of diabetes 
showed higher risk of T2DM than paternal history (Tan et al., 2008) (Tam et al., 2014), 
and sibling history even more risk than parental history (Annis et al., 2005) (Chien et al., 
2008) (Zhang et al., 2015).  
 
The pathophysiological mechanism underlying these inter-generational effects remain 
largely unknown. Some studies reported that maternal history of diabetes is associated 
with both IR and impaired first-phase insulin secretion (Chen et al., 2012). However, 
others finding found no difference in insulin sensitivity and secretion in the offspring for 
groups stratified according to paternal and maternal inheritance (Chien et al., 2008). 
Epigenetic processes are also suspected to have a key role in the process (Ma et al., 2015). 
 
Genetic factors 
 
Common genetic variants contributing to diabetes susceptibility have been identified in 
recent years due to advent of genome-wide association studies (GWAS) (McCarthy, 
2010). More than 40 genetic loci have been convincingly associated with T2DM, but they 
do not improve the clinical prediction of diabetes beyond traditional risk factors (Hu, 
2011). Moreover, genetic scores based on the number of risk alleles appear to be similar 
across different ethnic groups, therefore, they do not explain ethnic differences in 
diabetes risk  (Hu, 2011). 
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T2DM is the result of interaction between genetic and environmental factors such as 
dietary pattern. The Health Professionals’ Follow-up Study (HPFS) found significant 
interaction between a Western dietary pattern and a genetic risk score (GRS) of T2DM 
susceptibility based on 10 established single nucleotide polymorphisms (P = 0.020) (Qi 
et al., 2009). Interestingly, the Western dietary pattern was not associated with diabetes 
risk in those subjects with a lower GRS. Moreover, components which characterise the 
Western dietary pattern such as processed meat, red meat, and haem iron showed 
significant interactions with GRS in relation to T2DM risk (P for interaction 0.029, 0.020, 
and <0.001, respectively). This suggests that the detrimental effects of a Westernised diet 
may be enhanced by greater genetic susceptibility (Hu, 2011). 
 
Moreover, the “thrifty genotype” hypothesis defends that diseases such as obesity and 
T2DM are the outcome of efficient genotypes for energy and fat storage, advantageous 
during long periods of nutrient scarcity (NEEL, 1962). It would be a mismatch between 
the ancestral genes and modern environment. This hypothesis may explain the high rates 
of diabetes in some indigenous populations such as Pima Indians. However, the detection 
of the “thrifty genes” has so far remained elusive. 
 
The “thrifty phenotype” hypothesis would suppose a disarrangement between perinatal 
and adult life environments (Hales and Barker, 2001). It has been postulated that foetal 
undernutrition leads to metabolic changes that may increase the risk of disorders such 
as T2DM in adulthood (Gluckman et al., 2009). The risks of adverse consequences in 
adulthood are higher in a nutritionally rich than in a scarcity environment. 
 
Both foetal undernutrition and overnutrition are related to an increase future risk of 
diabetes (Yajnik, 2009), likely, through epigenetics changes (chromatin modification, 
DNA methylation,…) rather than genetics (Burdge and Lillycrop, 2010). 
 
Increasing age 
 
One of the most prominent, but also non-modifiable, risk factor for T2DM is advancing 
age. The burden of T2DM has been accelerated in recent years by an increase in the 
ageing population. IDF Diabetes ATLAS 2013 points that, almost half of all adults with 
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diabetes are between the ages of 40 and 59 years. This age group will continue to 
comprise the greatest number of people with diabetes in the coming years. By 2035, it is 
expected that the number will increase to 264 million. The reasons for this association of 
age and many metabolic diseases are degenerative processes leading to cellular 
apoptosis beyond regeneration or repairs (Navarro and Boveris, 2007). 
 
Gender factors 
 
According IDF Diabetes ATLAS 2013, there are differences between men and women in 
T2DM prevalence (International Diabetes Federation, 2013). Thereby, there are about 
14 million more men than women with diabetes (198 million men vs 184 million women) 
in 2013. However, this difference is expected to increase to 15 million (303 million men 
vs 288 million women) in 2035 (International Diabetes Federation, 2013). 
 
There are fundamental aspects of the control of metabolic homeostasis that are regulated 
differently in males and females. This perspective discusses the most fundamental 
gender differences in metabolic homeostasis, diabetes, and obesity. Together, the role of 
genetic sex, the programming effect of testosterone in the prenatal period in males, and 
the activational role of sex hormones at puberty produce two different biological systems 
in males and females that need to be studied separately. These gender-specific 
differences in energy homeostasis and metabolic dysfunction represent a source of 
factors that can be justify the onset of diabetes, and other metabolic disease (Mauvais-
Jarvis, 2015). 
 
Ethnicity 
 
T2DM prevalence is increasing worldwide, particularly among people from non-white 
ethnic groups (Venkataraman et al., 2004) (Brancati et al., 2000) (Tillin et al., 2013). It 
has been seen that T2DM is up to six times more common in people of South Asian 
descent and up to three times more common among people of African and African-
Caribbean origin than white populations (Ntuk et al., 2014) (Tillin et al., 2013) (Bennet 
et al., 2014). Thus, south Asians seem to have the highest prevalence of diabetes, followed 
by Chinese and black participants, with whites having the lowest prevalence (Ntuk et al., 
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2014). Obesity is a risk factor in all ethnic groups, but it has observed, in the UK Biobank 
study that the risk associated with obesity was two- to fourfold higher in non-white 
participants. Even, in non-white groups, the prevalence of diabetes was equivalent to 
that in white populations at much lower levels of BMI and waist circumference (Ntuk et 
al., 2014). 
 
It has been postulated that ethnic differences may be explained by a higher IR among 
Asian and black populations that would increase the visceral and liver fat depots at a 
lower BMI. In addition, the “thrifty gene” inherited from Asian ancestors enabled to store 
energy more efficiently during long periods of nutrient scarcity, but predisposes to 
overweight and obesity in the current obesogenic environment (Bhopal, 2013), and 
therefore to an increase in the risk of T2DM. Lower birth weight, deficient physical 
activity, and other physiological differences such as reduced capacity for fat oxidation 
have also been proposed as related factors (Hall et al., 2010) (Bhopal, 2013). 
 
Gestational diabetes mellitus 
 
GDM is a significant and growing problem in healthcare worldwide. It has been estimated 
that the prevalence of GDM is of around 1-14% of all pregnant women, depending on the 
population studied and the diagnostic test employed (American Diabetes Association, 
2013). As noted above, it is known that women who have had GDM are at a higher risk of 
developing T2DM later in life (Bellamy et al., 2009).  
 
Moreover, there is no question that poorly controlled hyperglycaemia during pregnancy 
is harmful for the foetus and can cause significant morbidity. In this sense, it has been 
suggested that the offspring or mothers with GDM are at an increased risk of developing 
diabetes themselves. However, existing data do not support this hypothesis (Donovan 
and Cundy, 2015). 
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2.5 DIAGNOSTIC CRITERIA FOR PREDIABETES AND TYPE 2 
DIABETES MELLITUS  
 
Initially, diabetes has been diagnosed, according to the National Diabetes Data Group 
criteria, by the presence of the classic signs and symptoms of diabetes and unequivocally 
elevated blood glucose levels, by fasting plasma glucose (FPG) ≥140mg/dl, or by venous 
plasma glucose ≥200mg/dL at 2 hours after a 75-g oral glucose test (OGTT) (Group, 
1979). Moreover, individuals with intermediate plasma glucose levels between those 
considered normal and those considered diabetic, were included in a new category 
named impaired glucose tolerance (IGT) (see table 9). It was proposed to abandon the 
terms chemical, latent, borderline, subclinical, and asymptomatic diabetes, which have 
been applied to persons in this class (Group, 1979). Thereafter, the World Health 
Organization (WHO) Expert Committee on Diabetes in 1980 added this new category in 
(World Health Organization, 1980). 
 
 In 1997, the first Expert Committee on the Diagnosis and Classification of Diabetes 
Mellitus revised the diagnostic criteria, using the observed association between FPG 
levels and presence of retinopathy as the key factor with which to identify glucose level 
threshold (ADA, 1997). These analyses confirmed the long-standing diagnostic 2-hours 
plasma glucose value of ≥200mg/dL (11.1mmol/L). However, the older FPG diagnostic 
cut point of 140 mg/dL (7.8mmol/L) was noted to identify far fewer individuals with 
diabetes than the 2-hours plasma glucose cut point. The FPG diagnostic cut point was  
reduced to ≥126mg/dL (7.0mmol/L).  
 
Table 8. Evolution of diagnostic criteria for type 2 diabetes mellitus. 
  
NDDG 1979           
OMS 1985 
ADA 1997 
OMS 1999 
ADA 2010 OMS 2011 
Fasting blood glucose (mg/dL)a >140 (7.8 mmol/L) >126 (7.0 mmol/L) 
2-hours plasma glucose (mg/dL)a >200 (11.1 mmol/L) 
Random plasma glucose (mg/dL)b >200 (11.1 mmol/L) 
HbA 1C (%)a   >6.5% 
a In the absence of unequivocal hyperglycemia, results should be confirmed by repeat testing. 
b In patient with classic symptoms of hyperglycaemia or hyperglycaemic crisis. 
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Furthermore, the Expert Committee on Diagnosis and Classification of Diabetes Mellitus 
(ADA, 1997) established another intermediate group of individuals whose glucose levels 
do not meet criteria for diabetes, yet are higher than those considered normal, the IFG. It 
should be noted that the 2003 ADA Expert Committee report reduced the lower FPG cut 
point to define IFG from 110mg/dL (6.1mmol/L) to 100mg/dL (5.6mmol/L), in part to 
ensure that prevalence of IFG was similar to that of IGT (Genuth et al., 2003). However, 
the WHO and many other diabetes organizations did not adopt this change in the 
definition of IFG. The current criteria for diagnosing both groups of prediabetes, 
according to this Expert Committee on Diagnosis and Classification of Diabetes Mellitus 
(Genuth et al., 2003), are the following: 
 
 Impaired fasting glucose, defined as having FPG levels 100mg/dL (5.6mmol/L) to 
125mg/dL (6.9mmol/L).  
 
 Impaired glucose tolerance, with 2-hour values in the OGTT of 140mg/dL 
(7.8mmol/L) to 199mg/dL (11.0mmol/L). 
 
Individuals with IFG and/or IGT have relatively high risk to develop diabetes in the 
future. They are not clinical entities in their own right, but rather risk factors for diabetes 
as well as cardiovascular disease. IFG and IGT are associated with obesity (especially 
abdominal or visceral obesity), dyslipidaemia with high triglycerides and/or low HDL 
cholesterol, and hypertension (American Diabetes Association, 2015). Later, in 2010, 
ADA established an HbA1c range of 5.7% - 6.4% in order to identify individuals with 
prediabetes (American Diabetes Association, 2010). 
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Table 9. Evolution of diagnostic criteria for prediabetes, IFG and IGT.       
  
NDDG 1979 
OMS 1985 
ADA 1996        
OMS 1999 
ADA 2003 OMS 2006 ADA 2010 OMS 2011 
IFG 
Fasting plasma 
glucose (mg/dL) 
≥ 140              
(7.8 mmol/L) 
110 - 125         
(6.1-6.9mmol/L) 
100 - 125        
(5.6-6.9mmol/L) 
110 - 125        
(6.1-6.9mmol/L) 
100 - 125                     
(5.6-6.9 mmol/L) 
IGT 
2-hours plasma 
glucose (mg/dL) 
140 - 199 (7.8-11.1 mmol/L) 
IFG & IGT HbA1C         5.7 - 6.4%   
IFG (Impaired Fasting Glucose), IGT (Impaired Glucose Tolerance). 
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In 2008, an International Expert Committee was designated from the ADA, the European 
Association for the Study of Diabetes (EASD) and the International Diabetes Federation 
(IDF) in order to redefine the diagnosis of diabetes using glycated haemoglobin (HbA1c). 
They propose to use the A1C test to diagnose diabetes, with a threshold of ≥6.5%. The 
diagnostic A1C cut point of 6.5% is associated with an inflection point for retinopathy 
prevalence, as are the diagnostic thresholds for FPG and 2-hours plasma glucose 
(International Expert Committee, 2009). Finally, in 2010 the ADA incorporates for the 
first time HbA1c as a diagnostic test for diabetes, and defined three breakpoints for 
HbA1c ≤5.6%, non-diabetic levels; between 5.7% and 6.4%, prediabetic levels; and 
≥6.5%, consistent with the diagnosis of diabetes (American Diabetes Association, 2010). 
In addition, patients with severe hyperglycaemia such as those who present with severe 
classic hyperglycaemic symptoms (polyuria, polydipsia, weight loss, polyphagia and 
blurred vision) or hyperglycaemic crisis can continue to be diagnosed when random (or 
casual) plasma glucose of ≥200mg/dL (11.1mmol/L) is found (see table 8). 
 
2.5.1 Methods for the assessment of insulin resistance and β-cell 
dysfunction 
 
IR is typically defined as decreased sensitivity or responsiveness to metabolic actions of 
insulin (Muniyappa et al., 2008). There are several methods to evaluated IR, such as: 
 
Hyperinsulinemic euglycemic glucose clamp 
 
The glucose clamp technique is the reference standard for directly determining 
metabolic insulin sensitivity in humans. It was originally developed by DeFronzo et al. in 
1979 (DeFronzo et al., 1979). The technique consists of insulin infused intravenously at 
a constant rate that may range from 5 to 120μU·m-2·min-1 (dose per body surface area 
per minute), after an overnight fast. This results in a new steady-state insulin level that 
is above the fasting level (hyperglycaemia). Glucose disposal is increased in skeletal 
muscle and adipose tissue, whereas hepatic glucose production is suppressed. In this 
moment, a bedside glucose analyser is used to frequently monitor blood glucose levels 
at 5- to 10-min intervals. Meanwhile, 20% dextrose is given intravenously at a variable 
rate to “clamp” blood glucose concentrations in the normal range (euglycaemia). Finally, 
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steady-state conditions is achieved for blood glucose, plasma insulin, and the glucose 
infusion rate. Thereby, the latter rate must be equal to the glucose disposal rate 
(Muniyappa et al., 2008). 
  
Clearly this is unphysiological, thus the hyperinsulinaemic euglycaemic glucose clamp is 
not appropriate when an estimation of insulin action and glucose dynamics under 
normal physiological conditions is required. The main advantage of using the glucose 
clamp to estimate insulin sensitivity/resistance in humans is that it directly measures 
whole body glucose disposal at a given level of insulinaemia under steady-state 
conditions. It is a direct measure of insulin sensitivity (Muniyappa et al., 2008). 
 
Frequently sampled intravenous glucose tolerance test 
 
It provides an indirect measurement of metabolic insulin sensitivity/resistance 
according to glucose and insulin data obtained during a frequently sampled intravenous 
glucose tolerance test. After an overnight fast, an intravenous bolus of glucose (0.3g/kg 
body weight) is infused over 2 minutes starting at time 0. Currently, a modified 
frequently sampled intravenous glucose tolerance test (FSIVGTT) is used where 
exogenous insulin (4mU·kg-1·min-1) is also infused over 5min beginning 20min after the 
intravenous glucose bolus (Saad et al., 1997) (Quon et al., 1994). Blood samples are taken 
for plasma glucose and insulin measurements at different moments. These data are then 
subjected to minimal model analysis using the computer program MINMOD to generate 
an index of insulin sensitivity (Muniyappa et al., 2008). 
 
Owing to the complexity of the hyperinsulinaemic euglycaemic clamp, the FSIVGTT may 
be preferred as an alternative option and, as such, can be considered the ‘silver’ standard 
(Bergman, 2007). The main FSIVGTT techniques available are the standard (classical) 
technique and the more modern insulin-modified version. Hyperinsulinaemic 
euglycaemic glucose clamp and FSIVGTT are considered reference techniques (Borai et 
al., 2011). 
 
 
 
UNIVERSITAT ROVIRA I VIRGILI 
IRON EXCESS AND RISK OF TYPE 2 DIABETES MELLITUS IN A PROSPECTIVE COHORT OF MEDITERRANEAN POPULATION 
José Cándido Fernández Cao 
Introduction 
104 
 
Homeostasis model assessment 
 
Homeostasis model assessment (HOMA), developed in 1985 (Matthews et al., 1985), is a 
model of interactions between glucose and insulin dynamics that is then used to predict 
fasting steady-state glucose and insulin concentrations for a wide range of possible 
combinations of IR and β-cell function. HOMA assumes a feedback loop between the liver 
and β-cell (Levy et al., 1998) (Matthews et al., 1985); i.e., glucose concentrations are 
regulated by insulin-dependent hepatic glucose production, whereas insulin levels 
depend on the pancreatic β-cell response to glucose concentrations. Thus, deficient β-
cell function reflects a diminished response of β-cell to glucose-stimulated insulin 
secretion. Likewise, IR is reflected by diminished suppressive effect of insulin on hepatic 
glucose production. HOMA describes this glucose-insulin homeostasis by a set of 
empirically derived nonlinear equations. The model predicts fasting steady-state levels 
of plasma glucose and insulin for any given combination of pancreatic β-cell function and 
insulin sensitivity (Borai et al., 2011). 
 
HOMA is a relatively simple, non-invasive alternative to the clamp technique(Borai et al., 
2011), defined as:  
 
HOMA-IR = fasting glucose (mmol/L) × fasting insulin (µIU/mL)/22.5 
 
Quantitative insulin sensitivity check index 
 
Quantitative insulin sensitivity check index (QUICKI) is an empirically derived 
mathematical transformation of fasting blood glucose and plasma insulin concentrations 
that provides a reliable, reproducible, and accurate index of insulin sensitivity with 
excellent positive predictive power (Muniyappa et al., 2008). 
 
QUICKI = 1/ [log (fasting insulin, IU/mL) + log (fasting glucose, mg/dL)]. 
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Homeostasis model β assessment 
 
HOMA-β is calculated using steady-state blood concentrations of fasting glucose and 
insulin to estimate the degree of β-cell deficiency and the target-tissue sensitivity to 
insulin (Cersosimo et al., 2014). The HOMA-β equation is: 
 
HOMA-β = [20 * fasting insulin (µIU/mL)]/ [fasting glucose (mmol/L) - 3.5] 
 
2.5.2 Biomarkers related to type 2 diabetes mellitus  
 
Adiponectin 
 
Human adiponectin, a 244-amino acid collagen-like protein is solely secreted by 
adipocytes and acts as a hormone with anti-inflammatory and insulin-sensitizing 
properties. Adiponectin secretion, in contrast to secretion of other adipokines, is 
paradoxically decreased in obesity which may be attributable to inhibition of adiponectin 
gene transcription (Ghoshal and Bhattacharyya, 2015). 
 
Adiponectin exhibits two major mechanisms of action by which it inhibits T2DM, one by 
increasing insulin sensitivity and the other way is to increase fatty acid oxidation. APPL1, 
stimulated by adiponectin can interact with adiponectin receptors and can mediate the 
downstream events such as lipid oxidation and membrane translocation of GLUT4, thus 
increasing glucose uptake, providing a platform for increased insulin sensitization (Mao 
et al., 2006). APPL1 modulates the insulin signalling pathway by acting with Akt and PI3K 
(Manning and Cantley, 2007). 
 
The major form of storing and transporting fatty acids is triglycerides. Adiponectin has 
been reported to decrease tissue triglyceride content by increasing the expression of 
CD36, a fatty acid transporter (Yamauchi et al., 2001). Thus, lowering of tissue 
triglyceride content promotes insulin sensitivity. 
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In addition, it has been established that adiponectin enhances insulin-stimulated IRS-1 
tyrosine and Akt phosphorylation, facilitating GLUT4 translocation. Adiponectin also 
defeats T2DM by increasing fatty acid oxidation, which also elevates insulin sensitivity. 
 
In summary, there are several mechanisms through which adiponectin may decrease the 
risk of T2DM, including: suppression of hepatic gluconeogenesis, stimulation of insulin 
secretion, increase insulin sensitivity, stimulation of fatty acid oxidation. Therefore, 
adiponectin could be a novel target for the therapeutic approach to treat diabetes 
mellitus (Ghoshal and Bhattacharyya, 2015). 
 
Osteocalcin 
 
Osteocalcin (OC) is the most prevalent non-collagenous protein, of 49 amino acids in 
human, produced in bone. It is a small protein (49 amino acids in human) that undergoes 
post-translational modification by vitamin K-dependent γ-carboxylation of three 
glutamic acid residues (Motyl et al., 2010). OC is a cell specific molecule secreted by 
osteoblasts, first produced as a prepropeptide, and its mature form is present in fair 
concentration in the circulation. Although OC is detected at high concentration in the 
bone extracellular matrix, it has several characteristic of a hormone. (Ferron and 
Lacombe, 2014). According to previous animal studies, it is the uncarboxylated form of 
OC, and not the carboxylated form of OC, that regulates glucose metabolism. 
 
Analysis of the OC knockout mice (Ocn-/-) revealed that they are abnormally fat 
suggesting that somehow OC might affect glucose metabolism. A comprehensive analysis 
revealed that insulin secretion, glucose tolerance and insulin sensitivity are all decreased 
in Ocn-/- mice under normal chow diet. In addition, islets number, β-cell area, β-cell mass 
and insulin content are reduced in the pancreas of Ocn-/- mice. Importantly, OC appears 
to transcriptionally regulate insulin biosynthesis (Lee et al., 2007). 
 
OC is also a potent insulin secretagogue due to its ability to increase cytosolic calcium 
levels (Hinoi et al., 2008). Therefore, osteoblast-derived OC control glucose metabolism 
by directly affecting pancreatic islets biology as well as insulin synthesis and secretion. 
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It has seen that OC infusions or injections in wild type mice decreased their fat mass, 
their serum triglyceride levels and the expression of lipolysis inducing genes (Tgl and 
Perilipin) in fat (Ferron et al., 2008)(Ferron et al., 2012). The mechanism by which fat 
mass is influenced by OC is unknown, however OC can directly induce expression of 
adiponectin and its target genes in white fat (Ferron et al., 2008). While a role for 
adiponectin in insulin sensitivity in mice fed a high fat diet has been suggested (Yamauchi 
et al., 2001), a recent study has shown that adiponectin regulates bone mass in mice fed 
a normal diet without affecting glucose metabolism (Kajimura et al., 2013). It was also 
reported that OC can directly modulate glucose transport in adipocytes, can suppress the 
secretion of pro-inflammatory cytokines and induce the secretion of anti-inflammatory 
cytokines as well as adiponectin (Hill et al., 2014). 
 
In addition, OC infusion in wild-type mice increases the expression of genes involved in 
thermogenesis (Pgc1a and Ucp1) in brown adipose tissue (Ferron et al., 2008). OC might 
also be affecting glucose uptake in skeletal muscle since it has been shown to modulate 
this function in vascular smooth muscle cells (Idelevich et al., 2011). These observations 
suggested that the protective effect of OC on obesity and IR might be, at least in part, due 
to its capacity to increase energy expenditure in brown adipose tissue and skeletal 
muscle. 
 
 
2.6 PREVALENCE AND INCIDENCE OF TYPE 2 DIABETES 
MELLITUS: EPIDEMIOLOGICAL STUDIES 
 
Diabetes is the most common metabolic disorder worldwide, and its prevalence has been 
increasing in the last years in developed and developing countries (Souto et al., 2011) 
(International Diabetes Federation, 2013). It has been estimated that the number of 
people aged 20 to 79 affected by diabetes will increase from 285 million in 2010 (6.4%) 
to 439 million in 2030 (7.7%) (Shaw et al., 2010). Meanwhile, WHO notes a global 
prevalence of diabetes of 5% among adults aged >18 years (World Health Organization, 
2015). IDF’s most recent estimates indicate that 8.3% (387 million people) of adults in 
the same age range had diabetes in 2014, and the number is expected to rise beyond 592 
million (55% more) in less than 25 years (International Diabetes Federation, 2013) 
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(International Diabetes Federation, 2014). This rise is associated with economic 
development, ageing populations, increasing urbanisation, dietary changes, reduced 
physical activity, and changes in other lifestyle patterns (International Diabetes 
Federation, 2013). 
 
The majority of the 387 million people with diabetes are aged between 40 and 59, and 
80% of them live in low- and middle-income countries. With more than 138 million 
people affected, the Western Pacific has more people with diabetes than any other region. 
In Europe, the number of people with diabetes is estimated to be 52 million (7.9%) of the 
adult population (see Figure 11), 37% over 50 years. Turkey has the highest prevalence 
(14.7%) and Germany has the greatest number of people with diabetes (7.3 million) in 
Europe, followed by Turkey (7.2 million), Russian Federation (6.8 million), Spain (3.7 
million), Italy (3.5 million), France (3.2 million), and the UK (2.5 million) (International 
Diabetes Federation, 2014). 
 
Figure 11. Number of people with diabetes by International Diabetes Federation 
Region. 
 
Source: (International Diabetes Federation, 2014) 
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Figure 12. Evolution of the prevalence of T2DM in the last years in different regions 
of Spain.  
 
Update from Valdés et al. 2007 
 
In Spain, traditionally, it has been used surveys, especially the National Health Survey 
(NHSurv) medical records or estimations based on drug consumption in order to 
determine the prevalence of T2DM. According to data from the NHSurv of Spain in 2013 
(figure 13), Galicia, Extremadura, Andalucia and Murcia were the regions with higher 
prevalence of T2DM (up to 11%) (Ministerio de Sanidad Servicios Sociales e Igualdad, 
2013). The last study done in the whole Spanish territory in people over 18 years, the 
Di@bet.es study, showed a higher prevalence of T2DM (13.8%) (Soriguer et al., 2012) 
than data from the last NHSurv of Spain (up to 11%) and the IDF Diabetes ATLAS (up to 
10.5%) (International Diabetes Federation, 2014). Further, a 6% of the diabetics were 
unaware of their disease (Soriguer et al., 2012). The highest prevalence of diabetes in 
Spain has been observed in the Canary Islands (13.2%) in 2006 (Boronat et al., 2006), 
but we can perceive an increase in the prevalence of T2DM in the whole Spanish 
population from 1992 to 2012. Figure 12 shows the evolution of the prevalence of T2DM 
in the last years in different regions of Spain. 
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Diabetes is one of the most common non-communicable diseases. It is the fourth or fifth 
leading cause of death in most high-income countries and there is substantial evidence 
that it is epidemic in many economically developing and newly industrialised countries. 
Approximately 5.1 million people aged 20 to 79 died from diabetes in 2013, represents 
8.4% of global all-cause mortality among people in this age group. In Europe, one in 10 
deaths in adults can be attributed to diabetes, 619,000 in 2013. The vast majority (90%) 
of these deaths occurred in people over 50. Diabetes and its complications are major 
causes of early death worldwide. About half of deaths (48%) are people under 60. 
Nonetheless, IDF estimates that as many as 175 million people worldwide, or near half 
of all people with diabetes, are unaware of their disease. Most of these cases are T2DM. 
Likely, because there are few symptoms during the early years of T2DM, although high 
blood glucose is silently damaging the body and diabetes complications may be 
developing (International Diabetes Federation, 2013). 
 
Figure 13. Prevalence of diabetes (%) in adult population according to Spanish 
region and gender. 
 
Adapted from National Health Survey 2013 
 
The economic burden of this disease is enormous, taking up about USD 548 billion dollars 
in health spending (11% of the total spent worldwide) in 2013, and it is expected to rise 
beyond USD 627 billion dollars in 2035. A look at health spending on diabetes by region 
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reveals huge disparities in responses to the epidemic. Two regions spent more on 
diabetes than the rest of the regions put together: North America and Caribbean, with an 
estimated USD 263 billion, equal to nearly half the world’s health expenditure on 
diabetes; and Europe with USD 147 billion. On the contrary, despite their growing 
diabetes populations, spending in South-East Asia and Africa accounted for less than 1% 
of all global health expenditure on the disease (International Diabetes Federation, 2013). 
 
Finally, differences between men versus women, and rural versus urban were noted. 
According IDF Diabetes ATLAS, there are about 14 million more men than women with 
diabetes (198 million men vs 184 million women). However, this difference is expected 
to increase to 15 million (303 million men vs 288 million women) by 2035. Further, there 
are more people with diabetes living in urban (246 million) than in rural (136 million) 
areas. By 2035, the difference is expected to widen, with 347 million people living in 
urban areas and 145 million in rural areas (International Diabetes Federation, 2013). 
 
Population-based studies of the incidence of T2DM, is less frequent than those that assess 
its prevalence. Two prospective, population-based studies have been undertaken, both 
in northern Spain (Asturias (Vazquez et al., 2000) and País Vasco (Valdés et al., 2007)); 
the incidence of T2DM was 8 and 10.8 cases per 1000 person-years, respectively. A later 
study carried out in southern Spain found a greater incidence than previous studies (19.1 
cases per 1000 person-years). Probably the high prevalence of obesity and the increase 
in weight in sample, a risk factor on the onset of T2DM, could have played a role (Soriguer 
et al., 2008). More recently, a prospective study from Madrid, among subjects over 24 
years, showed an incidence of diabetes in 2007 of 9.4 cases per 1000 person-years, 
although this incidence was reduced to 8.6 cases per 1000 person-years in 2010 (Martín 
Martínez et al., 2013). 
 
T2DM incidence has also been studied in northern of European countries. Thus, in 
England, the incidence of T2DM was examined in a population-based longitudinal study 
(1990–2000) (Forouhi et al., 2007a). The 10-year cumulative incidence of diabetes was 
7.3 per 1000 person-years. Curiously, diabetes incidence was lower in normoglycaemic 
subjects (2.4 per 1000 person-years), than in IFG individuals from 5.6 to 6.0mmol/L (6.2 
per 1000 person-years) and IFG subjects from 6.1 to 6.9mmol/L (17.5 per 1000 person-
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years). Similarly, the incidence of T2DM in Germany among normoglycaemic subjects 
was lower (5.5 per 1000 person-years) than in IFG subjects (24.2 per 1000 person-years) 
and IGT subjects (42.0 per 1000 person-years) (Rathmann et al., 2009), but significantly 
increased regarding England incidence (Forouhi et al., 2007a). In other European 
countries, the incidence of T2DM varies widely from Sweden (3.7 and 3.8 cases per 1000 
person-years in 1997 and 2003, respectively (Ringborg et al., 2008)), to Italy (7.6 per 
1000 person-years) (Bonora et al., 2004). 
 
From USA, the National Center for Health Statistics (NCHS), Centers for Disease Control 
and Prevention (CDC) conducted continuously since 1957 the National Health Interview 
Survey (NHIS) in order to estimate the incidence of diagnosed diabetes in adults aged 18-
79. From 1980 to 2013, the crude incidence of diagnosed diabetes increased from 3.3 to 
7.1 per 1000 person-years (National Center for Health Statistics, 2015). 
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3.1 THE ROLE OF IRON IN THE PATHOPHYSIOLOGAL 
MECHANISMS IMPLICATED IN THE ONSET OF TYPE 2 
DIABETES MELLITUS 
 
Iron seems to have a central role in the development of T2DM. Both, dietary iron intake, 
specially haem iron, and body iron stores have been related to the risk of T2DM, although 
the exact mechanism implicated is not completely understood. 
 
3.1.1 Iron intake and type 2 diabetes mellitus 
 
Despite increasing evidence about the association between high haem iron intake and 
the risk of T2DM, the exact mechanism is not known. Neither is it fully understood why 
results vary according to the form of iron intake, non-haem and haem iron. There is 
strong evidence that supports that non-haem iron absorption in the proximal intestine 
is accurately regulated by hepcidin to ensure that overall body iron levels are maintained 
at adequate levels (Gulec et al., 2014). Meanwhile, haem iron absorption seems to be 
responsive to changes in body iron status, although to a lesser extent than non-haem 
iron. Recently, Cao et al. observed, in an animal model, that hepcidin has also impact in 
haem iron absorption (59%), although less than non-haem iron assimilation (63%) (Cao 
et al., 2014). In addition, it has been shown that elevated haem iron intake is associated 
with high levels of SF (Vander et al., 2006). It has been speculated that the increase of 
iron stores could play a role in the production of ROS, such as hydroxyl radicals, inducing 
tissue damage (Lipinski, 2011). This mechanism could give an explanation why high 
dietary haem iron intake, in addition to body iron stores (Rajpathak et al., 2009b) 
(Fonseca-Nunes et al., 2015) (Pourmoghaddas et al., 2014) (Lee et al., 2011) (Sharifi et 
al., 2010), has been related to T2DM (Rajpathak et al., 2006). 
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3.1.2 Body iron status and type 2 diabetes mellitus 
 
Iron seems to have a central role in the aetiopathogenesis of T2DM (see figure 14) 
because of its ease to be reversibly oxidised and reduced. This ability turns iron a strong 
pro-oxidant agent that catalyses the generation of powerful ROS, such as hydroxyl 
radical, increasing the oxidative stress (Schulze and Hu, 2005) (Drews et al., 2010). It is 
believed that oxidants can cause the release of catalytic iron (Schulze and Hu, 2005); and 
thereby, a vicious cycle is initiated that leads to the production of more ROS. This 
contributes to tissue damage that may potentially elevate the risk of T2DM. Therefore, 
oxidative stress could be the mechanism by which iron excess is associated with a higher 
incidence of T2DM. 
 
Figure 14. Potential mechanisms for the role of iron in aetiology of type 2 diabetes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from (Rajpathak et al., 2009a) 
 
Precisely, through its oxidative properties (Schulze and Hu, 2005) (Drews et al., 2010), 
body iron has been suggested to play a role in IR (Syrovatka et al., 2009) and beta cell 
dysfunction (Kolberg et al., 2009), which are cardinal features of altered glucose 
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homeostasis. Another possible mechanism is the peroxidation of lipids, especially free 
fatty acids, induced by an increased iron stores in muscle, which would reduce insulin 
sensitivity. Also, iron deposition in the liver may induce hyperinsulinaemia by impeding 
its capacity for insulin extraction, thereby resulting in impaired suppression of hepatic 
glucose production (Niederau et al., 1984) (Ferrannini, 2000). 
 
Similar mechanisms have been shown in mouse models of haemochromatosis, in  which 
iron is accumulated specifically in the endocrine pancreas resulting in decreased β-cell 
function and increased β-cell death (Huang et al., 2011) (Cooksey et al., 2004). 
Additionally, these models have shown that iron overload had deleterious effects on both 
the liver and skeletal muscle, and also, increased iron levels in adipocytes were found to 
be negatively correlated with secretion of adiponectin, an adipocytokine that correlates 
with insulin sensitivity (Huang et al., 2011) (Gabrielsen et al., 2012).  
 
3.1.2.1 Iron and insulin sensitivity 
 
Accumulating epidemiological studies have reported an association between body iron 
stores and IR, measured as HOMA-IR (Syrovatka et al., 2009) (Kim et al., 2011a) (Pham 
et al., 2013) (Aregbesola et al., 2015). In a recent cross-sectional study, a weak and direct 
association was observed between body iron stores, as assessed by SF quartiles, and IR 
using HOMA-IR in normoglycaemic subjects. However, a dose-dependent direct 
association was observed in prediabetes and T2DM individuals (Aregbesola et al., 2015). 
Likewise, a previous large population study reported that SF concentrations were 
highest in T2DM, followed by prediabetes, and lowest in normoglycaemia (men: 186, 176 
and 156μg/L respectively; women: 85, 75 and 59μg/L respectively) (Kim et al., 2011a). 
 
In addition, in studies among β-thalassemic subjects, insulin sensitivity is significantly 
decreased (Merkel et al., 1988) (Cario et al., 2003), causing a reduction of 40% in insulin 
sensitivity (Cavallo-Perin et al., 1995). 
 
A possible mechanism by which iron induces IR is the peroxidation of lipids, especially 
free fatty acids. The increase in free fatty acids oxidation causes decreased glucose 
uptake by the muscles, which stimulates gluconeogenesis in the liver and results in 
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increased IR (Felber et al., 1987) (DeFronzo, 1988). Therefore, both decreased glucose 
utilization and increased glucose production may occur with higher levels of body iron 
(Rajpathak et al., 2009a). Also, iron deposition in the liver may induce hyperinsulinaemia 
by impeding its capacity for insulin extraction (Niederau et al., 1984), thereby resulting 
in impaired suppression of hepatic glucose production (Ferrannini, 2000). Recently, 
iron-regulated adiponectin and iron-mediated adipocyte IR have also been suggested 
(Gabrielsen et al., 2012). 
 
3.1.2.2 Iron and β-cell function 
 
Pancreatic β-cell function has been shown to be associated with body iron stores (Haap 
et al., 2003) (Aregbesola et al., 2015). In a cross-sectional study the association between 
body iron stores, measured as SF, and  β-cell function, measured by HOMA- β, was 
assessed in normoglycaemia, prediabetes and T2DM subjects (Aregbesola et al., 2015). 
The study showed a weak and direct association in normoglycaemia, direct in 
prediabetes and inverse in T2DM. Authors suggested that this observation could not be 
evident whether the association is assessed in the general population without separation 
into the three glycaemic states. It is recognised that accumulation of body iron stores 
impairs glucose homeostasis by first increasing the IR (Niederau et al., 1984). Then, 
insulin secretion by β-cells would be enhanced in response to the increasing IR up to a 
level, and thereafter, the compensatory mechanism would start to fail, resulting in the 
depreciation of β-cell function. 
 
The iron deposition in pancreatic islets, albeit variable, is preferentially restricted to β-
cells (Rahier et al., 1987). This iron accumulated in β-cell would catalyse the formation 
of hydroxyl radicals, which may attack pancreatic β-cells through increasing oxidative 
stress, since antioxidant enzymes, such as superoxide dismutase, catalase, and 
glutathione peroxidase, are less expressed in pancreatic islets than in other tissues. 
These features makes β-cells particularly susceptible to oxidative damage (Tiedge et al., 
1997), which favours apoptosis (Lenzen, 2008) (Utzschneider and Kowdley, 2010), and 
therefore the impaired insulin  synthesis and secretion (Evans et al., 2002).  
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Similarly, in a mouse model of haemochromatosis, iron excess is accumulated specifically 
in the endocrine pancreas, resulting in β-cell oxidant stress and decreasing insulin 
secretory capacity secondary to β-cell apoptosis and desensitization of glucose-induced 
insulin secretion (Cooksey et al., 2004) (Huang et al., 2011). Another study showed that 
even at ‘normal’ levels, iron exerted detrimental effects on pancreatic β-cell function, and 
that these effects were reversible with dietary restriction or iron-chelation therapy 
(Cooksey et al., 2010). 
 
 
3.2 STUDIES RELATING IRON EXCESS AND RISK OF TYPE 2 
DIABETES MELLITUS 
 
3.2.1 Studies relating iron intake and risk of type 2 diabetes 
mellitus 
 
Few years after Salonen et al. had reported a positive association between excess iron 
deposits and the risk of T2DM in 1998 (Salonen et al., 1998), it became apparent the 
relationship between haem iron intake and the disease in American cohorts. Thus, Lee et 
al., in postmenopausal women within the Iowa Women’s Health Study (IWHS), and Frank 
B. Hu research group, in men within the HPFS, found that haem iron intake was positively 
associated with the incidence of T2DM (Jiang et al., 2004a), especially, in subjects who 
consumed alcohol (Lee et al., 2004). This link was observed more evidently with haem 
iron intake from red meat sources than from other sources (Jiang et al., 2004a). It has 
been suggested that the association between haem iron intake and T2DM was 
confounded by the food source (Rajpathak et al., 2009a), since the most important source 
of haem iron in the diet is red meat. It is known, as Loma Linda University’s Adventist 
Health Study had reported for the first in 1985 (Snowdon and Phillips, 1985), that high 
meat intake is associated with T2DM risk, which it has been consistently observed by 
several other studies (Pan et al., 2011). However, a subsequent prospective study 
conducted in another US cohort, the Nurse’s Health Study (NHS), confirmed earlier 
findings in relation to the haem intake, from all sources, and T2DM risk (Rajpathak et al., 
2006). 
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Results from studies carried out among Chinese population are inconsistent (Shi et al., 
2006) (Luan de et al., 2008). While Luan et al. also found association between haem iron 
intake and T2DM (Luan de et al., 2008), as well as in the previous four American cohorts 
(Jiang et al., 2004a) (Lee et al., 2004) (Song et al., 2004) (Rajpathak et al., 2006); 
surprisingly, Shi et al., within the Jiangsu Nutrition Study (JIN) cohort, observed a 
positive relationship between high total iron (Shi et al., 2006) and non-haem iron (Shi 
and Pan, 2008) intake and risk of T2DM in women, but not in men. However, a 
subsequent prospective analysis in this cohort showed higher risk of T2DM in those 
subjects with the highest haem iron intake (Shi et al., 2010), in accordance with previous 
studies. Finally, one prospective study within the Multi-Ethnic Study of Atherosclerosis 
(MESA) conducted among U.S. adults found no association between haem iron intake and 
T2DM incidence (de Oliveira Otto et al., 2012). 
 
Moreover, the direct association between haem iron intake before pregnancy and/or 
during the early period of pregnancy and the risk of gestational diabetes was also 
reported in the NHS II (Bowers et al., 2011) and the U.S. Omega cohort (Qiu et al., 2011). 
 
3.2.2 Studies relating iron status and risk of type 2 diabetes mellitus 
 
3.2.2.1 Iron status and type 2 diabetes mellitus in general population 
 
sTfR/ferritin ratio 
 
The relation between iron stores and the risk of T2DM among general population was 
reported for the first time by Salonen et al. in 1998 in a longitudinal case-control study 
(Salonen et al., 1998). They observed that elevated iron stores increased the risk of T2DM 
among Finnish adult men (HR = 2.5, 95% CI: 1.1-6.0; P = 0.040) comparing the lowest 
with the highest quartile of sTfR/ferritin ratio. These results were prospectively 
confirmed later within the Nurses’ Health Study (RR = 2.4, 95% CI: 1.55-3.71, P-trend = 
0.020) (Jiang et al., 2004b), the European Prospective Investigation of Cancer (EPIC) 
(RR= 0.57, 95% CI: 0.38-0.85, P-trend = 0.005, using the lower quintile as reference) 
(Montonen et al., 2012), and the Kuopio Ischemic Heart Disease Risk Factor (KIHD) 
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cohorts (HR = 1.75, 95% CI: 1.06-2.88, P-trend = 0.170) (Aregbesola et al., 2013) in USA, 
German, and Finish  population, respectively.  
 
Ferritin 
 
Ferritin is the most widely used biomarker of body iron stores in epidemiological studies. 
Positive association has been observed between high levels of this biomarker and the 
risk of T2DM in different cohorts, such as, the NHS (Jiang et al., 2004b), the EPIC from 
Norfolk (Forouhi et al., 2007b) and Potsdam (Montonen et al., 2012), the Aerobics Center 
Longitudinal Study (Le et al., 2008), the Diabetes Prevention Program (DPP) (Rajpathak 
et al., 2009b), the FINRISK97 and HEALTH 2000 (Salomaa et al., 2010), the Nutrition and 
Health of Aging Population (NHAP) (Sun et al., 2013), and the KIHD (Aregbesola et al., 
2013), in American (Jiang et al., 2004b) (Le et al., 2008) (Rajpathak et al., 2009b), Chinese 
(Sun et al., 2013), and northern Europe (Forouhi et al., 2007b) (Salomaa et al., 2010) 
(Montonen et al., 2012) (Aregbesola et al., 2013) population. Only the Atherosclerosis 
Risk in Communities (ARIC) prospective study (Jehn et al., 2007), conducted on American 
subjects between 45 and 64 years of age, found no association after adjusting for 
components of metabolic syndrome (MetS), a strong risk factor of T2DM (Zeng et al., 
2011). 
 
In addition, a cross-sectional study found that SF concentration increased from 
normoglycaemia through prediabetes to T2DM (133.8, 149.1 and 242.2μg/L 
respectively; P <0.001) (Zheng et al., 2011), suggesting that the gradual increase in 
ferritin levels would lead to a progressive alteration of glucose metabolism. 
 
sTfR 
 
Few prospective studies evaluating the association between iron status and risk of T2DM 
have used sTfR as a biomarker (Montonen et al., 2012)(Rajpathak et al., 
2009b)(Aregbesola et al., 2013) and this relationship is not clear. Thus, while in the 
Potsdam EPIC cohort association was not observed (Montonen et al., 2012), in the DPP 
(Rajpathak et al., 2009b) high levels of sTfR were associated  to an increased risk of 
T2DM. In addition, in the KIHD study, a U-shaped association was observed. Thus, men 
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with moderate levels of sTfR had a lower risk of T2DM regarding men with low sTfR 
concentrations (Aregbesola et al., 2013). 
 
Transferrin saturation 
 
Ellervik et al. carried out the first and largest population-based study that consistently 
demonstrated transferrin saturation as a risk marker of any form of diabetes, and of type 
1 and type 2 diabetes separately, in three independent studies. They found that 
transferrin saturation ≥50% was associated with a twofold increased risk of developing 
T2DM (Ellervik et al., 2011). However, in recent cross-sectional studies inverse 
associations with prevalent T2DM were reported in both, population-based Cooperative 
Health Research in the Region of Augsburg (KORA) F4 study from Germany (Huth et al., 
2015) and in men in an Australian study of Caucasian subjects, but no significant 
association was observed in women (Yeap et al., 2015). Also, no association was found 
between elevated serum transferrin saturation and the development of diabetes in a 
retrospective cohort study based on merging the National Health and Nutrition 
Examination Survey I (NHANES I) with the NHANES I Epidemiologic Follow-up Study 
(Mainous et al., 2002). 
 
Transferrin 
 
Transferrin has been much less investigated as an iron biomarker of T2DM incidence. 
This biomarker is synthesised if body iron stores are low, and thus is inversely correlated 
with ferritin. Nevertheless, studies observed strong positive associations between higher 
transferrin levels and T2DM (Wlazlo et al., 2012) (Huth et al., 2015). These results 
suggest that the association between transferrin and T2DM risk could be explained 
through an iron-independent mechanism. Transferrin may be elevated because of 
inflammation, therefore it might mask a potential association (Wish, 2006). 
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Haemoglobin 
 
Although there are different factors associated with low haemoglobin levels, the most 
common cause of anaemia in developing countries is iron deficiency (World Health 
Organization, 2001). To the best of our knowledge, only one cross-sectional study has 
assessed the relationship between haemoglobin levels and the risk of T2DM in Chinese 
population (Shi et al., 2006). In this study, higher haemoglobin levels were associated 
with an increased risk of T2DM. In addition, an inverse association between anaemia and 
T2DM risk was reported. These last results do not support the hypothesis that low iron 
levels would prevent the development of T2DM. 
 
3.2.2.2 Iron status and type 2 diabetes mellitus in special situations 
 
Haemochromatosis 
 
The first evidence about that systemic iron overload could contribute to abnormal 
glucose metabolism was initially provided by Trousseau in 1865, from the observation 
that the prevalence of T2DM increased in classic HH patients (Trousseau, 1865). It was 
initially referred as “bronze diabetes”, due to the pigmentation that occurs with the 
disease. The prevalence of diabetes among these patients varied between 22% 
(O’Sullivan et al., 2008) and 63% (Dymock et al., 1972) in different studies over the past 
half-century.  
 
Transfusional iron overload 
 
β-thalassemia major is a transfusion-dependent chronic haemolytic anaemia and the 
most common cause of acquired iron overload. The same observation than 
haemochromatosis was done in this genetic disorder of iron metabolism, revealing that, 
irrespective of the cause or the gene involved, iron overload results in an increased 
incidence of T2DM (Swaminathan et al., 2007). The reported prevalence of T2DM in 
these patients ranges from 6% (Borgna-Pignatti et al., 2004) to 14% (Vogiatzi et al., 
2009b), or even 19.5% (Chern et al., 2001). Precisely, a study among β-thalassemic 
individuals, SF significantly correlated with F2-isoprostanes (r = 0.57) and superoxide 
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dismutase (r = 0.46), two important markers of oxidative stress, suggesting that the 
relationship between iron overload and T2DM could be mediated by elevated oxidative 
stress (Rajpathak et al., 2009a). 
 
Until date, β-thalassemia major is the most important example of diabetes due to 
transfusional iron overload, but there are other causes, like bone marrow 
transplantation, warranting repeated blood transfusion, that have also reported diabetes 
as a complication (Baker et al., 2007) 
 
Other causes of iron overload 
 
In porphyria cutanea tarda, a cutaneous condition associated with increased iron 
overload, up to 87% of patients were glucose intolerant (Franks et al., 1979). 
 
HCV infection is well-known to be associated with an accumulation of iron in the liver 
parenchyma. Many patients with chronic HCV infection often have elevated serum iron, 
transferrin saturation and ferritin levels, and a few have severe hepatic iron overload 
(Boujaoude et al., 2000). This might suggest that iron overload has a role in the 
pathogenic link between HCV and accelerated end-organ damage in diabetes 
(Swaminathan et al., 2007). 
 
Friedreich’s ataxia, an inherited neurodegenerative disease with an alteration in the first 
intron of the FRDA gene, is a classic disorder associated with mitochondrial iron 
accumulation. FRDA is associated with a high incidence of T2DM (Rivaud-Pechoux et al., 
1998), suggesting a possible relation between mitochondrial iron accumulation leading 
to mitochondrial DNA damage and T2DM. Disruption of the FRDA gene in pancreatic β-
cells causes T2DM following cellular growth arrest and apoptosis, in parallel to an 
increase in ROS in islets (Ristow et al., 2003). 
 
 
 
 
UNIVERSITAT ROVIRA I VIRGILI 
IRON EXCESS AND RISK OF TYPE 2 DIABETES MELLITUS IN A PROSPECTIVE COHORT OF MEDITERRANEAN POPULATION 
José Cándido Fernández Cao 
Introduction 
123 
 
3.2.2.3 Blood donation, phlebotomy, and iron-chelating agents and type 2 diabetes 
mellitus 
 
The best evidence for the causality between iron and T2DM is the improvement in the 
diabetic state after iron depletion. 
 
Blood donation and phlebotomy 
 
Blood donations and phlebotomy have also been observed to have a positive effect on 
insulin sensitivity and T2DM risk because they reduce body iron levels. Fernandez-Real 
et al. observed a decrease in body iron levels associated to and improvement in insulin 
sensitivity in healthy subjects who made frequent blood donations (at least 2 in the 
previous 5 years) (Fernández-Real et al., 2005). They also found that the number of 
donations was positively correlated with insulin sensitivity. The same authors had 
previously observed that both insulin secretion and sensitivity, and glycosylated 
haemoglobin levels improved in diabetic patients undergoing phlebotomy (Fernández-
Real et al., 2002). These results appear to show that iron reduction has a beneficial effect 
on the occurrence of T2DM. Interestingly, even in apparently healthy individuals, blood 
donation, resulting in decreased iron stores, has also been associated with a low 
incidence of T2DM (Ascherio et al., 2001). 
 
Other pathology associated with increased SF, independently of C-reactive protein and 
increased liver iron, is insulin resistance hepatic iron overload, or dysmetabolic iron 
overload disease. In this condition, iron depletion therapy has been shown to increase 
peripheral and hepatic insulin sensitivity, increase pancreatic insulin sensitivity, reduce 
HbA1c, and improve liver function test results (Aigner and Datz, 2008). 
 
Nevertheless, Zheng et al. found no significant differences in the risk of T2DM between 
frequent donors (>8 donations per 2 year) and infrequent donors (1–2 per 2 year) 
(Zheng et al., 2007). The HPFS study conducted in 33,541 men did not support a link 
between blood donation and risk of T2DM (Jiang et al., 2004a). 
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Iron-chelating agents 
 
Iron chelation is another treatment modality to reduce body iron levels. In a recent 
laboratory experiment, iron depletion with deferoxamine was shown to improve insulin 
sensitivity (upregulated glucose uptake and increased insulin receptor activity and 
signalling) in hepatocytes (Dongiovanni et al., 2008). In a study among nine T2DM 
patients without HH, iron chelation therapy with intravenous deferoxamine resulted in 
a significant improvement in metabolic control as seen by reduction in blood glucose and 
glycosylated haemoglobin levels (Cutler, 1989). In another study, five T2DM patients 
with high ferritin levels were treated with intramuscular injections of deferoxamine 
(Kaye et al., 1993). Two of these patients achieved a normalization of ferritin levels after 
12 weeks of deferoxamine injections twice weekly; however, none obtained any 
significant clinical change in the use of antidiabetic medication, and deferoxamine had 
no effect on glycaemia. Controlled trials are required to address both the beneficial and 
potential adverse effects of iron chelation therapy. 
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Diabetes is the most common metabolic disorder worldwide. Its prevalence in both 
developed and developing countries has been increasing in the last few years in parallel 
to the obesity epidemic. It has been estimated that the number of people aged 20 to 79 
affected by diabetes will increase from 6.4% in 2010 to 7.7% in 2030 and that this trend 
will continue into the future. Diabetes has become an important public health problem 
since it is one of the main causes of morbidity and death. The International Diabetes 
Federation recently estimated that roughly 5.1 million people aged between 20 and 79 
died from diabetes in 2013, accounting for 8.4% of global all-cause mortality among 
people in this age group. In Europe, one in 10 adult deaths (619,000 in 2013) can be 
attributed to diabetes. The vast majority of these deaths (90%) were in people over the 
age of 50. However, diabetes and its complications are also major causes of early death 
worldwide. The evolution of this illness leads to complications such as cardiovascular 
disease, retinopathy, nephropathy, neuropathy, leg ulcers and gangrene, These common 
disorders are costly and shorten life expectancy. 
 
Type 2 diabetes mellitus (T2DM) is a multifactorial disease that increases with age, 
obesity, and inadequate lifestyles habits such as smoking, an unhealthy diet and a lack of 
physical activity. An excessive caloric intake is a major driving force behind escalating 
T2DM epidemics worldwide but dietary quality also has independent effects. Much 
evidence shows the negative effects of an unhealthy diet on T2DM. Foods such as white 
rice, with a high glycaemic index; red meat and processed meat have been associated 
with an increased risk of T2DM. Meat in particular is a source of many components that 
may elevate the risk of T2DM, such as saturated fatty acids, cholesterol, sodium, 
advanced glycation end products (AGEs), dioxins, phthalates, bisphenol A, nitrosamines, 
trimethylamine N-oxide, nitrates, nitrites and haem iron. Haem iron intake has been 
associated with the risk of T2DM in U.S. and Chinese populations but this relationship 
has not been studied in the European population. 
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Although the potential mechanism that mediates the relationship between haem iron 
and T2DM is not well-established, iron could play a role in glucose metabolism because 
of its action as a pro-oxidant. It is speculated that an increase in iron stores may play a 
role in the production of ROS, such as hydroxyl radicals, thus leading to tissue damage. 
Specifically, it is suggested that via its oxidative properties, body iron may play a role in 
IR and β-cell dysfunction, which are two key events in the clinical development of T2DM. 
New biomarkers, such as osteocalcin (OC), have recently been related to glucose 
metabolism. Much research has indicated that iron overload affects bone tissue causing 
both osteopenia and osteoporosis. Interestingly, in vitro studies have shown that ferritin 
itself can directly inhibit osteogenesis in a dose-responsive manner through its 
ferroxidase activity. Iron is also reported to have a detrimental effect on the 
differentiation, proliferation, and activity of osteoblasts, which synthesise OC. It would 
be interesting, therefore, to investigate the possible relationship between body iron 
stores and OC concentrations as a potential mechanism for explaining iron-induced 
T2DM. 
 
As well as to haem iron intake, body iron stores have also been associated with T2DM in 
U.S., Chinese, and northern European population. To date, however, no studies have been 
conducted in southern Europe to explore this relationship. Some characteristics of iron 
metabolism in southern European populations are quite different from those of 
previously studied populations. For example, the consumption of food items of animal 
origin is greater in northern Europe than in southern Europe. It would be interesting, 
therefore, to evaluate the relationship between iron intake and body iron stores and the 
risk of T2DM in a southern European population.
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Elevated iron levels could lead to an increase in oxidative stress. This could cause 
progressive failure of pancreatic β-cell function and a decrease in insulin sensitivity, 
which are two key events in the pathophysiology of type 2 diabetes mellitus (T2DM). Iron 
may therefore be a risk factor in the development of T2DM. 
 
In a Mediterranean population, a high iron intake and/or elevated iron status could 
increase the risk of T2DM. 
 
 
 
To assess, in a prospective study, the effect of elevated dietary iron intake and body iron 
status on the risk of T2DM in an adult Mediterranean population and to evaluate the 
relationship between iron status and serum osteocalcin (OC) as a potential mechanism 
for explaining iron-induced T2DM. 
 
 
 
1. To compare, at the beginning of the longitudinal study, the socio-demographic and 
lifestyle variables, anthropometrical measurements, and food and nutrient intake of 
incident and non-incident diabetic subjects. 
 
2. To evaluate the effect of iron intake, at baseline, on the risk of new-onset T2DM 
during follow-up, while taking into account other factors that are associated with 
this relationship, such as socio-demographic, anthropometric, lifestyle, and dietary 
factors.  
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3. To analyse the association between iron status and serum OC concentrations as a 
potential mechanism for explaining iron-induced T2DM in both impaired fasting 
glucose subjects and normal glucose metabolism subjects, while taking into account 
other factors that are associated with this relationship, such as socio-demographic, 
anthropometric, lifestyle, inflammation and oxidation confounding variables. 
 
4. To compare, at the beginning of the longitudinal study, the iron status, fasting 
glucose and insulin levels, insulin resistance, inflammation, lipid profile, metabolic 
syndrome (MetS) status and prevalence of related pathologies in incident and non-
incident diabetic subjects. 
 
5. To prospectively assess the effect of iron status at baseline, measured as serum 
ferritin (SF) and soluble transferrin receptor (sTfR), and the risk of new-onset T2DM 
during follow-up, while taking into account other factors that are associated with 
this relationship, such as socio-demographic, anthropometric, lifestyle and dietary 
factors, inflammation, and MetS components. 
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The following three studies were included in the present thesis in order to assess the 
objectives: 
 
Study 1: Iron intake and type 2 diabetes mellitus 
 
Study 2: Body iron status and serum osteocalcin levels 
 
Study 3: Body iron status and type 2 diabetes mellitus 
 
Data collected from Reus-Tarragona, Pamplona and Barcelona centres of the PREDIMED 
study was used. Men, aged 55 to 80, and women, aged 60 to 80, free of T2DM and CVD at 
baseline, but at high cardiovascular risk, were enrolled. The protocol, design, aims and 
methodology of the PREDIMED trial have been described in detail previously (Martínez-
González et al., 2012), and is available in http://www.predimed.es. The study protocol 
was approved by the Clinical Research Ethics Committee of the Hospital 
Clínic de Barcelona and the other institutions involved. The protocol was in accordance 
with the Declaration of Helsinki and was registered in the ISRCTN clinical trials register 
(http://www.controlled-trials.com/ISRCTN35739639). 
 
 
1. STUDY 1: IRON INTAKE AND TYPE 2 DIABETES MELLITUS 
 
An observational cohort analysis was conducted in order to evaluate the effect of 
elevated iron intake on the risk of T2DM. At baseline, a subset of 1,073 non-diabetic 
participants, 460 men aged 55 to 80 years and 613 women aged 60 to 80 years, were 
included in the analysis from two Spanish centres (Reus-Tarragona and Pamplona). 
During the follow-up (median: 4.9 ± 1.3 years), a total of 131 incident cases of T2DM 
were diagnosed using the ADA criteria (American Diabetes Association, 2013). 
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Medical information was collected on subjects’ medical record of a 47-item 
questionnaire about education, lifestyle, history of illnesses and medication use 
(Appendix II). Trained personnel measured baseline weight, height and waist 
circumference as previously reported, as well as blood pressure in triplicate with a 
validated semiautomatic oscillometer (Omron HEM-705CP, Hoofddorp, Netherlands) 
(Redón and Coca 2003). Energy expenditure in leisure-time physical activity was 
estimated using the validated Spanish version of the Minnesota Questionnaire (Elosua et 
al., 1994) (Appendix IV). Sociodemographic and smoking data were also recorded at 
baseline. 
 
A validated 137-item FFQ (Appendix III) was administered (Fernández-Ballart et al., 
2010).  Consumption of the following food groups was calculated: dairy; meat, fish and 
eggs; cereals, legumes and nuts; vegetables; fruits; oils and fats; candies and sweetened 
beverages; alcoholic beverages; tea and coffee. Total energy and nutrient intake were 
calculated on the basis of Spanish food composition tables (Mataix, 2003) (Moreiras et 
al., 2009). According to the Monsen model, an average of 40% of total iron in meat, fish 
and poultry was considered as haem iron (Monsen et al., 1978). Then, we created a 
categorical variable of haem iron intake: low (<3.173mg), medium (3.173– 4.130mg) and 
high (>4.130mg) consumers. 
 
Serum levels of total triglycerides, and total and HDL-cholesterol were measured by 
standard enzymatic methods. LDL-cholesterol was calculated using the Friedewald 
equation. From these data, hypercholesterolaemia (total cholesterol ≥240mg/dL), and 
hypertriglyceridaemia (triglycerides ≥200mg/dL) was calculated. These cardiovascular 
risk factors, besides hypertension, were defined according to the Third Report of the 
National Cholesterol Education Program Expert Panel on Detection, Evaluation, and 
Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (Expert Panel 
on Detection, Evaluation, 2001). 
 
In order to assess the association between haem iron intake and T2DM, we used several 
proportional hazard models. The first model used raw data with unadjusted haem iron 
intake. The second model used data adjusted for energy intake. And the final model was 
adjusted for dietary, anthropometric, socio-demographic and lifestyle variables: for 
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example, age, gender, waist circumference, smoking, education level and intervention 
group. Some components of foods that can interfere with haem iron absorption were 
introduced as confounding variables, such as: fruit; meat, fish and eggs [animal protein]; 
cereals, legumes and nuts [vegetable protein]; calcium; alcohol beverages; tea and coffee 
(the last two representing the consumption of polyphenols). No interactions were found 
between gender or age. 
 
The methodological characteristics of this study are more widely discussed in the 
corresponding article included in the results section. 
 
 
2. STUDY 2: BODY IRON STATUS AND SERUM OSTEOCALCIN 
LEVELS 
 
A cross-sectional study was performed with the purpose of assess the relationship 
between iron status and serum concentration of osteocalcin (OC). A sample of 423 non-
diabetic subjects, men aged 55 to 80, and women aged 60 to 80, were randomly selected 
from three Spanish centres (Reus-Tarragona, Navarra and Barcelona). 
 
Medical information was collected on subjects’ medical record of a 47-item 
questionnaire about education, lifestyle, history of illnesses and medication use 
(Appendix II). Trained personnel measured baseline weight, height and waist 
circumference as previously reported, as well as blood pressure in triplicate with a 
validated semiautomatic oscillometer (Omron HEM-705CP, Hoofddorp, Netherlands) 
(Redón and Coca 2003). Energy expenditure in leisure-time physical activity was 
estimated using the validated Spanish version of the Minnesota Questionnaire (Elosua et 
al., 1994) (Appendix IV). Sociodemographic and smoking data were also recorded. 
 
Serum levels of fasting glucose, total cholesterol, HDL-cholesterol and triglycerides were 
measured by standard enzymatic automated methods. LDL-cholesterol concentrations 
were calculated using Friedewald’s equation in those patients whose triglyceride levels 
were <400mg/dL. Plasma fasting insulin concentrations were measured by an ELISA kit 
for human insulin (Millipore, St. Charles, Missouri, USA). IR was estimated by the HOMA 
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method using the following equation (Matthews et al., 1985). Altered β-cell function was 
estimated using HOMA-β (homeostasis model assessment- β-cell) (Matthews et al., 
1985). 
 
Serum concentrations of total and uncarboxylated OC were measured by 
electrochemiluminescence immunoassay (N-mid osteocalcin, Roche, Indianapolis, IN). 
Serum ferritin (SF) (Ferritin Elecsys, Roche diagnostics, Mannheim, Germany) and 
soluble transferrin receptor (sTfR) (Access sTfR 0QC, Beckman Coulter, USA) were 
measured by immunochemiluminescence. Adiponectin levels were measured using an 
enzymatic immunoassay (Millipore, St. Charles, Missouri, USA). Plasma oxidised LDL 
(oxLDL) concentrations were also measured by a commercial ELISA (Mercodia Oxidised 
LDL ELISA, Uppsala, Sweden). Plasma concentrations of high-sensitivity C-reactive 
protein (hs-CRP) were measured using a highly sensitive immunoassay (Helica 
Biosystems Inc., Santa Ana, CA, USA). 
 
In order to examine the relationship between markers of iron metabolism with serum 
concentrations of total and uncarboxylated OC, linear regression models were fitted 
including gender, age, BMI, smoking status, total energy intake, energy expenditure in 
leisure-time physical activity, fasting plasma glucose and insulin, and markers of 
inflammation or oxidation (adiponectin, CRP, oxLDL) as potentially confounding 
variables in the fully adjusted model. In addition, both regressions analyses with either 
SF or sTfR as outcomes were mutually adjusted for each other to account for negative 
confounding because they are both independently associated with IR despite their 
negative reciprocal correlation (Fumeron et al., 2006) (Vari et al., 2007). Interactions 
between iron status with gender, and glucose metabolism were tested in the fully 
adjusted models. For loge-transformed outcome variables (i.e. serum concentrations of 
total and uncarboxylated OC) regression coefficients were converted into percentages of 
relative change in the original variable (percentage decrease in total or uncarboxylated 
OC per 50ng/mL increase in ferritin or per 1ng/mL of increased sTfR). 
 
The methodological characteristics of this study are more widely discussed in the 
corresponding article included in the results section. 
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3. STUDY 3: BODY IRON STATUS AND TYPE 2 DIABETES 
MELLITUS 
 
A prospective nested case-control study was conducted to evaluate the relationship 
between excess body iron and the risk of T2DM. At baseline, from 1378 Caucasian non-
diabetic individuals aged 55 to 80, recruited from three Spanish centres (Reus-
Tarragona, Pamplona and Barcelona-Clinic), we selected all the 153 individuals who 
developed T2DM during a median follow-up of 6.0 years (interquartile range: 3.9-6.5). 
For every subject who developed T2DM, two controls were matched to the cases by age, 
gender, BMI, and dietary intervention group, resulting in 306 controls. The 1225 non-
diabetic subjects that were candidates for inclusion in the control group were classified 
according to categories of matching variables: age (≤67 or >67 years), gender, BMI (≤27 
or >27kg/m2), and intervention group (Mediterranean diet supplemented with virgin 
olive oil, Mediterranean diet supplemented with nuts or control group). In total 24 
groups were created (2*2*2*3 = 24 groups). Then, out of each of the 24 groups, two 
controls were randomly selected for every case belonging to the same group. The 
effective sample size for statistical analyses was 459 participants. 
 
Medical information was collected on subjects’ medical record of a 47-item 
questionnaire about education, lifestyle, history of illnesses and medication use 
(Appendix II). Trained personnel measured baseline weight, height and waist 
circumference as previously reported, as well as blood pressure in triplicate with a 
validated semiautomatic oscillometer (Omron HEM-705CP, Hoofddorp, Netherlands) 
(Redón and Coca 2003). Energy expenditure in leisure-time physical activity was 
estimated using the validated Spanish version of the Minnesota Questionnaire (Elosua et 
al., 1994) (Appendix IV). Sociodemographic and smoking data were also recorded. New 
onset T2DM during follow-up was diagnosed using the criteria of the ADA (American 
Diabetes Association, 2013). 
 
Serum levels of fasting glucose, total cholesterol, HDL-cholesterol and triglycerides were 
measured by standard enzymatic automated methods. LDL-cholesterol concentrations 
were calculated using Friedewald’s equation in those patients whose triglyceride levels 
were <400mg/dL. Plasma fasting insulin concentrations were measured by an ELISA kit 
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for human insulin (Millipore, St. Charles, Missouri, USA). IR was estimated by the HOMA 
method using the following equation (Matthews et al., 1985). 
 
Plasma concentrations of high-sensitivity C-reactive protein (hs-CRP) were measured 
using a highly sensitive immunoassay (Helica Biosystems Inc., Santa Ana, CA, USA). SF 
(Ferritin Elecsys, Roche diagnostics, Mannheim, Germany) and sTfR (Access sTfR 0QC, 
Beckman Coulter, USA) were measured by immunochemiluminescence.  
 
In order to analyse the relationship between body iron levels and the incidence of T2DM, 
participants were categorised into quartiles according to the distributions of SF, sTfR and 
sTfR/ferritin ratio at baseline in control individuals. Given the documented differences 
between males and females with respect to body i stores, the independent variables were 
adjusted for gender. The adjusted variables were categorised to avoid any assumption of 
linearity, and to evaluate the dose–response relationship in the onset of T2DM. Several 
conditional logistic regression models were applied. A crude model (without 
adjustment) was fitted with each independent variable. The model was re-fitted with 
adjustment for lifestyle variables such as marital status (married/not married), 
educational level (primary/secondary/tertiary), smoking (current smoker/former 
smoker/never smoked), alcohol consumption (drinker/non-drinker), physical activity 
(200 metabolic equivalents (MET)-min/d/ ≥200MET-min/d); family history of T2DM 
(yes/no). components of the MetS, according to the harmonised criteria proposed by 
International Diabetes Federation (IDF) and the American Heart Association/National 
Heart, Lung, and Blood Institute (AHA/NHLBI)(26), i.e. blood pressure ≥135/85mmHg, 
serum TAG ≥1.7mmol/L, HDL-cholesterol ,1.03mmol/L in males and,1.3mmol/L in 
females, waist circumference ≥102cm in men and ≥88cm in women, and fasting glucose 
concentration ≥5.6mmol/L; dietary variables categorised by quartiles, such as, energy, 
Mg, vitamins D and E, dairy products, meat, vegetables and fruits; and hs-CRP (mg/L). 
The test for linear trend across the quartiles was performed by assigning the median 
value to each category and introducing these new variables into the conditional logistic 
regression as continuous variables. 
 
The methodological characteristics of this study are more widely discussed in the 
corresponding article included in the results section.
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Heme iron intake and risk of new-onset diabetes
in a Mediterranean population at high risk of
cardiovascular disease: an observational
cohort analysis
Jose Candido Fernandez-Cao1, Victoria Arija1,2,3*, Nuria Aranda1,3, Monica Bullo3,4,5, Josep Basora2,3,5,
Miguel Angel Martínez-González6, Javier Díez-Espino6,7 and Jordi Salas-Salvadó3,4,5*
Abstract
Background: Several epidemiological studies have observed an increased risk of type 2 diabetes mellitus (T2DM)
among subjects with a higher consumption of red and processed meat. Heme iron intake has been directly
associated with a higher risk of T2DM in healthy adult Chinese and U.S populations. The objective of the present
study was to evaluate the association between heme iron intake and the incidence of T2DM in a Mediterranean
population at high cardiovascular risk.
Methods: We assessed a subset of participants in the PREDIMED trial as an observational cohort, followed up for a
maximum of eight years. We initially included 1073 non-diabetic subjects (57.1% women) aged 67.3 ± 6.0 years, at
high cardiovascular risk. Diet was assessed at the study baseline using a validated, semi-quantitative food frequency
questionnaire.
Results: During the follow-up period 131 diabetics were newly diagnosed. The risk of developing T2DM was assessed
using baseline heme iron intake and proportional hazard models, first unadjusted, then adjusted for energy, and finally
adjusted for dietary, anthropometric, socio-demographic and lifestyle variables. Significant direct associations with the
incidence of T2DM were found for heme iron (Hazard Ratio [HR] 1.30, 95% confidence interval [CI], 1.02 to 1.66).
Secondarily, we have also observed that coffee (HR:0.93, 95% CI, 0.89 to 0.98) and alcoholic beverages (HR: 1.02, 95% CI,
1.01 to 1.04) were also found to reduce and increase the risk of T2DM, respectively.
Conclusion: High dietary intake of heme iron was associated with an increased risk of developing T2DM in a
Mediterranean population at high cardiovascular risk.
Trial registration: Identifier: ISRCTN35739639.
Background
In recent years the prevalence of T2DM has increased
worldwide. It has been estimated that the number of
people aged 20 to 79 years affected by T2DM will in-
crease from 285 million in 2010 (6.4%) to 439 million in
2030 (7.7%) [1].
Diet is one of the components of lifestyle that has
most been studied in the prevention of T2DM. A recent
meta-analysis reported that red meat, and particularly
processed meat [2], is associated with a greater risk of
T2DM incidence. In recent years, some studies in healthy
adult Chinese [3,4] and U.S populations [5-7] suggest that
the component of meat responsible for this association
could be the intake of total iron [3] or heme iron [4-7].
The deregulation of iron homeostasis has been impli-
cated in the origin of such pathologies as cancer, Alzhei-
mer’s disease, cardiovascular disease and T2DM, among
others [8]. Although the exact mechanism by which iron
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induces T2DM is not clear, it has been speculated that,
being a pro-oxidant element, it strengthens the forma-
tion of hydroxyl radicals [9], thus favouring situations of
oxidative stress and contributing to insulin resistance or
long-term pancreatic failure [9].
The association between heme iron intake and in-
creased risk of T2DM has been studied in the general
population, but not in individuals at high cardiovascular
risk. Therefore, the objective of the present study was to
evaluate the effect of heme iron intake on the incidence
of T2DM in a nondiabetic Mediterranean population at
high cardiovascular risk.
Methods
The study design was an observational cohort analysis of
a subset of non-diabetic participants in the PREDIMED
trial [10], who were followed up between 1 and 8 years
(median 4.85 ± 1.28 years). PREDIMED is a large multi-
centre, randomized, controlled trial that attempts to test
the efficacy of the Mediterranean diet (MeDiet) in the
primary prevention of cardiovascular disease. Two trad-
itional Mediterranean diets were evaluated – one enriched
with extra virgin olive oil and the other with mixed nuts –
along with a control low-fat diet normally recommended
for cardiovascular disease prevention in a high-risk popu-
lation. Full details of the PREDIMED trial (http://www.
controlled-trials.com/ISRCTN35739639) have been pub-
lished elsewhere [10].
Study participants
The present study was conducted on 1 073 subjects: 460
men aged 55 to 80 years, and 613 women aged 60 to
80 years from two PREDIMED trial centers (Reus and
Pamplona). The subjects included were non-diabetics and
had three or more of the following cardiovascular risk fac-
tors: current smoker (>1 cigarette/day for the past month),
high blood pressure (systolic ≥ 140 mmHg or diastolic ≥
90 mmHg or taking blood pressure medication), LDL chol-
esterol ≥ 169 mg/dl or lipid-lowering treatments, HDL
cholesterol ≤ 40 mg/dL in men or ≤ 50 mg/dL in women;
body mass index (BMI) ≥ 25 kg/m2; and family history of
premature coronary disease (≤ 55 years in men and ≤
60 years in women). Exclusion criteria were a previous his-
tory of cardiovascular disease (coronary heart disease,
stroke or peripheral arterial disease); any severe chronic ill-
ness; alcohol or drug abuse; BMI > 40 kg/m2; more than a
5% loss in body weight in the last year; and a history of al-
lergy to nuts [10]. The Clinical Research Ethics Committee
of the Hospital Sant Joan de Reus approved the study
protocol and all participants provided written informed
consent.
During the follow-up a total of 131 incident cases of
T2DM were diagnosed using the American Diabetes As-
sociation criteria [11] (fasting blood glucose ≥ 7.0 mmol/
L or blood glucose ≥ 11.1 mmol/L after an oral dose of
75 g glucose, measured annually). A second test with the
same criteria was required to confirm the diagnosis. In-
cident T2DM cases were confirmed by the PREDIMED
study’s Clinical Events Committee.
Measurements
Dietary intake was determined at baseline using a validated
137-item, semi-quantitative food frequency questionnaire
[12]. For the present analysis, food was grouped according
to its nutritional composition. Finally, consumption of the
following food groups was calculated: dairy; meat, fish and
eggs; cereals, legumes and nuts; vegetables; fruits; oils and
fats; candies and sweetened beverages; alcoholic beverages;
tea and coffee. Total energy and nutrient intake were calcu-
lated on the basis of Spanish food composition tables [13].
Sociodemographic, anthropometric (weight, height, waist
circumference) and biochemical data were also recorded at
baseline and on each annual visit to identify health prob-
lems such as obesity (BMI ≥ 30 kg/m2), hypercholesterol-
emia (total cholesterol ≥ 240 mg/dl), hypertriglyceridemia
(triglycerides ≥ 200 mg/dl) and hypertension (systolic blood
pressure ≥ 140 mmHg and/or diastolic blood pressure ≥
90 mmHg). The last three cardiovascular risk factors were
defined according to the Third Report of the National
Cholesterol Education Program (NCEP) Expert Panel on
Detection, Evaluation, and Treatment of High Blood Chol-
esterol in Adults (Adult Treatment Panel III) [14].
The participants were divided into three grups: 0 –
control group; 1 – Mediterranean Diet supplemented with
olive oil; and 2 – Mediterranean Diet supplemented with
nuts. Subjects were assessed as smokers or non-smokers.
Education was recoded into two categories: high-medium
and low. Finally, we created a categorical variable of heme
iron intake: 1 – low (< 3.173 mg), 2 – medium (3.173–
4.130 mg) and 3 – high (> 4.130 mg) consumers.
Statistical analysis
The data are presented as a percentage or average ± stand-
ard deviation. Statistical testing included chi-square tests
for qualitative variables and the t-Test for quantitative data.
First, we studied whether there was a linear relation-
ship between heme iron intake and T2DM. Because the
association between heme iron intake and T2DM was
linear and at the border of significance (P = 0.05), we de-
cided to analyze the association in the total population
with several proportional hazard models. The first model
used raw data with unadjusted heme iron intake. The
second model used data adjusted for energy intake. And
the final model was adjusted for dietary, anthropometric,
socio-demographic and lifestyle variables: for example,
age, sex, waist circumference, smoking, education level
and intervention group. Some components of foods that
can interfere with heme iron absorption were also adjusted
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for: for example, fruit, meat, fish and eggs [animal protein],
cereals, legumes and nuts [vegetable protein], calcium, al-
cohol beverages, tea and coffee (the last two representing
the consumption of polyphenols). Fruit was included as an
adjustment variable because consumption was significantly
higher in the group of non-diabetics. The variable “time to
onset of T2DM” was measured in days. No interactions
were found between sex and age.
Because the association between heme iron intake and
T2DM was linear and at the border of significance, we
decided to analyze the association for each tertile of
heme iron intake, using the same adjustment variables
and the last proportional hazard model.
Significance was set at P < 0.05. The data were ana-
lysed using version 20.0 of the SPSS statistical package
for Windows.
Results
A total of 12.2% of the initial sample developed T2DM
with a median follow-up of 4.8 ± 1.3 years. Table 1 shows
the general baseline characteristics of non-incident and in-
cident diabetics. At baseline, weight, BMI, waist circum-
ference and smoking prevalence were significantly higher
in incident than in non-incident T2DM subjects.
Table 2 shows the average consumption of the differ-
ent food groups, the total energy intake and the con-
sumption of main nutrients at baseline in non-incident
and incident diabetics in total subjects and subjects clas-
sified according to tertiles of heme intake. The group of
incident T2DM subjects consumed less fruit (P = 0.010)
and coffee (P = 0.001), and more heme iron (P = 0.036)
than the non-incident group in the total sample but not by
tertiles. Only in the second (P = 0.040) and third (P = 0.029)
tertiles was coffee consumption significantly higher in
non-incident than incident diabetics.
To evaluate the association between heme iron intake
and various components of the diet with the risk of T2DM,
proportional hazard models were applied (Table 3). The
first model used raw data with unadjusted heme iron intake
(HR = 1.13, 95% CI, 0.99 to 1.30; p = 0.075). The second
model used data adjusted for energy intake (HR = 1.20, 95%
CI, 1.02 to 1.42; p = 0.029). And the final model was ad-
justed for dietary, anthropometric, socio-demographic and
lifestyle variables and showed that greater heme iron intake
(HR = 1.30, 95% CI, 1.02 to 1.66; p = 0.037) was associated
with an increased risk of T2DM onset. Although it was not
our principal aim, we also observed an association between
others components of the diet and the risk of T2DM. Thus,
the consumption of alcohol beverages was associated with
an increased risk of T2DM (HR= 1.02, 95% CI, 1.01 to
1.04), while coffee was associated with better protection
against T2DM incidence (HR = 0.93, 95% CI, 0.89 to 0.98).
Furthermore, when we constructed the last propor-
tional hazard model, by dividing subjects into tertiles of
heme iron intake, we observed no significant association
in either the first tertile of heme iron intake (HR = 1.58,
95% CI, 0.52 to 4.78; P = 0.175) or the second (HR = 1.59,
95% CI, 0.50 to 5.06; P = 0.013), but there was a significant
association in the third tertile and T2DM (HR = 1.57, 95%
CI, 1.09 to 2.27; P = 0.003).
Discussion
Several epidemiological studies have linked excess iron de-
posits and risk of T2DM [3,4,15]. However, few studies have
analysed the association between heme iron intake and
T2DM [3-7,16]. The present prospective study shows that
higher amounts of dietary heme iron are associated with a
higher risk of T2DM. This is the first time that this associ-
ation has been assessed in a large elderly Mediterranean
population at high cardiovascular risk.
This association has been evaluated in four long-term
prospective studies [5-7,16] and two cross-sectional studies
[3,4]. However, most of them were conducted in healthy
cohorts of U.S adults (Professionals Follow-up Study,
Women’s Health Study, Nurse’s Health Study and MESA),
and showed that the intake of heme iron is associated with
an increase in the risk of T2DM [5-7]. Only one study
found no association [16]. In the Health Professionals
Follow-up Study cohort, heme iron derived from red meat
consumption, but not total iron intake, was positively asso-
ciated with risk of T2DM [5]. In the Iowa Women’s Health
Study cohort of postmenopausal women, a high intake of
heme iron and/or iron supplements was associated with in-
creased incidence of T2DM, especially in subjects who
consumed alcohol [7]. Lastly, in the Nurses Health Study,
the association between T2DM incidence and iron intake
was demonstrated only for heme iron intake, but not for
Table 1 Baseline general characteristics of participants in
incident and non-incident diabetics
VARIABLES TOTAL n = 1073
NON
INCIDENT
INCIDENT
DIABETICS
p
n = 942 (87.8%) n = 131 (12.2%)
Age (years) 67.3 ± 6.0 66.3 ± 5.7 0.073
Weight (kilograms) 75.3 ± 10.8 79.2 ± 10.6 < 0.001
IMC (kg/m2) 29.4 ± 3.1 30.4 ± 3.1 0.001
Waist circumference (cm) 97.2 ± 9.9 101.8 ± 9.3 < 0.001
Women (%) 57.7 52.7 0.271
Obesity (%) 41.5 48.1 0.153
Hypercholesterolemia (%) 35.8 35.7 0.992
Hypertriglyceridemia (%) 16.3 23.8 0.239
Hypertension (%) 65.6 62.8 0.719
Smoking (%) 16.3 25.2 0.012
Medium-high education (%) 26.9 27.9 0.807
Results expressed as mean ± standard deviation or percentages.
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total iron, iron supplements, or non-heme iron intake [6].
The association between total iron [3] or heme iron intake
[4] and prevalent T2DM was also cross-sectionally ob-
served in healthy adult Chinese populations. Finally, a re-
cent meta-analysis and systematic review suggest that
increased heme iron intake is associated with higher risk of
T2DM [17]. The association between heme iron intake
before pregnancy and/or during the early period of
pregnancy and gestational diabetes was also recently re-
ported in the Nurses Health Study II [18] and the U.S.
Omega cohort [19].
These findings have been reinforced by the fact that
several studies have found an association between ele-
vated levels of iron and the risk of T2DM [3,4,15]. Re-
cently, a study on the Potsdam EPIC cohort found that
high ferritin levels – above 110 ng/mL in females and
280 ng/mL in males – were associated with an increased
risk of T2DM [15].
Blood donations and phlebotomy have also been ob-
served to have a positive effect on insulin sensitivity and
risk of T2DM because they reduce body iron levels.
Fernandez-Real et al. observed a decrease in body iron
levels and improved insulin sensitivity in healthy subjects
who made frequent blood donations (at least 2 in the pre-
vious 5 years) [20]. They also found that the number of
donations was positively correlated with insulin sensitivity.
The same authors had previously observed that both insu-
lin secretion and sensitivity, and glycosylated hemoglobin
levels improved in diabetic patients undergoing phlebot-
omy [21]. These results appear to show that iron reduc-
tion has a beneficial effect on the occurrence of T2DM
and controls the parameters associated with T2DM. Inter-
ventional studies should be carried out to determine
whether reducing the heme iron intake diminishes the risk
of healthy subjects developing T2DM and improves con-
trol and management of patients with T2DM.
Although the exact mechanism by which iron induces
T2DM and other diseases is unclear [8], there is increas-
ing evidence to suggest that iron status has a considerable
influence on the oxidative damage suffered by biomole-
cules such as DNA [22]. It has been speculated that this
phenomenon can affect the physiopathology of such key
events in the onset of T2DM as insulin resistance or defi-
ciency [9]. For example, storage of iron in pancreatic β
cells could affect β cell secretion [23], inducing apoptosis
mediated by oxidative stress [24].
The bioavailability of heme iron is determined by diet
and is probably one of the important factors that ex-
plains why heme iron is the component of the diet that
has consistently been associated with a risk of T2DM by
our study and others. For this reason, the following factors
were included in the proportional hazard models: meat,
fish and eggs [animal protein]; cereals, legumes and nuts
[vegetable protein]; alcoholic beverages; tea and coffee and
calcium. This last factor, in conjunction with polyphenols
[25], inhibits heme iron absorption [26]. The effects of
polyphenols were regarded as being indirectly due to the
consumption of tea and coffee, which are rich in phenolic
compounds. Alcohol beverages were included because it
has been suggested that acute or chronic exposure to alco-
hol can suppress hepcidin expression in the liver, which
increases the intestinal transport of iron into plasma [27].
Table 3 Cox regression evaluating the association between heme iron intake and the risk of new onset diabetes
VARIABLES P1 HAZARD RATIO 95% Confidence interval for hazard ratio
Lower Higher
Model 1: Heme iron 0.075 1.13 0.99 1.30
Model 2: Heme iron + 0.029 1.20 1.02 1.42
Energy 0.210 0.98 0.94 1.01
Model 3: Heme iron + 0.037 1.30 1.02 1.66
Energy + 0.113 0.95 0.88 1.01
Animal protein + 0.155 0.97 0.93 1.01
Vegetable protein + 0.320 1.02 0.99 1.05
Fruit + 0.339 0.99 0.98 1.01
Alcoholic beverages + 0.005 1.02 1.01 1.04
Coffee + 0.005 0.93 0.89 0.98
Tea + 0.665 0.98 0.89 1.08
Calcium 0.747 1.01 0.95 1.08
Last model adjusted also for age (years), gender, waist circumference (cm) (P < 0.001; Exp(B) = 1.05), education level (medium-high, low), intervention group
(control, olive oil and nuts) and smoking.
Heme iron (mg/day), energy intake (100 kcal/day), animal protein [meat, fish and eggs] (10 g/day), vegetables protein [cereals, legumes and nuts] (10 g/day), fruit
(10 g/day), alcoholic beverages (20 cc/day), coffee (10 cc/day), tea (10 cc/day), calcium (100 mg/day).
1P-value for hazard ratio.
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In our study, the effect of vegetable protein, another new
factor that influences heme iron absorption [28], was esti-
mated from the consumption of cereals, legumes and
nuts. Another important factor involved in heme iron ab-
sorption is animal protein [28]. In the proportional hazard
models this is presented as “meats, fish and eggs [animal
protein]”. Although the variable “meats, fish and eggs [ani-
mal protein]” shows collinearity with “heme iron”, we de-
cided to include both in the proportional hazard models
because they assess different aspects. “Heme iron” is asso-
ciated with the quantity of iron in the diet and “meats and
fish [animal protein]” with facilitating iron absorption. In
addition, “meats, fish and eggs [animal protein]” improved
the β coefficient of the primary variable, “heme iron”, and
the general model, both of which support the inclusion of
these variables.
The results of our study are in agreement with those
of other epidemiological studies [3-7]: a high intake of
heme iron seems to be associated with an increased risk
of T2DM, also in a Mediterranean population at high
cardiovascular risk. This relationship was particularly evi-
dent in our study at high doses of heme iron intake. Al-
though it is not fully understood why results vary according
to the form of iron intake, heme iron is more bioavailable
because its absorption is independent of body iron status
and elevated heme iron intake has been associated with
high levels of serum ferritin [29], which in turn is related to
greater risk of T2DM [4].
On the final proportional hazard model applied, we also
observed a positive association between the consumption
of alcohol beverages and an increased risk of T2DM. On
the other hand, coffee consumption was associated with a
reduced risk, as has previously been observed in other
studies [30]. The negative relationship between coffee con-
sumption and the risk of T2DM could also be explained
by the positive relationship between caffeine and insulin
sensitivity, and between decaffeinated coffee and β cell
function [31]. Polyphenols, including coffee and tea poly-
phenols, seem to inhibit the uptake of intestinal hemo iron
[25], thus reducing its adverse effects. In the case of alco-
hol beverages, the presence of alcohol seems to have a det-
rimental effect on the metabolism of iron. In American
postmenopausal women aged 55 to 69 years, an associ-
ation was observed between higher heme iron or supple-
mented iron intake and greater risk of developing T2DM,
especially in those who also consumed alcohol [7]. High
or moderate consumption of alcohol was associated with
a significant increase in the risk of iron overload [32]. In
this regard, Whitfeld et al. observed that ferritin and iron
serum were increased by alcohol consumption [33], and
this, in turn, was associated with a risk of TDM2 [34].
Because of the observational nature of our study, we
cannot completely establish a cause-effect relationship be-
tween heme iron intake and the risk of developing T2DM.
However, the covariates in the statistical models minimize
the major sources of confounding. One of the strengths of
the study was that the diagnosis of T2DM was not self-
reported and was verified by a second analytical test, thus
making the identification of new incident cases more reli-
able and accurate. However, some participants did not
undergo an OGTT, so T2DM could only be diagnosed by
fasting blood sugar ≥ 7.0 mmol/L confirmed by a second
test. This might have falsely lowered overall incidence
rates. Finally, the dietetic variables used in the analysis
were obtained from a semiquantitative food frequency
questionnaire that had been validated in the same popula-
tion so that the possibility of error was reduced [12].
Conclusion
In conclusion, the results of the present study show that
an elevated heme iron intake was associated with a sig-
nificant increase in the risk of T2DM incidence in a
Mediterranean population at high cardiovascular risk.
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Abstract
Background: Increased iron stores are associated with increased risk of type 2 diabetes, however, the mechanisms
underlying these associations are poorly understood. Because a reduction of circulating osteocalcin levels after iron
overload have been demonstrated in cell cultures, and osteocalcin is related to glucose and insulin metabolism, the iron-
induced osteocalcin reductions could contribute to explain the role of iron metabolism in the development of type 2
diabetes mellitus.
Objective: To analyzed the associations between serum total and uncarboxylated osteocalcin and adiponectin
concentrations with serum ferritin and soluble transferrin receptor (sTfR) in elderly subjects.
Design: We evaluated a total of 423 subjects from the PREDIMED cohort in a population-based cross-sectional analysis.
Extensive clinical, nutritional and laboratory measurements, including total and uncarboxylated osteocalcin, adiponectin,
ferritin and sTfR were recorded.
Results: Serum ferritin was positively correlated with increased glucose and insulin circulating levels but also with HOMA-IR,
and was inversely associated with total osteocalcin and adiponectin. A regression analysis revealed that serum ferritin and
transferrin receptor levels were significantly associated with a decrease in total and uncarboxylated osteocalcin. Serum sTfR
levels were associated with lower uncarboxylated osteocalcin levels in the whole-study subjects and remained significant
only in the IFG (impaired fasting glucose) individuals.
Conclusions: We described, for the first time, an inverse association between serum ferritin and sTfR with osteocalcin and
extend previous results on adiponectin, thus supporting that factors related to iron metabolism could contribute to the
insulin resistance and the development of type 2 diabetes mellitus.
Trial Registration: Controlled-Trials.com ISRCTN35739639 ,http://www.controlled-trials.com/ISRCTN35739639..
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Introduction
Iron is an essential mineral for humans although is potentially
hazardous in excess amounts. Excessive iron stores in patients with
hereditary hemochromatosis (HH) have been causally related with
the development of type 2 diabetes mellitus (T2DM) [1]. However,
moderately increased iron stores are also associated with
hyperglycemia and hyperinsulinemia, or an increased risk of type
2 diabetes mellitus in apparently healthy subjects [2–5]. These
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findings have been confirmed in a recent meta-analysis of five
prospective epidemiologic studies, giving a pooled RR of 1.63 for
type 2 diabetes mellitus in subjects with the highest levels of ferritin
[6]. Additionally, in a nested case-control study, increased soluble
transferrin receptor (sTfR) levels were associated with increased
T2DM risk (OR 2.26 [1.37–4.01] [7]. Increased iron stores have
also been associated with gestational diabetes [8], prediabetes [9],
central adiposity [10], metabolic syndrome [11], cardiovascular
disease [12] and osteopenia or osteoporosis [13,14].
Possible mediators linking iron stores and diabetes are still
poorly understood. Serum ferritin levels, the commonly used
marker for total body iron stores, has been associated with insulin
resistance measured by homeostasis model assessment (HOMA
IR) or hyperinsulinemic euglycemic clamp [15,16] but not with
pancreatic beta-cell function in humans [3], whereas in obese
mouse, dietary iron restriction protects from loss of beta cell
function [17]. Iron deposition in the muscle decreases glucose
uptake due to muscle damage [18] and it has additionally been
suggested that iron deposition in pancreatic b-cells impairs insulin
secretion in more advanced states of iron overload [19]. Despite
that, the effect of iron depots on other insulin-related tissues such
as adipose or bone tissues is far from clear. Recent studies
conducted in animals or in humans have demonstrated a direct
and causal effect of iron stores in circulating levels of adiponectin,
independently of other peripheral markers of inflammation
[20,21], thus explaining the attenuated association between ferritin
and incident type 2 diabetes mellitus observed after adjustment for
circulating adiponectin levels [5]. Additionally, a dose-response
decreased expression of genes related to the osteoblast phenotype,
including osteocalcin, after iron overload have been demonstrated
in cell cultures [22–24]. Thus, because osteocalcin (OC) has been
related to a decrease in fasting glucose concentrations and to an
increase of pancreatic beta-cell proliferation, insulin secretion and
sensitivity [25], the iron-induced osteocalcin reductions could
contribute to explain the role of iron overload in the development
type 2 diabetes mellitus.
To our best knowledge, there are no studies demonstrating a
direct association between markers of iron metabolism and
osteocalcin concentrations in humans. We therefore conducted
the present study to evaluate possible associations between serum
total and uncarboxylated osteocalcin concentrations with serum
ferritin and (sTfR) in elderly subjects at high cardiovascular risk.
Methods
Study design and population
For the present analysis, non-diabetic participants from three
Spanish centers (Reus-Tarragona, Navarra and Barcelona-Clinic)
within the framework of the PREDIMED study were randomly
selected. The PREDIMED study is a multicenter, randomized
clinical trial conducted in Spain to assess the effects of the
Mediterranean diet (MedDiet) on the primary prevention of
Table 1. Baseline characteristics of the study subjects.
Total subjects NGM IFG P
N 423 250 173
Men/women 202/221 111/139 91/82 0.097
Age (years) 66.360.3 66.360.4 66.260.4 0.902
BMI (kg/m2) 29.660.1 29.460.2 29.860.2 0.161
Waist circumference (cm) 99.0060.45 97.9460.60 100.4460.70 0.007
Total energy intake (Kcal/day) 2377.75628.78 2368.37637.20 2391.21645.53 0.707
Physical activity (METs-min/day) 273.4611.6 272.4615.3 274.9617.9 0.916
Smoking habit (yes/no) 96/327 59/191 37/136 0.757
Fasting glucose (mg/dL) 97.00 (89.01, 109.01) 90.00 (85.00, 95.29) 111.15 (105.00, 122.75) ,0.001
Total cholesterol (mg/dL) 223.2161.84 223.0762.22 223.4163.17 0.929
HDL cholesterol (mg/dL) 55.2960.67 56.6760.95 53.3060.89 0.014
LDL cholesterol (mg/dL) 139.6161.57 139.5962.02 139.6362.51 0.990
Triglyceride level (mg/dL) 141.8264.27 133.7364.51 153.5768.12 0.022
Fasting plasma insulin (mU/mL) 4.61 (3.12, 7.01) 4.23 (3.06,6.48) 5.04 (3.332,7.61) 0.037
HOMA-IR 1.3560.04 1.1460.04 1.6860.07 ,0.001
HOMA-BCF % 63.1262.88 77.3764.40 41.9361.87 ,0.001
Total osteocalcin (ng/mL) 8.00 (6.17,10.75) 8.50 (6.36, 11.52) 7.44 (5.78,9.64) 0.005
Uncarboxylated osteocalcin (ng/mL) 4.15 (2.38,6.06) 4.58 (2.59,6.80) 3.56 (2.15,5.46) 0.003
Ratio ucOC/OC 0.5860.02 0.6260.03 0.5360.03 0.077
Adiponectin (ng/mL) 8.30 (5.29,13.22) 9.15 (6.10,14.23) 6.98 (4.68,11.54) 0.001
C-Reactive Protein (ng/mL) 1.32 (0.26,3.58) 1.24 (0.22,3.17) 1.43 (0.31,3.90) 0.612
oxLDL (mU/L) 59.1761.26 60.5861.62 57.1162.01 0.150
Ferritin (ng/mL) 126.20 (67.98, 212.47) 118.85 (66.64, 204.75) 132.70 (75.38, 230.91) 0.104
Transferrin receptor (mg/L) 1.24 (1.07,1.42) 1.25 (1.09,1.43) 1.22 (1.07,1.41) 0.242
Ratio Transferrin/ferritin 0.01860.0012 0.01960.0018 0.01560.027 0.155
Data expressed as mean 6 SE, mean (IQR). P* are differences between normal glucose metabolism (NGM) and impaired fasting glucose (IFG) groups.
doi:10.1371/journal.pone.0076433.t001
Iron Metabolism and Osteocalcin
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Figure 1. Correlations between serum ferritin levels and selected biochemical parameters. Correlation coefficients are based on loge-
transformed values of markers except HOMA-IR and HOMA-BCF.
doi:10.1371/journal.pone.0076433.g001
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cardiovascular disease. The design of the PREDIMED trial
(http://www.controlled-trials.com/ISRCTN35739639) has been
reported elsewhere [26,27], and it is available at http://www.
predimed.org and www.predimed.es. Subjects were men aged 55
to 80 years and women aged 60 to 80 years without prior
cardiovascular disease (CVD) at baseline but with at least three
cardiovascular risk factors namely: smoking, hypertension, dysli-
pidemia, overweight (Body mass index (BMI) $25 kg/m2), and a
family history of early-onset coronary heart disease (before age
55 years in men or before age 65 years in women) in first-degree
relatives [27]. The exclusion criteria for the PREDIMED study
were any severe chronic illness, alcohol or drug addiction, history
of food allergy to olive oil or nuts, or a low predicted likelihood of
changing dietary habits according to Prochaska and DiClemente’s
stages-of-change model [28].
We performed the current cross-sectional analyses at baseline
evaluation of a subsample of 455 subjects of this cohort, after
excluding 9 participants with very low values of serum ferritin who
were clearly outside the normality levels according to the cut-off of
our central laboratory to exclude individuals with ferropenia
(,10 ng/dL in women and,20 ng/dL in men). We also excluded
other 23 subjects with missing data on plasma glucose, insulin or
some important covariates for the analysis.
The PREDIMED study protocol was approved by the
institutional review boards of all the centres involved, and all
subjects agreed to participate in the study and gave their written
informed consent.
Measurements
Medical information was collected on subjects’ medical record
of a 47-item questionnaire about education, lifestyle, history of
illnesses and medication use. A validated 137-item food frequency
questionnaire (FFQ) was administered [29] and dietary energy
intake was calculated from Spanish food composition tables [30].
Trained personnel measured baseline weight, height and waist
circumference as previously reported, as well as blood pressure in
triplicate with a validated semiautomatic oscillometer (Omron
HEM-705CP, Hoofddorp, Netherlands). Enegy expenditure in
leisure-time physical activity (LTPA) was estimated using the
validated Spanish version of the Minnesota Questionnaire.
Blood samples were collected from all participants after an
overnight fast and were immediately processed, coded, and
shipped to a central laboratory. Serum levels of fasting glucose,
total cholesterol, HDL-cholesterol and triglycerides were mea-
sured by standard enzymatic automated methods. LDL-cholester-
ol concentrations were calculated using Friedewald’s equation in
those patients whose triglyceride levels were,400 mg/dL. Plasma
fasting insulin concentrations were measured by an ELISA kit for
human insulin (Millipore, St. Charles, Missouri, USA). Insulin
resistance was estimated by the HOMA method using the
following equation [31]: HOMA-IR = [fasting insulin (mIU/
mL) x fasting glucose (mmol/L)]/22.5. Serum total and un-
carboxylated osteocalcin levels were measured by electrochemilu-
minescence immunoassay (N-mid osteocalcin, Roche, Indianapo-
lis, IN); the intra- and inter-assay coefficients of variation were
,3.6% and ,6.6% respectively). Altered beta-cell function was
estimated using HOMA-BCF (homeostasis model assessment-beta
cell) as previously described [32]. Serum ferritin and soluble
transferrin receptor were measured by a particle-enhanced
immunoturbidimetric assay using the Hitachi analyzer and
sTfR:ferritin ratio was calculated. C-reactive protein (CRP)
concentrations were measured via a highly sensitive immunoassay
(Helica Biosystems Inc, Santa Ana, CA). Adiponectin levels were
measured using an enzymatic immunoassay (Millipore, St.
Charles, Missouri, USA). Plasma oxidized LDL (oxLDL) concen-
trations were also measured by a commercial ELISA (Mercodia
Oxidized LDL ELISA, Uppsala, Sweden).
Statistical analysis
Variables with skewed distribution according to the Kolmo-
gorov–Smirnov tests were loge-transformed before analysis. Means
(SE), percentages (%) or median (IQR) were used for descriptive
purposes. Whether the associations differed between sexes were
tested by adding the interaction terms sex*ferritin and sex*sTfR to
the fully adjusted models. Because no interaction was found, all
results are presented for the whole population studied. Although no
interaction was observed betweenmarkers of iron status and glucose
metabolism (IFG*ferritin and IFG*sTfR) it is physiologically
plausible that impaired fasting glucose (IFG) (considered when
fasting glucose levels were higher than 100 mg/dL) could affect the
associations between ferritin and sTfR with total and uncarboxy-
lated osteocalcin or adiponectina [33]. For this reason, results are
also presented stratified according to glucose metabolism for two
different groups: for subjects with normal glucose metabolism
(NGM) and for those with IFG. General characteristics of the study
subjects were compared between both sexes using ANOVA.
Associations between markers of iron metabolism (ferritin, trans-
ferrin receptor and the ratio sTfR:ferritin) and metabolic or
inflammatory variables were examined using Spearman’s correla-
tions. To examine the relationship between markers of iron
metabolism with total or uncarboxylated osteocalcin, linear
regression models were fitted including sex, age, BMI, smoking
status, total energy intake, energy expenditure in leisure-time
physical activity, fasting plasma glucose and insulin, and markers of
inflammation or oxidation (adiponectin, CRP, oxLDL) as poten-
tially confounding variables in the fully adjusted model. In addition,
both regressions analyses with either serum ferritin or sTfR as
outcomes were mutually adjusted for each other to account for
negative confounding because they are both independently associ-
ated with insulin resistance despite their negative reciprocal
correlation [16,34]. For loge-transformed outcome variables (i.e.
total and uncarboxylated osteocalcin) regression coefficients were
converted into percentages of relative change in the original variable
(percentage decrease in total or uncarboxylated osteocalcin per
50 ng/mL increase in ferritin or per 1 ng/mL of increased sTfR).
All analyses were performed using the SPSS 20.0 software (SPSS
Inc, Chicago, IL).
Results
General characteristics of the study subjects are reported in
Table 1. Total and uncarboxylated osteocalcin and adiponectin
were significantly lower in subjects with impaired fasting glucose.
A tendency to higher ferritin concentrations and a lower ratio of
sTfR:ferritin were observed in individuals with impaired fasting
glucose in comparison to those with normal glucose metabolism as
expected, although these differences didn’t reach statistical
significance.
In the whole-study population, serum ferritin was positively
correlated with increased glucose and insulin circulating levels but
also with HOMA-IR, and was inversely related with total and
uncarboxylated osteocalcin and adiponectin but not with HOMA-
BCF (Figure 1). Soluble transferrin receptor concentrations were
positively related with plasma oxLDL levels (r = 0.134, p= 0.006)
and non- related with plasma glucose (r =20.078, p = 0.113,
insulin (r = 0.003, p = 0.946), HOMAIR (r =20.032, p= 0.522)
and HOMA-BCF (r = 0.014, p = 0.771). A non-significant corre-
lation was observed between sTfR and ucOC (r =20.088,
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p= 0.071), and between sTfR:ferritin and glucose, insulin and
HOMA-IR (r =20.154, r =20.177, r =20.194 p,0.001 for all).
Total OC and adiponectin were negative associated with
HOMA-IR (20.193 and 20.338, p,0.001 respectively). In
addition, ferritin and sTfR serum levels were inversely correlated
(r =20.250, p,0.001). In a linear regression model, serum ferritin
and transferrin receptor concentrations were significantly associated
with a decrease in total OC (p= 0.004) per 50 ng/mL of increased
Table 2. Association between markers of iron metabolism and total or uncarboxylated osteocalcin serum levels.
For each 50ng/mL of increased ferritin For each 1ng/mL of increased sTfR
For each 0.1 ng/mL of increased ratio
sTfRferritin
Outcome
Regression
coefficient 95% CI P-value
Regression
coefficient 95% CI P-value
Regression
coefficient 95% CI P-value
In the whole population
Total OC (ng/mL) (% change)
Crude 23.82 25.25, 22.27 ,0.001 28.05 219.42, 4.91 0.211 9.85 26.48,
29.04
0.250
Model 1 22.76 24.30, 21.09 0.001 26.76 217.96, 6.07 0.286 5.02 210.41,
23.24
0.543
Model 2 22.46 24.01, 20.79 0.004 212.97 223.73, 20.79 0.038 0.80 213.92,
18.05
0.921
Uncarboxylated OC (ng/mL) (% change)
Crude 21.98 24.49, 0.70 0.140 217.05 233.16, 2.83 0.088 7.03 217.79,
39.37
0.612
Model 1 20.29 22.95, 2.53 0.859 217.55 233.30, 2.02 0.075 22.95 225.54,
26.49
0.825
Model 2 20.39 23.24, 2.42 0.765 222.11 237.76, 22.56 0.029 25.25 227.45,
23.86
0.694
In the NGM
Total OC (ng/mL) (% change)
Crude 24.11 26.26, 21.98 ,0.001 214.27 227.31, 1.00 0.066 0.60 216.80,
21.65
0.951
Model 1 22.95 25.25, 20.59 0.013 210.05 223.58, 5.86 0.200 0.002 217.30,
20.92
0.998
Model 2 22.95 25.06, 20.69 0.010 216.13 229.03, 20.98 0.038 24.87 221.25,
14.91
0.603
Uncarboxylated OC (ng/mL) (% change)
Crude 20.99 24.78, 2.94 0.620 216.97 237.12,
9.52
0.186 21.39 228.46,
35.79
0.929
Model 1 1.00 23.05, 5.01 0.644 214.61 235.07, 12.29 0.257 29.87 234.62,
24.11
0.521
Model 2 0.40 23.72, 4.81 0.815 216.13 237.37, 12.29 0.236 210.05 235.20,
24.85
0.542
In the IFG
Total OC (ng/mL) (% change)
Crude 23.14 25.16,
20.98
0.005 0.90 218.86, 25.35 0.939 32.04 22.37,
78.42
0.071
Model 1 22.37 24.59,
20.19
0.036 21.29 220.30, 22.14 0.901 15.83 214.78,
57.45
0.345
Model 2 22.17 24.49,
0.30
0.080 27.03 225.91, 16.64 0.526 14.50 215.88,
55.89
0.386
Uncarboxylated OC (ng/mL) (% change)
Crude 22.27 25.63,
1.10
0.183 222.81 244.95,8.22 0.132 20.44 225.09,
93.67
0.441
Model 1 21.39 24.87,
2.32
0.468 225.53 248.31, 1.51 0.061 3.97 236.36,
69.89
0.875
Model 2 22.07 25.82,
1.91
0.308 234.29 254.38, 25.35 0.024 3.35 237.37,
70.57
0.897
b values are unstandardized regression coefficients and represents the change in total and uncarboxylated osteocalcin according to increases in ferritin, soluble
transferrin receptor and the ratio of sTfR/ferritin. Model 1: adjusted for sex, age and BMI, smoking status, total energy intake and energy expenditure in leisure-time
physical activity. Model 2: additionally adjusted for fasting plasma glucose, insulin and markers of inflammation and oxidative stress (adiponectin, C-reactive protein,
oxidized LDL) and ferritin and transferrin receptor adjusted for each other).
doi:10.1371/journal.pone.0076433.t002
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ferritin, and a decrease in uncarboxylated osteocalcin (ucOC)
(p = 0.038) per 1 ng/mLof increased sTfR even after adjustment for
sex, age, BMI, smoking status, total dietary energy intake, physical
activity, fasting plasma glucose, and insulin, and peripheral markers
of inflammation and oxidation (adiponectin, CRP, oxLDL), and
sTfR or serum ferritin (for models with ferritin or TfR as the
outcome, respectively). These associations were apparent both in
normoglycemic and in subjects with impaired fasting glucose,
although in the last case the association between ferritin and total
OC was not statistical significance (p = 0.080). Serum sTfR levels
were associated with lower ucOC levels in the whole-study subjects
and remained significant only in the IGM individuals (Table 2). In
contrast, sTfR:ferritin ratio was not significantly associated nor with
total OC neither with ucOC.
Discussion
The present study confirmed, for the first time, that both serum
ferritin and soluble TfR levels, as markers of iron metabolism, are
independently and inversely associated with total and uncarboxy-
lated osteocalcin. Because osteocalcin has been related not only
with bone metabolism but also with insulin resistance and
sensitivity, our results would help to explain one of the possible
mechanisms relating iron metabolism, insulin resistance and risk of
type 2 diabetes mellitus. We also confirm and extend previous
results showing the inverse association between serum ferritin and
adiponectin concentrations as a potential mechanism linking iron
stores with insulin resistance [21,35].
Serum OC levels were used to evaluate bone metabolism
because it has been considered a better sensitive marker of bone
formation than serum alkaline phosphatase. However, increasing
data supporting extra-skeletal roles of OC have emerged, being
widely accepted its hormonal effect on energy metabolism,
angiogenesis or insulin metabolism [36]. In this sense, mice
lacking osteocalcin show lower beta-cell proliferation, glucose
intolerance, and insulin resistance than wild-type mice [15].
Additionally, osteocalcin knockout mice have reduced levels of
serum adiponectin, which suggests a potential role for osteocalcin
in insulin sensitivity and secretion. In a previous study, our group
demonstrated, for the first time, that increased total or
uncarboxylated OC serum concentrations were directly associated
with HOMA-BCF and inversely with insulin resistance deter-
mined by HOMA-IR [25].
Iron overload can damage several important organs such as
liver, pancreas and heart. Many lines of evidence indicated that
iron overload affects bone tissue causing both osteopenia and
osteoporosis [37]. Addition of iron to a culture of human
osteoblasts decreased osteocalcin concentrations dose-responsive-
ly. This has been attributed to the ferroxidase activity of ferritin
rather than its iron sequestering capacity [24]. Furthermore, iron
exposure on human osteoblast-like cells reduced the expression of
genes involved in bone matrix formation or osteoblast differen-
tiation such as COL1AI, Runx2 or osteocalcin [23,38]. The
observed inverse associations of ferritin with total and uncar-
boxylated osteocalcin observed in our study, independently of
other inflammatory markers and glucose metabolism status,
extend the results obtained in vitro. Given that ferritin is
inversely correlated with sTfR we expected a negative relation-
ship between sTfR uncarboxylated osteocalcin rather than the
negative observed in our study. However, our results are in
agreement to those reported by Rajpathak and coworkers who
observed, in a nested case-control study conducted in the
framework of the Diabetes Prevention Program, a positive
association between serum sTfR levels and T2DM risk even
after adjusting by ferritin levels, thus suggesting another potential
mechanism linking sTfR and T2DM unrelated to iron overload
[7]. Increased levels of sTfR have been observed in vitro after
insulin administration to rats (32) and it cannot be discard sTfR
levels as a biomarker of other factors causally related to T2DM
[7]. In our study subjects, sTfR levels could be the result of a
compensatory mechanism for a reduction of free iron levels
secondary to inflammatory or oxidative status common in old
subjects at cardiovascular risk. Moreover, in addition to other
epidemiological studies, we also showed positive associations of
ferritin and sTfR with fasting glucose, insulin and HOMA-IR,
but not with HOMA-BCF, suggesting that the contribution of
iron metabolism to type 2 diabetes mellitus is basically related to
the induction of insulin resistance more than through an effect
on beta-cell function [3,15]. In contrast to previous prospective
studies suggesting that lower ratios of sTfR: ferritin were
associated with increased risk of type 2 diabetes [2,4], no impact
on the association of sTfR:ferritin and osteocalcin or adiponectin
was observed in our study. However, as expected, we observed a
negative tendency in the association between this ratio and
HOMA-IR.
Iron stores could also induce insulin resistance through induction
of oxidative stress [39] and serum ferritin has been associated with
circulating oxidized LDL lipoproteins and advanced oxidation
products [40].Nevertheless, we observed a significant relationship of
iron markers and osteocalcin or adiponectin independently of
oxidized LDL, suggesting that the associations between iron and
insulin resistance could be additionally mediated by other pathways
rather than oxidative stress.
One concern of the present study is that ferritin concentrations
may reflect other physiological aspects rather than iron storage,
especially subclinical systemic inflammation related to insulin
resistance. This is more relevant in our subjects because they are
old, obese and at high cardiovascular risk. The cross-sectional
nature of our assessment also hinders the possibility of a proper
ascertainment of the direction of the causal sequence and we
acknowledge this limitation. Also, because the associations
between iron metabolism and osteocalcin forms observed in our
study are weak, we must be cautious to consider iron metabolism
markers as predictors of osteocalcin levels. Therefore, further
prospective investigations should be designed to confirm these
associations.
We tried to minimize the potential confounding by obesity and
inflammation controlling for BMI and oxidative and inflammatory
status (CRP, adiponectin, oxLDL) in the multivariate models.
However, we cannot rule out the possibility that our resultsmay have
been influenced by other unmeasured factors. In any case, the high
cardiovascular risk of our study subjects is to our advantage because
they are a homogeneous population with smaller between-subjects
variability in cardiovascular risk factors than a sample of the general
population.
In sum, we described an inverse association between serum
ferritin and sTfR with total or uncarboxylated osteocalcin and
adiponectin in subjects at high cardiovascular risk. These findings
suggest that body iron metabolism may contribute to the induction
of insulin resistance through the inhibition of adiponectin and
osteocalcin thus providing support for the hypothesis that iron
metabolism could contribute to the origin of type 2 diabetesmellitus.
Further research is warranted to understand the exactlymechanisms
by which ferritin and sTfR levels induce insulin resistance.
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Abstract
A prospective nested case–control study within the PREvention with MEDiterranean Diet (PREDIMED) was conducted to evaluate the
relationship between excess body Fe (measured as serum ferritin (SF), soluble transferrin receptor (sTfR) and sTfR:ferritin ratio) and
the risk of type 2 diabetes mellitus (T2DM) in a Mediterranean population at a high risk of CVD, without T2DM at the start of the
study. The study contained 459 subjects, 153 with incident T2DM (cases) and 306 without incident T2DM (controls). The follow-up
period was for 6·0 (interquartile range 3·9–6·5) years. For each incident diabetic subject, two subjects were selected as controls who
were matched broadly for age as well as for sex, intervention group and BMI. We observed a relationship between SF values
.257mg/l in males and .139mg/l in females and the risk of T2DM, following adjustment in the conditional logistic regression model
for high-sensitivity C-reactive protein, fasting glucose and other components of the metabolic syndrome (OR 3·62, 95% CI 1·32, 19·95;
P¼0·022). We also found an association between low sTfR:ferritin ratio levels and the incidence of T2DM (OR 3·02, 95% CI 1·09, 8·39;
P¼0·042), but no association with sTfR (OR 1·29, 95% CI 0·51, 3·23; P¼0·722). Oxidative stress has been hypothesised to contribute
to the development of insulin resistance and b-cell dysfunction, the two key events in the clinical development of T2DM. Following
adjustment for other risk factors for T2DM, excess body Fe (measured as SF and sTfR:ferritin ratio) was associated with an increased
risk of developing T2DM in a Mediterranean population at a high risk of CVD.
Key words: Serum ferritin: Soluble transferrin receptor: Body iron stores: Type 2 diabetes
The worldwide prevalence of diabetes in adults was estimated
as 6·4% in 2010, and has been forecast to increase to 7·7% by
2030(1). Recently, excess body Fe has been shown to be a risk
factor for type 2 diabetes mellitus (T2DM)(2).
Serum ferritin (SF) is the most widely used biomarker of
body Fe stores in epidemiological studies, despite being
shown to be affected by inﬂammation status. Conversely, sol-
uble transferrin receptor (sTfR) is not altered by inﬂammatory
processes(3), and their levels in blood are proportional to the
cell requirements for Fe(4).
Several prospective studies(2,5–14) have identiﬁed excess
Fe as a risk factor for T2DM. Oxidative stress could be the
mechanism by which excess Fe is associated with a higher
incidence of T2DM. Oxidative stress would mediate in the
pathophysiology of several key events related to the onset
of T2DM, such as insulin resistance (IR) and b-cell dysfunc-
tion(15). Most of these studies(2,5–12) used SF as a biomarker
to estimate body Fe levels. However, in assessing the relation-
ships between SF and the risk of T2DM, few studies had
adjusted for fasting glucose levels(8) and other components
of the metabolic syndrome (MetS)(5), which are the parameters
with a high predictive capacity for T2DM(16). As such, it is still
not clear whether the relationship between SF levels and the
risk of T2DM is independent of these risk factors.
*Corresponding authors: Dr V. Arija, fax þ34 977 759322, email victoria.arija@urv.cat; Dr J. Salas-Salvado´, fax þ34 977 759322, email jordi.salas@urv.cat
Abbreviations: CLR, conditional logistic regression; hs-CRP, high-sensitivity C-reactive protein; IR, insulin resistance; MetS, metabolic syndrome; PREDIMED,
PREvention with MEDiterranean Diet; sTfR, soluble transferrin receptor; SF, serum ferritin; T2DM, type 2 diabetes mellitus.
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Few prospective studies evaluating the association between
excess body Fe and the risk of T2DM have used sTfR as a
biomarker(2,7,11), and despite having found that elevated SF
levels increased the risk of T2DM, the relationship between
sTfR and T2DM was not clear. Thus, while the Potsdam
European Prospective Investigation into Cancer and Nutrition
(EPIC) cohort study did not observe any association(2), the
Diabetes Prevention Program (DPP) cohort study(7) observed
that high levels of sTfR increased the risk of T2DM. Also, the
recent Kuopio IHD Risk Factor (KIHD) study observed a
U-shaped association(11).
To date, no studies have been conducted in southern Europe
exploring the relationship between excess Fe and the risk of
T2DM. Of note is that some characteristics of Fe metabolism,
such as genetic predisposition and/or dietary intake in southern
Europe, are quite different from the populations studied earlier,
such as those in the USA(7), China(10) and northern Europe(2).
For example, while in northern Europe, the prevalence of the
C282Y polymorphism in the haemochromatosis (HFE) gene is
5–10% and that of the H63D polymorphism is 10–20%, in
southern Europe, the prevalence is 1–5% and .20%, respect-
ively(17). In Spain, the prevalence of the H63Dmutation reaches
46% in certain regions(18). Furthermore, the consumption of
food items of animal origin is greater in northern compared
with southern Europe(19).
To test the hypothesis that high body Fe stores increase
the risk of T2DM in our geographical area, we measured
excess body Fe (as SF, sTfR and sTfR:ferritin ratio) in relation
to the risk of T2DM in a Mediterranean population at a high
risk of CVD, without T2DM at the start of the prospective
study.
Experimental methods
Study design
This is a case–control study nested in the PREDIMED
(PREvention with MEDiterranean Diet) cohort, followed-up
for a median of 6·0 (interquartile range 3·9–6·5) years. The
PREDIMED trial(20) was intended to test the effectiveness
of the Mediterranean diet on the primary prevention
of CVD. The comparisons were between two traditional
Mediterranean diets (one enriched with extra virgin olive oil
and the other with nuts) v. advice alone on a low-fat diet.
The present study was registered at ClinicalTrials.gov (regis-
tration no. ISRCTN35739639; http://www.controlledtrials.
com/ISRCTN35739639).
The present study was conducted according to the
guidelines laid down in the Declaration of Helsinki, and all
procedures involving human subjects were approved by the
Clinical Research Ethics Committee of the Hospital Sant
Joan de Reus. Written informed consent was obtained from
all subjects.
Subjects
The present study was conducted with 459 Caucasian subjects
aged 55–80 years, free of T2DM at baseline, and with three or
more CVD risk factors; 153 were incident T2DM (cases) and
306 non-incident (control) individuals. The study population
was recruited in the Primary Care Centres of Reus, Barcelona
and Pamplona. For every incident diabetic individual identi-
ﬁed, two subjects were randomly selected as controls matched
for age (#67 v. .67 years), sex, intervention group and BMI
(#27 v. .27 kg/m2), using an incidence density sampling
procedure.
Ascertainment of incident type 2 diabetes mellitus
The 153 cases of incident T2DM were diagnosed during the
follow-up, according to the American Diabetes Association cri-
teria(21), i.e. fasting plasma glucose concentration $7·0mmol/l
or plasma glucose concentration $11·1mmol/l measured 2 h
after a 75 g oral glucose load. A routine glucose test was per-
formed on all participants in the PREDIMED study at least
once a year to detect new cases of diabetes. When new-onset
T2DMwas identiﬁed by the physicians of Primary Care Centres,
the test was repeated within the next 3 months to conﬁrm
the diagnosis. The homeostasis model assessment (HOMA)
index was calculated for each individual as follows:
HOMA-IR ¼ fasting insulin ðU=lÞ
£ fasting glucose ðmmol=lÞ=22·5Þ:
Biochemical determination
All blood samples were collected after an overnight fast at the
beginning of the study. Aliquots of serum and EDTA plasma
were immediately processed, coded and shipped to a central
laboratory in a portable cooler (248C), and stored at 2808C
until analysis. The time between blood sampling and freezing
was less than 1 h. Serum levels of fasting glucose, total
TAG, total and HDL-cholesterol were measured by standard
enzymatic methods. LDL-cholesterol was calculated using
the Friedewald equation. Fasting plasma insulin concen-
trations were measured in duplicate by ELISA (Ezhi-14K; Milli-
pore). Plasma concentrations of high-sensitivity C-reactive
protein (hs-CRP) were measured using a highly sensitive
immunoassay (Helica Biosystems, Inc.). The assay has a sensi-
tivity of 0·2mg/l, with intra- and inter-assay CV of #3·7 and
,4·8%, respectively. SF (Elecsys Ferritin; Roche Diagnostics)
and sTfR (Access sTfR 0QC; Beckman Coulter) were measured
by immunochemiluminescence. The assay has a sensitivity of
0·05mg/l for ferritin, and intra- and inter-assay CV of #2 and
,3·5%, respectively, for SF. The assay has a sensitivity of
0·05 nmol/l for sTfR, and intra- and inter-assay CV of #5 and
#8%, respectively (1mg/l ¼ 13·55 nmol/l of sTfR).
Other measures
At baseline and at each annual visit, a general questionnaire on
sociodemographic and lifestyle characteristics was adminis-
tered, and anthropometric variables were measured. Also, a
semi-quantitative 137-item FFQ that had been previously
validated(22) was applied. Nutrients and energy intake were
quantiﬁed according to the Spanish food composition
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tables(23). Leisure-time physical activity was assessed according
to a validated questionnaire(24). Blood pressure was measured
in triplicate using a calibrated semi-automatic oscillometer
(Omron HEM-705CP; Omron Healthcare Europe BV)(25).
Statistical methods
Variables showing a non-normality of distribution were
log-transformed to normalise the distributions. Qualitative
variables were compared using the x 2 test. Quantitative
variables were compared using the Student’s t test or the
Mann–Whitney test. Data are presented as percentages,
means or geometric means and standard deviations, and
medians and interquartile ranges in the case of variables
being non-normally distributed.
Partial correlation coefﬁcients of SF, sTfR and the sTfR:ferritin
ratio adjusted for sex, age and BMI, as well as for several T2DM
risk factors such as MetS components, fasting insulin, HOMA-IR
and hs-CRPwere calculated in the overall study sample, controls
and cases (Table 2). A multiple linear regression analysis was
applied to evaluate the inﬂuence of SF on IR.
To analyse the relationship between body Fe levels and the
incidence of T2DM, participants were categorised into quar-
tiles according to the distributions of SF, sTfR and sTfR:ferritin
ratio at baseline in control individuals. Given the documented
differences between males and females with respect to body
Fe stores, the independent variables were adjusted for sex.
The adjusted variables were categorised to avoid any
assumption of linearity, and to evaluate the dose–response
relationship in the onset of T2DM. Several conditional logistic
regression (CLR) models were applied. A crude model (with-
out adjustment) was ﬁtted with each independent variable.
The model was re-ﬁtted with adjustment for lifestyle variables
including the following: marital status (married/not married);
educational level (primary/secondary/tertiary); smoking
(current smoker/former smoker/never smoked); alcohol
consumption (drinker/non-drinker); physical activity (200
metabolic equivalents (MET)-min/d/$200MET-min/d); family
history of T2DM (yes/no). Adjustment also included four
diagnostic criteria of the MetS, according to the harmonised
criteria proposed by International Diabetes Federation (IDF)
and the American Heart Association/National Heart, Lung,
and Blood Institute (AHA/NHLBI)(26), i.e. blood pressure
$135/85mmHg, serum TAG $1·7mmol/l, HDL-cholesterol
,1·03mmol/l in males and ,1·3mmol/l in females, and
waist circumference $102 cm in men and $88 cm in
women. Dietary variables measured in relation to the risk of
T2DM were categorised by quartiles, and included energy,
Mg, vitamins D and E, dairy products, meat, vegetables and
fruits(27). Then, hs-CRP (mg/l) was introduced in model 1.
Finally, fasting glucose concentration $5·6mmol/l was intro-
duced into the model. The test for linear trend across the
quartiles was performed by assigning the median value to
each category and introducing these new variables into the
CLR as continuous variables.
The effects of SF and fasting glucose on the risk of T2DM
were evaluated in another CLR model adjusted as ‘enter’
mode for all the variables included in model 1, except SF
and fasting glucose, which were introduced as ‘conditional’
mode (CLR-conditional). We performed the same analysis for
sTfR and the sTfR:ferritin ratio.
All data analyses were performed with the SPSS package for
Windows (version 20.0; SPSS, Inc.). A value of P,0·05 was
considered statistically signiﬁcant.
Results
Of the 459 subjects, two individuals were removed from the
study for not having the values of SF and sTfR recorded,
and another two for having extreme values of SF. The ﬁnal
analysis contained 455 individuals.
There were no signiﬁcant interactions between SF, sTfR and
the sTfR:ferritin ratio v. sex (P.0·05). These interactions were
assessed in the same CLR models in which we studied the
association between high SF, sTfR and the sTfR:ferritin ratio
levels and the risk of T2DM.
Table 1 summarises the baseline characteristics of the over-
all group, as well as the case and control groups separately.
Of the participants, 71% had abdominal obesity, 42% the
MetS, 34% hypertriacylglycerolaemia, 97% hypertension and
25% IR. Additionally, prevalences of the MetS and IR were
higher in the cases than in the controls. Compared with the
controls, patients with incident diabetes had greater waist
circumference and higher levels of fasting glucose, insulin,
TAG and IR. Also, SF levels were higher in the cases than in
the controls, while sTfR levels were similar in both groups.
Table 2 summarises the partial correlation coefﬁcients
adjusted for sex, age and BMI between SF, sTfR and the
sTfR:ferritin ratio together and several T2DM risk factors
such as MetS components, fasting insulin, HOMA-IR and hs-
CRP in the overall study sample, and in the controls as well
as cases. SF and sTfR:ferritin ratio, but not sTfR levels, corre-
lated signiﬁcantly with fasting glucose, fasting insulin and
HOMA-IR in the overall study sample. Furthermore, both bio-
markers of body Fe stores signiﬁcantly correlated with fasting
insulin and HOMA-IR in non-incident diabetic individuals, and
with SF alone in incident diabetic subjects. Conversely, SF was
not correlated with hs-CRP, while sTfR was positively corre-
lated with this biomarker of inﬂammation. SF and the sTfR:
ferritin ratio were poorly correlated with the components of
the MetS. Nevertheless, components such as blood pressure,
TAG and HDL-cholesterol were signiﬁcantly correlated with
sTfR in the overall non-incident diabetic group.
To evaluate the association between the levels of SF and the
risk of T2DM, several CLR models were applied (Table 3). The
OR for the crude model (without adjustment for any variable)
was 1·99 (95% CI 1·12, 3·52; P¼0·022). Model 1 adjusted for
lifestyle variables, family history of T2DM, and four com-
ponents of the MetS showed an improvement in the trend
(OR 2·39, 95% CI 1·11, 5·16; P¼0·030). This trend did not
substantially change when hs-CRP was included in the multi-
variable model (OR 2·38, 95% CI 1·10, 5·14; P¼0·031). Finally,
adjusting the model for fasting glucose showed an improve-
ment in the trend (OR 3·62, 95% CI 1·32, 9·95; P¼0·017).
The same models were employed in evaluating the relation-
ship between the sTfR:ferritin ratio and the risk of T2DM.
V. Arija et al.1898
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Table 1. Baseline characteristics of the overall study participants, and segregated by cases and controls
(Mean values and standard deviations; medians and interquartile ranges (IQR))
All (n 455)
Non-incident
diabetics (n 302)
Incident diabetics
(n 153)
Mean SD Mean SD Mean SD P
Sociodemographic characteristics
Men (%) 47·0 47·1 47·2 1·000
Age (years) 66·30 6·04 66·29 6·12 66·33 5·89 0·940
Married (%) 78·50 79·50 76·50 0·462
Low educational level (%) 69·70 69·90 69·30 0·898
Family history of diabetes (%) 28·10 24·20 35·90 0·008
Lifestyle
Never smoked (%) 55·20 57·90 49·70
Current smoker (%) 22·90 21·20 26·10 0·239
Former smoker (%) 22·00 20·90 24·20
Alcohol consumer (%) 67·30 66·60 68·60 0·657
Sedentary behaviour (%) 44·20 45·70 41·20 0·359
Anthropometry
Weight (kg) 77·27 10·97 76·65 10·79 78·46 11·25 0·091
BMI (kg/m2) 29·91 3·06 29·77 2·99 30·20 3·17 0·157
Waist circumference (cm) 99·59 9·79 98·50 9·79 101·73 9·46 0·001
Obesity (%) 45·90 45·00 47·70 0·588
Diet
Energy (kJ/d) 9923·77 2463·45 9884·81 2362·25 10 000·67 2658·32 0·636
Dairy products (g/d) 357·70 218·66 359·56 212·18 354·03 231·59 0·799
Meat (g/d) 139·01 52·32 138·63 53·25 139·75 50·60 0·830
Vegetables (g/d) 284·41 109·90 280·60 104·10 291·92 120·55 0·323
Fruits (g/d) 344·19 184·49 344·65 183·04 343·27 187·93 0·940
Alcohol (g/d) 13·00 18·03 11·98 17·14 15·02 19·55 0·105
Mg (mg) 363·08 83·82 361·20 79·40 366·79 92·10 0·523
Vitamin D (mg/d) 5·69 3·20 5·77 3·22 5·54 3·18 0·474
Vitamin E (mg/d) 9·92 3·63 9·81 3·40 10·14 4·05 0·369
Fe (mg/d) 16·13 3·77 16·02 3·55 16·35 4·17 0·403
Haem Fe (mg/d) 1·47 0·58 1·44 0·58 1·52 0·58 0·138
Biochemistry
Total cholesterol (mmol/l) 5·80 0·97 5·84 0·91 5·73 1·08 0·251
LDL-cholesterol (mmol/l) 0·161
Median 3·57 3·64 3·47
IQR 3·03–4·20 3·07–4·23 2·97–4·60
HDL-cholesterol (mmol/l) 1·39* 0·03 1·41* 0·03 1·34* 0·03 0·030
TAG (mmol/l) 1·45* 0·02 1·41* 0·02 1·54* 0·02 0·031
Fasting glucose (mmol/l) ,0·001
Median 5·38 5·16 6·11
IQR 4·94–6·83 4·83–5·49 5·55–6·80
Fasting insulin (pmol/l) 33·45* 1·80 32·00* 1·79 36·54* 1·86 0·022
HOMA-IR 1·14* 1·88 1·03* 1·83 1·40* 1·89 ,0·001
SF (mg/l) 112·27* 2·53 105·22* 2·53 127·59* 2·53 0·037
sTfR (mg/l) 1·27* 1·27 1·27* 1·26 1·26* 1·29 0·930
sTfR:ferritin ratio 11·27* 2·81 12·03* 2·80 9·9* 2·80 0·057
hs-CRP (mg/l) 0·756
Median 1·49 1·40 1·65
IQR 0·33–4·01 0·33–4·12 0·30–3·92
Metabolic syndrome (%) 41·50 30·80 62·70 ,0·001
High waist circumference (%)† 71·40 65·20 83·70 ,0·001
Low HDL-cholesterol (%)‡ 19·60 17·50 23·50 0·129
HTG (%)§ 34·10 30·10 41·80 0·013
HT (%)k 96·90 97·00 96·70 0·867
High fasting glucose (%){ 21·80 8·90 47·10 ,0·001
Insulin resistance (%) 25·10 19·90 35·30 ,0·001
HOMA-IR, homeostasis model assessment for insulin resistance; SF, serum ferritin; sTfR, soluble transferrin receptor; hs-CRP, high-sensitivity
C-reactive protein; HTG, hypertriacylglycerolaemia; HT, hypertension.
*Geometric mean.
†High waist circumference for men $102 cm and women $88 cm.
‡ Low HDL-cholesterol for men #1·03mmol/l and women #1·30mmol/l.
§HTG (TAG $1·70mmol/l).
kHT (blood pressure $135–85mmHg).
{High fasting glucose ($5·6mmol/l).
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In the crude model, low levels of the sTfR:ferritin ratio showed
a signiﬁcant trend towards increased incidence of T2DM (OR
1·73, 95% CI 0·99, 3·05; P¼0·042). In model 1 the trend
increased (OR 2·32, 95% CI 1·08, 4·98; P¼0·035). The intro-
duction of hs-CRP did not alter the relationship very much
(OR 2·31, 95% CI 1·08, 4·97; P¼0·036). Finally, following the
inclusion of glucose as a potential confounding variable, the
association increased considerably (OR 3·02, 95% CI 1·09,
8·39; P¼0·42).
In contrast to SF and the sTfR:ferritin ratio, no signiﬁcant
association was observed between sTfR and T2DM after
applying the same models. The corresponding multivariate
OR for the lowest v. highest quartile of sTfR was 1·29 (95%
CI 0·51, 3·23; P¼0·722).
When we introduced SF and fasting glucose as ‘conditional’
mode (CLR-conditional), we observed that fasting glucose was
the strongest predictor of diabetes (OR 20·07, 95% CI 8·36,
48·20; P,0·001) along with SF (OR 3·62, 95% CI 1·32, 9·95;
P,0·017). In the model of sTfR, the OR of glucose was
16·58 (95% CI 7·15, 38·41; P,0·001) and of sTfR was 1·29
(95% CI 0·51, 3·23; P,0·722). Finally, in the sTfR:ferritin
ratio model, the OR of glucose was 17·51 (95% CI 7·50,
40·89; P,0·001) and of the sTfR:ferritin ratio was 3·02 (95%
CI 1·09, 8·39; P,0·042).
Discussion
In the present study, a direct relationship was demonstrated
between high body Fe stores (measured as SF and sTfR:ferri-
tin ratio) and the incidence of T2DM in a Mediterranean
cohort with an elevated risk of CVD. This association was
found after adjustment for hs-CRP, fasting glucose and other
components of the MetS. These ﬁndings add data from popu-
lation that is different from those previously studied, i.e. a
southern European population. We did not observe any
association between the levels of sTfR and the incidence of
T2DM.
The prospective design of the study helps reduce tempor-
ality bias. Also, the study design enables a better control of
confounding factors such as sex and ranges of age and BMI
since each case in the incident T2DM group was broadly
matched for these variables with two control individuals
without T2DM.
SF and sTfR were measured using immunochemilum-
inescence, a widely used method with high sensitivity and
speciﬁcity. The diagnosis of T2DM was according to the cri-
teria of the reference organisation, i.e. the American Diabetes
Association(21). Of note is that, in the present study, not only
was there an adjustment made for classical variables predictive
of T2DM risk (such as age, family history of T2DM, smoking,
dietary intake, waist circumference and inﬂammation), but
also adjustment for fasting glucose and other components of
the MetS since these components are strongly associated
with the development of T2DM(28).
We need to highlight the limitation of extrapolating the
results of the present study to the general population, given
that the study was conducted in a population with various
CVD risk factors. As occurs in cohort studies, there is noT
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assurance that some of the control individuals would not
develop T2DM subsequent to the follow-up period. However,
the median period of follow-up of 6·0 (interquartile range
3·9–6·5) years is greater than that in the majority of studies
conducted to date(2,5–7,10,13).
SF, which closely reﬂects the estimation of body Fe
levels, has been observed to be inﬂuenced by inﬂammation
status. Hence, hs-CRP was measured in the present study.
The objective was to adjust for this confounding variable
when evaluating the effect of excess Fe in relation to T2DM.
Also, we assessed the relationship of another marker
that measures Fe status, i.e. sTfR. sTfR in plasma is directly
proportional to the cell requirements for Fe(4). Hence, it is
considered to represent a good biomarker in the evaluation
of body Fe status(3). However, some studies have suggested
that sTfR levels are increased by other factors such as the
degree of glucose tolerance or IR(29), hyperinsulinaemia(30),
inﬂammation(31), general obesity and/or abdominal obes-
ity(32). Also, the sTfR:ferritin ratio appears to be a better
marker of Fe stores(33). It is especially useful in population
studies since it is sensitive not only to elevated, but also
decreased, levels of Fe stores(34).
In the present results, we observed signiﬁcantly higher
levels of ferritin (127·59 (SD 2·53) v. 105·22 (SD 2·53)mg/l)
and lower levels of sTfR:ferritin ratio (9·9 (SD 2·80) v. 12·03
(SD 2·80)) with borderline signiﬁcance in subjects with
incident diabetes compared with those with non-incident
diabetes. However, we did not observe any difference in
sTfR levels. When analysing the relationship using adjusted
CLR models, we observed that the values of SF .257mg/l in
males and .139mg/l in females were associated with a high
risk of the appearance of T2DM. These values of SF are typical
of Fe overload status, according to the WHO (.200mg/l in
males and .150mg/l in females)(35), and are similar to the
values found in the studies of Norfolk(6) and Potsdam(2) of
the EPIC cohort and the Atherosclerosis Risk in Communities
(ARIC) study(5) conducted in the general population.
The associations encountered between SF and T2DM were
maintained following the adjustment for classic risk factors
including inﬂammation, fasting glucose and other components
of the MetS. The MetS, and its components, have been
strongly associated with the development of T2DM, especially
with an elevated level of fasting glucose(28). Many prospective
studies have adjusted their models using some of these classic
Table 3. Risk of type 2 diabetes segregated by quartiles of serum ferritin (SF), soluble transferrin receptor (sTfR) and sTfR:ferritin ratio,
and adjusted for sex
(Odds ratios and 95% conﬁdence intervals)
Q1 Q2 Q3 Q4 Ptrend
SF
Men (mg/l) ,78·80 78·80–161·60 161·60–256·90 .256·90
Women (mg/l) ,48·13 48·13–96·27 96·27–139·00 .139·00
Cases 30 36 31 56
Controls 75 76 76 75
Crude* 1 1·25 0·68, 2·31 1·06 0·57, 1·96 1·99 1·12, 3·52 0·022
Model 1† 1 1·09 0·50, 2·40 0·76 0·35, 1·67 2·39 1·11, 5·16 0·030
Model 1 þ hs-CRP‡ 1 1·09 0·49, 2·39 0·75 0·34, 1·66 2·38 1·10, 5·14 0·031
Model 1 þ hs-CRP‡ þ glucose§ 1 1·17 0·44, 3·07 0·65 0·24, 1·79 3·62 1·32, 9·95 0·017
Q4 Q3 Q2 Q1
sTfR
Men (mg/l) .1·45 1·22–1·45 1·07–1·22 ,1·07
Women (mg/l) .1·46 1·27–1·46 1·09–1·27 ,1·09
Cases 36 39 36 42
Controls 76 76 76 74
Crude* 1 1·11 0·63, 1·97 1·02 0·59, 1·77 1·21 0·70, 2·09 0·499
Model 1† 1 1·76 0·82, 3·78 1·10 0·55, 2·21 1·39 0·68, 2·87 0·575
Model 1 þ hs-CRP‡ 1 1·76 0·82, 3·79 1·11 0·55, 2·22 1·39 0·68, 2·86 0·583
Model 1 þ hs-CRP‡ þ glucose§ 1 1·59 0·61, 4·18 1·14 0·47, 2·76 1·29 0·51, 3·23 0·722
Q4 Q3 Q2 Q1
sTfR:ferritin ratio
Men (mg/l) .15·04 7·29–15·04 4·35–7·29 ,4·35
Women (mg/l) .25·41 14·02–25·41 8·53–14·02 ,8·53
Cases 32 33 34 54
Controls 75 76 76 75
Crude* 1 1·04 0·56, 1·93 1·10 0·61, 1·97 1·73 0·99, 3·05 0·042
Model 1† 1 1·39 0·61, 3·14 1·04 0·48, 2·22 2·32 1·08, 4·98 0·035
Model 1 þ hs-CRP‡ 1 1·38 0·61, 3·13 1·03 0·48, 2·21 2·31 1·08, 4·97 0·036
Model 1 þ hs-CRP‡ þ glucose§ 1 1·65 0·58, 4·67 1·06 0·40, 2·79 3·02 1·09, 8·39 0·042
Q, quartile; hs-CRP, high-sensitivity C-reactive protein.
* Crude: unadjusted.
†Model 1: marital status (married/not married); educational level (low/medium/high); smoking status (current/former/never); physical activity (,200metabolic
equivalents (MET)-min/d or $200MET-min/d); alcohol consumption (yes/no); family history of diabetes (yes/no); waist circumference (men ,102 or
$102 cm, women ,88 or $88 cm); hypertension (,135, 85 or $135/85mmHg); hypertriacylglycerolaemia (,1·70 or $1·70mmol/l); HDL-cholesterol
(men $1·03 or ,1·03mmol/l, women $1·30 or ,1·30mmol/l); diet (energy, dairy products, meat, vegetables, fruits, Mg, and vitamins D and E).
‡ hs-CRP in mg/l.
§Glucose ,5·6 or $5·6mmol/l.
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risk factors, including inﬂammation(2,5–7,9–11). However, the
associations, following the adjustment for fasting glucose
and other components of the MetS, have not been observed
previously. Only the ARIC study(5), conducted with US males
and females between 45 and 64 years of age, observed the
association, and which was lost when adjusted for the com-
ponents of the MetS. Another study, conducted with cohorts
from the Finish FINRISK and Health 2000(8) studies composed
of males and females .25 years of age, encountered
increased SF levels related to the incidence of T2DM even fol-
lowing the adjustment for glucose, but not for the components
of the MetS. In the present study, SF and fasting glucose
entered the CLR-conditional model signiﬁcantly, suggesting
that the two variables are risk factors for T2DM. This is in
concordance with the current consensus that glucose is the
principal risk factor for T2DM, which can indicate that, apart
from glucose, SF plays an aetiologic role in the development
of this pathology. Another study performed in the general
adult population have as well observed SF and glucose as
the risk factors of T2DM(8).
As we have stated above, the sTfR:ferritin ratio seems to be
a good biomarker of Fe deposits given that it is sensitive to
elevated as well as decreased levels of Fe(34). However, it is
possible that, since we did not ﬁnd any association between
sTfR and T2DM, the association encountered between the
sTfR:ferritin ratio and T2DM could be due exclusively to SF
concentrations. Further support for this hypothesis comes
from the observation of a strong partial correlation (adjusted
for sex, age and BMI) between SF and the sTfR:ferritin ratio,
but not so strong a correlation between sTfR and the sTfR:
ferritin ratio (Table 2).
The present results and those of previous studies(2–14)
suggest that the observed association between ferritin and
the sTfR:ferritin ratio v. T2DM was very probably due to the
excess levels of Fe. Ferritin, in addition to reﬂecting body Fe
status, increases with inﬂammation. We measured hs-CRP con-
centrations to control for this effect in the multivariate analyses
of the relationship between excess Fe and the onset of T2DM.
In the present results, we observed that hs-CRP levels were
similar in incident and non-incident diabetic individuals,
while SF was signiﬁcantly higher in the incident diabetic
group. This supports the hypothesis that excess Fe acts inde-
pendently of the level of inﬂammation in the development
of T2DM. Further support for this interpretation comes
from previous studies that have analysed the relationship
between ferritin and T2DM following adjustments for
one(2,7,9,10) or more(6) inﬂammatory markers showing similar
ﬁndings to ours.
In the DPP(7) cohort of obese subjects with impaired basal
glucose, an association was found not only between SF and
T2DM, but also between sTfR and T2DM. This latter relation-
ship was contrary to expectation, i.e. increased levels of sTfR,
indicative of low Fe stores, were associated with an increased
risk of T2DM. More recently, the Finnish KIHD cohort(11), con-
ducted with middle-aged men, also observed that Fe
deﬁciency and excess Fe (using sTfR as a biomarker)
increased the risk of T2DM. A recent review has concluded
that extreme conditions of Fe deﬁciency, as well as Fe
overload, were associated with increased risk of CVD(36).
As such, the hypothesis is that Fe deﬁciency could also
cause an increase in the incidence of T2DM.
Of considerable note as well is that sTfR levels were much
higher in those cohorts in whom an association was observed
between sTfR and T2DM, e.g. DPP(7) (median 4th quartile
4·4mg/l; mean of the overall sample 3·4mg/l) and KIHD(11)
(0·6–8·2mg/l) studies compared with the present study
(0·69–2·65mg/l) and the EPIC Potsdam study(2) (mean of
the overall sample 1·13mg/l), albeit Fe stores measured by
SF were similar in these four cohort studies. Also, sTfR levels
have been documented to be affected by mechanisms other
than those related to Fe metabolism (such as insulin sensitivity
and obesity), and they could be causally linked to T2DM(4). As
such, not only lower Fe storage would lead to increased levels
of sTfR, but also sTfR would be a biomarker of another factor
causally related to the risk of T2DM.
The essential role of ferritin in the organism is in the storage
of Fe. Fe is a catalyst for oxygen reactive species and, as such,
contributes to oxidative stress(37). A proposed underlying
mechanism is that certain ‘trigger’ molecules associated with
some pathologies could open up the structure of the ferritin
molecule, thus provoking the liberation of the stored Fe(37).
This, in turn, could favour the risk associated with oxidative
stress and its consequences. Experimental data and clinical
studies have suggested that an oxidative environment contrib-
utes to the development of IR(38) and b-cell dysfunction,
which are two key events in the clinical development of
T2DM(15). Also, the increase in oxidative stress provokes an
increase in b-cell apoptosis in studies with animal models(39)
and an increase in IR in human in vivo studies(40). Similarly,
evidence exists from cross-sectional studies(41) that elevated
levels of SF are associated with increased IR. We observed
this relationship in the present study (b ¼ 0·001; P¼0·020),
i.e. for each mg/l of SF, there was an increase of 0·001 in
HOMA-IR. Also, ferritin was correlated with HOMA-IR in the
overall study sample, as well as in incident and non-incident
diabetic individuals. This suggests that this relationship with
HOMA-IR could be occurring in the entire general population.
The mechanisms that underlie this relationship have not been
identiﬁed to date, although there has been speculation that the
pro-oxidant role of Fe would activate a series of stress avenues
related to the family of serine/threonine kinases and, ﬁnally,
causing a disruption in the insulin signalling process(38). It is
possible then that IR is an intermediate link in the relationship
between high Fe deposits and the risk of T2DM.
Conclusion
Excess body Fe (measured as SF and sTfR:ferritin ratio) is
associated with an increased risk of T2DM in a Mediterranean
population at a high risk of CVD, even following the adjust-
ment for hs-CRP, fasting glucose and other components of
the MetS. This association was not evident with sTfR.
The potential mechanism that mediates this relationship
could be related to IR. More studies are warranted to conﬁrm
this mechanism since it is becoming increasingly evident that
excess Fe is related to the incidence of T2DM.
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The findings obtained in this thesis contribute to existing scientific evidence in the field 
of iron and T2DM. Specifically, we have analysed, for the first time, how excess iron in 
the diet and/or body affects the risk of T2DM in a large elderly Mediterranean population 
at high cardiovascular risk. To better understand the mechanisms behind the 
associations between iron and T2DM reported in the current thesis, we have assessed 
the relationships between iron parameters and novel T2DM-associated biomarkers such 
as osteocalcin (OC). 
 
 
1. STUDY DESIGN AND POPULATION 
 
The participants selected for the study were elderly men and women from three cities of 
Spain, Reus-Tarragona, Pamplona and Barcelona, who were free of T2DM and CVD at 
baseline, but were at high cardiovascular risk. These features of the sample participants 
- advancing age and high cardiovascular risk – are strengths of this prospective study to 
analyse the relationship between iron in the diet and/or body and risk of T2DM. Firstly, 
since the incidence of this metabolic disease in Spain is around 9 cases per 1,000 person-
years (Martín Martínez et al., 2013), the sample of high cardiovascular risk subjects led 
to a higher incidence of T2DM than would be expected in a healthy population. We would 
otherwise have needed an extremely large sample to ensure a significant number of 
T2DM cases. And secondly, the subjects’ advancing age, one of the most prominent T2DM 
risk factors, also helped to increase the incidence of diabetes in our sample. This is easily 
seen if we compare the sample size for our study on iron intake and T2DM risk with the 
size of American samples (see table 10), and the respective percentage of diabetic 
subjects. Our study enrolled 1,073 participants of whom 131 (12.2%) developed T2DM. 
Most American prospective cohorts (HPFS, IWHS, WHS and NHS) of healthy populations 
have comprised very large samples (over 35,000 and even as many as 121,000 subjects), 
with a high number of incident diabetics (over 1,100) in those cohorts but a significantly 
lower percentage of T2DM subjects (between 3 and 5.4%). 
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Moreover, our follow-up period of up to 8 years, was larger than those of most other 
studies except those of the largest prospective American cohorts with healthy 
populations. This length of time also helped to reduce the possibility that some control 
individuals would develop T2DM after the follow-up period. 
 
 
2. METHODS 
 
New-onset T2DM during follow-up was diagnosed in accordance with ADA criteria (see 
table 8) (American Diabetes Association, 2013). Whenever cases of new-onset T2DM 
were identified by medical diagnosis from the medical charts or by glucose test during 
routine biochemical analyses (performed at least once a year), reports were sent to the 
Clinical Events Committee, whose members were blinded to treatment allocation. Only 
when a second test had been conducted with the same criteria and repeated within the 
following three months was a new case of diabetes definitively confirmed by the 
adjudication committee. In contrast, in most previous studies that have assessed the 
relationship between iron intake and/or body iron stores and risk of T2DM, diabetes was 
identified by self-reporting (Jiang et al., 2004a) (Jiang et al., 2004b) (Lee et al., 2004) 
(Song et al., 2004) (Rajpathak et al., 2006) (Forouhi et al., 2007a) (Shi et al., 2010) 
(Montonen et al., 2012). 
 
Trained dieticians completed a 137-item semi-quantitative FFQ in a face-to-face 
interview with each participant (Appendix III). This questionnaire had been previously 
validated in an elderly Spanish population at high cardiovascular risk (Fernández-Ballart 
et al., 2010). These widely used dietary assessment tools in epidemiological studies have 
several strengths (see point 1.2.2). For instance, they are a retrospective and direct 
method for estimating usual intake over a certain period of time. They are also highly 
cost-effective and, since they have a standard format, are easy to administer. 
 
The concentrations of SF and soluble transferrin receptor (sTfR) were measured using 
immunochemiluminescence and OC and uncarboxylated OC using 
electrochemiluminescence. These are widely used methods with high sensitivity and 
specificity. SF, which closely reflects estimates of body iron levels, is reported to be 
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influenced by inflammation status. In this study, we therefore also measured hs-CRP to 
adjust for this confounding variable when evaluating how excess iron affects the 
development of T2DM. We also assessed this relationship with sTfR, another marker that 
measures iron status. sTfR in plasma is directly proportional to the cell requirements for 
iron (Speeckaert et al., 2010) and is therefore considered a good biomarker for 
evaluating body iron status (Désidéri-Vaillant et al., 2011). However, some studies have 
suggested that sTfR levels may be increased by other factors such as the degree of glucose 
tolerance or IR (Fernández-Real et al., 2007), hyperinsulinaemia (Davis et al., 1986), 
inflammation (Kasvosve et al., 2006), and general and/or abdominal obesity (Tussing-
Humphreys et al., 2010). The sTfR/ferritin ratio appears to be a better marker of iron 
stores (Malope et al., 2001). It is particularly useful in population studies since it is 
sensitive to both elevated and decreased levels of iron stores (Skikne, 2008). 
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Table 10. Characteristics of prospective studies about haem iron intake and risk of T2DM. 
Author, 
year 
Study Location 
Follow-
up 
(years) 
Ethnicity Gender 
Age 
(years) 
Sample 
size 
Incident 
diabetics 
T2DM 
(%) 
Ascertainment 
of T2DM 
Dietary 
assessment 
method 
Haem 
iron 
intake 
(mg/day) 
Effect size 
estimate (95% 
CI), P-trend 
Jiang, 2004 HPFS U.S. 12 American Male 40–75 38,394 1,168 3.0 Self-report VFFQ 
Median 
Q5: 1.9 
1.28 (1.02-1.61), 
P = 0.045 
Lee, 2004 IWHS U.S. 11 American Female 55-69 35,698 1,921 5.4 Self-report VFFQ 
Median 
Q5: 2.2 
1.28 (1.04-1.58), 
P = 0.020 
Song, 2004 WHS U.S. 8.8 American Female ≥45 37,309 1,558 4.2 Self-report VFFQ 
Median 
Q5: 1.55 
1.46 (1.20-1.78), 
P<0.001 
Rajpathak, 
2006 
NHS U.S. 20 American Female 34-59 121,700 4,599 3.8 Self-report VFFQ 
Median 
Q5: 1.9 
1.28 (1.14-1.45), 
P<0.001 
Shi, 2010 JNS China 5 Chinese 
Male / 
Female 
≥20 1,056 23 2.2 Self-report VFFQ 
Median 
Q4: 4.4 
9.84 (1.41-68.75), 
P = 0.033 
de Oliveira 
Otto, 2012 
MESA U.S. 4.8 
White, 
African 
American, 
Hispanic, 
and Asian 
Male / 
Female 
45-84 4,982 499 10.0 
Self-report, 
glucose levels 
or new use of 
hypoglycemic 
medication 
VFFQ Q5 ≥ 1.07 
1.24 (0.86-1.78), 
P = 0.210 
Fernandez-
Cao, 2013 
PREDIMED Spain 8 Caucasians 
Male / 
Female 
55-80 1,073 131 12.2 ADA criteria VFFQ 
Median 
Q5: 5.2 
sample 
median: 
3.65 
1.30 (1.02-1.66), 
P = 0.037 
Overall risk of high versus low haem iron intake and the risk of T2DM (Heterogeneity = 0%, P = 0.467) 1.31 (1.21-1.42) 
CI (Confidence Interval), HPFS (Health Professionals' Follow-up Study), VFFQ (validated food frequency questionnaire), BMI (Body Mass Index), IWHS (Iowa Women's Health Study), WHS (Women's 
Health Study), NHS (Nurses' Health Study), JNS (Jiangsu Nutrition Study), MESA(Multi-Ethnic Study of Atherosclerosis), PREDIMED (PREvención con DIeta MEDiterránea). 
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Table 11. Characteristics of prospective studies about serum ferritin levels and risk of T2DM. 
Author, 
year 
Study Location Study design 
Follow-
up 
(years) 
Ethnicity Gender 
Age 
(years) 
Sample 
size 
Incident 
diabetics 
Ascertainment 
of T2DM 
Laboratory 
measurement 
of ferritin 
Serum 
ferritin 
(ng/mL) 
Effect size 
estimate (95% 
CI), P-trend 
Jiang, 2004 NHS U.S. 
Prospective 
nested case-
control 
10 American Female 30-55 1,414 698 Self-report ITA Q5 ≥ 107.2 
2.61 (1.68-4.07), 
P<0.001 
Jehn, 2007 ARIC U.S. 
Prospective 
nested case-
cohort 
7.9 
White, 
African 
American 
Male / 
Female 
45-64 1,289 599 
DDC or self-
reported 
ITA 
Median Q5: 
354.5 
0.79 (0.48-1.32), 
P= 0.078 
Forouhi, 
2007 
EPIC U.K. 
Prospective 
nested case-
control 
Mean: 
5.1±1.7 
White 
Male / 
Female 
40-74 1118 360 Self-report TR-FIA 
Median Q5: 
300 (male), 
150 (females) 
3.2 (1.3-7.6), 
P=0.007 
Le, 2008 ACLS U.S. 
Prospective 
cohort 
up to 12 
White  
(93.2 %) 
Male / 
Female 
20-83 5,512 220 ADA criteria  - 
Q4 >188 
(male), >60 
(pre-female), 
>90 (post-
female) 
Male: 1.67 (1.05-
2.66), P = 0.027; 
female: 0.59 (0.20-
1.76), P >0.050 
Rajpathak, 
2009 
DPP U.S. 
Prospective 
nested case-
control 
Mean: 2.8 Multiethnic 
Male / 
Female 
≥ 25 560 280 ADA criteria ITA 
Median Q4: 
203 
1.61 (0.85-3.02) , 
P= 0.030 
Montonen, 
2012 
EPIC Germany 
Prospective 
nested case-
cohort 
7 White 
Male / 
Female 
35-65 1,969 607 Self-report 
ADVIA 
Centaur 
XP 
Q5 ≥ 280 
(male), ≥110 
(female) 
1.73 (1.15-2.61), 
P= 0.002 
Aregbesola, 
2013 
KIHD Finland 
Prospective 
cohort 
Mean: 
16.8 
White Male 42-60 1,613 331 
DDC or self-
reported 
RIA Q5 ≥ 228 
1.5 (1.0-2.2), 
P=0.050 
Sun, 2013 NHAPC China 
Prospective 
cohort 
6 Chinese 
Male / 
Female 
50-70 2,198 538 
DDC or self-
reported 
ITA 
Geometric 
median Q5: 
325 (male), 
235 (females) 
1.59 (1.12-2.25), 
P= 0.002 
Arija, 2014 PREDIMED Spain 
Prospective 
nested case-
control 
Median: 6 Caucasian 
Male / 
Female 
55-80 459 153 ADA criteria ICL 
Q4 >257 
(male), >139 
(female) 
3.62 (1.32-9.95), 
P= 0.022 
Overall risk of high versus low serum ferritin levels and the risk of T2DM (Heterogeneity = 56.1%, P = 0.015) 1.64 (1.27-2.12) 
CI (Confidence Interval), NHS (Nurses' Health Study), ITA (ImmunoTurbidimetric Assay), ARIC (The Atherosclerosis Risk in Communities study), DDC (Diabetes Diagnostic Criteria: fasting glucose ≥7.0 mmol/L; or 
nonfasting glucose ≥11.1 mmol/L), EPIC (European Prospective Investigation of Cancer); TR-FIA (Time-Resolved FluoroImmunoAssay),  ACLS (Aerobics Center Longitudinal Study), HPFS (Health Professionals' Follow-up 
Study), ADA (American Diabetes Association), Q4 (Quartile 4), pre-females (premenopausal females), post-females (postmenopausal females), DPP (Diabetes Prevention Program), KIHD (Kuopio Ischemic Heart Disease Risk 
Factor), RIA (RadioImmunoAssay), NHAPC (The Nutrition and Health of Aging Population in China study), PREDIMED (PREvención con DIeta MEDiterránea), ICL (ImmunoChemiLuminiscence). 
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3. IRON INTAKE AND TYPE 2 DIABETES MELLITUS 
 
In our prospective cohort study, we assessed, for the first time in an European 
population, the relationship between high haem iron intake and T2DM. Our results 
showed that a high haem iron intake increases the risk of T2DM by 30%, in an elderly 
Mediterranean population at high cardiovascular risk. However, total iron and non-haem 
iron intake are not significantly related to T2DM.  
 
The relationship between haem iron intake and the risk of developing T2DM has been 
previously analysed in five long-term prospective epidemiological studies in US 
populations (Jiang et al., 2004a) (Lee et al., 2004) (Song et al., 2004) (Rajpathak et al., 
2006) (de Oliveira Otto et al., 2012), and in cross-sectional (Shi et al., 2006) (Luan de et 
al., 2008) and prospective (Shi et al., 2010) epidemiological studies in Chinese 
populations. Data from US cohorts - such as the HPFS (Jiang et al., 2004a) of men aged 40 
to 75, the IWHS (Lee et al., 2004) of postmenopausal women aged 55 to 69, the Women’s 
Health Study (WHS) (Song et al., 2004) of women aged ≥ 45, and the Nurse’s Health Study 
(NHS) (Rajpathak et al., 2006) of women aged 34 to 59, showed that subjects in the 
highest quantile of haem iron intake increased the risk of T2DM by between 28% (Jiang 
et al., 2004a) (Lee et al., 2004) (Rajpathak et al., 2006) and 46% (Song et al., 2004) with 
respect to the lowest. In addition, no associations were observed between total iron, non-
haem iron intake and/or iron supplementation and T2DM. Our results are consistent 
with those from the above American studies of men and pre- and postmenopausal 
women, which showed a similar T2DM risk (30%) in subjects aged 50-80 with an 
elevated intake of haem iron but not with total iron or no-haem iron intake. However, 
other prospective study of U.S. subjects aged 45 to 84, in the MESA cohort, found no 
association between haem iron intake and T2DM (de Oliveira Otto et al., 2012). The 
ethnic diversity of the MESA cohort could be the reason for the lack of association 
observed, since we know that certain ethnicities are more susceptible to T2DM than 
others. For example, T2DM is up to six times more common in people of South Asian 
descent and up to three times more common in people of African and African-Caribbean 
origin than in white populations (Ntuk et al., 2014) (Tillin et al., 2013) (Bennet et al., 
2014). South Asians followed by Chinese and black populations seem to have the highest 
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prevalence of diabetes, while with white populations have the lowest prevalence (Ntuk 
et al., 2014). 
 
Results from studies of Chinese populations are inconsistent (Shi et al., 2006) (Luan de 
et al., 2008). While Luan et al. also found an association between haem iron intake and 
T2DM (Luan de et al., 2008) as in our cohort and in four American cohorts (Jiang et al., 
2004a) (Lee et al., 2004) (Song et al., 2004) (Rajpathak et al., 2006), Shi et al. in the JIN 
study, surprisingly observed a positive relationship between high total iron (Shi et al., 
2006) and non-haem iron (Shi and Pan, 2008) intake and T2DM risk in women, but not 
in men. However, in accordance with previous studies, a subsequent prospective analysis 
of 1,056 participants from this cohort with FPG <5.6mmol/L and without diabetes at 
baseline showed a higher risk of hyperglycaemia and T2DM among subjects in the 
highest quartile of haem iron intake than among subjects in the lowest (Shi et al., 2010). 
 
It has been suggested that the association between haem iron intake and the risk of 
T2DM is confounded by food source (Jiang et al., 2004a) since the most important source 
of haem iron in the diet is red meat. It is known - as Loma Linda University’s Adventist 
Health Study first reported in 1985 (Snowdon and Phillips, 1985) and has since been 
consistently observed in several other studies (Pan et al., 2011) - that a high meat intake 
is associated with the risk of developing T2DM. However, later prospective studies of 
American (Lee et al., 2004) (Rajpathak et al., 2006) and Chinese (Shi et al., 2010) cohorts 
- and now of our European cohort - confirm earlier findings of associations between 
haem intake from all sources and T2DM. 
 
Although haem iron absorption is less stringently regulated in response to dietary 
inhibitors and enhancers, recent studies have shown that certain dietary components, 
such as animal and vegetal proteins (Hallberg et al., 1993) (Villarroel et al., 2011), 
calcium (Hallberg et al., 1991) (Hallberg et al., 1993) and polyphenols (Ma et al., 2010) 
(Ma et al., 2011), may inhibit its absorption, while other components such as ascorbic 
acid (Ma et al., 2011), may enhance it. It has also been found that intestinal iron 
absorption increases two-fold in chronic alcoholics, possibly due to changes in intestinal 
permeability (Duane et al., 1992). In addition to sociodemographic, anthropometric, and 
other variables, dietary components have been associated with T2DM risk (Salas-
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Salvadó et al., 2011). This is why the following dietary variables were included in the 
proportional hazard models for assessing the relationship between haem iron and 
T2DM: meat, fish and eggs (animal protein); cereals, legumes and nuts (vegetable 
protein); fruit; alcoholic beverages; tea; coffee; and calcium. 
 
Of our initial sample (1,073 subjects), 12.2% (131 subjects) developed T2DM with a 
median follow-up of 4.8 ± 1.3 years. At baseline, we described the general characteristics, 
and food, energy, and nutrient consumption in incident diabetics in comparison with 
non-incident diabetics among a Mediterranean population at high cardiovascular risk. 
Known risk factors, such as BMI (Abdullah et al., 2010), waist circumference (Adegbija 
et al., 2015) and smoking (Cho et al., 2009) were significantly higher in incident diabetics 
than in non-incident diabetics. Moreover, incident diabetics consumed significantly less 
fruit and coffee - which have a protective effect against the development of T2DM (Wu et 
al., 2015) (Ding et al., 2014) - but more haem iron. 
 
After adjusting the proportional hazard model for energy intake, we observed a 
significant association between haem iron intake and the risk of developing T2DM. In the 
final model applied, in addition to haem iron, we also observed a positive association 
between the consumption of alcohol beverages and an increased risk of T2DM. On the 
other hand, as has also been observed in other studies (Ding et al., 2014), coffee 
consumption was associated with a lower risk. The negative relationship between coffee 
consumption and risk of T2DM could also be explained by the positive relationships 
between caffeine and insulin sensitivity, and between decaffeinated coffee and β-cell 
function (Loopstra-Masters et al., 2011). Polyphenols, including those found in coffee and 
tea, seem to inhibit the uptake of intestinal haem iron (Ma et al., 2010) (Ma et al., 2011), 
thus reducing its adverse effects. Alcohol seems to have a detrimental effect on the 
metabolism of iron. In the IWHS, an association was observed between higher haem iron 
intake and a greater risk T2DM, especially in those who also consumed alcohol (Lee et 
al., 2004). Consuming two or more alcoholic drinks per day was associated with a higher 
risk of iron overload (Ioannou et al., 2004). It seems that acute or chronic exposure to 
alcohol suppresses the expression of hepcidin in the liver, thus leading to greater iron 
absorption (Bridle et al., 2006) (Harrison-Findik et al., 2006) (Ohtake et al., 2007) 
(Flanagan et al., 2007) (Harrison-Findik, 2007) (Harrison-Findik et al., 2007) (Harrison-
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Findik, 2009). Alcohol intake at low levels increases serum iron and ferritin and, 
therefore, body iron stores (Whitfield et al., 2001), and this in turn is associated with the 
risk of developing T2DM (Kim et al., 2011a). 
 
Although it is not fully understood why the risk of T2DM has been specifically linked with 
haem iron intake, Haem iron is known to be more bioavailable than non-haem iron 
(roughly 25% compared to 5–15%, respectively) (Rajpathak et al., 2009a). There is also 
strong evidence that non-haem iron absorption in the proximal intestine is accurately 
regulated by hepcidin to ensure that overall body iron levels are maintained at adequate 
levels (Gulec et al., 2014). In conditions of elevated iron stores, hepcidin therefore causes 
FPN internalization and proteolysis into lysosomes (De Domenico et al., 2007) and, 
probably, the proteasomal-mediated degradation of DMT1 (Brasselagnel et al., 2011). 
Non-haem iron absorption therefore becomes blocked, thus preventing enterocytes 
from allowing iron into the hepatic portal system and preventing an increase in body iron 
stores. Cao et al. recently observed that liver hepcidin explained 59% and 63% of the 
variation in haem and non-haem iron absorption, respectively, but had a greater relative 
impact on non-haem iron absorption (Cao et al., 2014). It is known that inside 
enterocytes, haem iron is mostly catabolised by HO-1 in biliverdin, CO and free iron. Free 
iron probably enters in the same pathways as non-haem iron and so some haem iron is 
probably regulated by hepcidin. Accordingly, a fraction of the haem iron absorbed seems 
to respond to changes in body iron status. However, it has been suggested that an intact 
haem iron fraction passes directly into the bloodstream (Mendiburo et al., 2011) (Cao et 
al., 2014). This fraction of haem iron that traverses enterocytes may avoid hepcidin 
control. Under these assumptions, people with an elevated intake of animal products 
could keep on absorbing iron - at least a fraction of haem iron - despite having high iron 
stores. Body iron levels would therefore continue to increase even when the hepcidin 
levels were elevated. In this context, elevated haem iron intake has been associated with 
high levels of serum ferritin (SF) (Vander et al., 2006). 
 
It is speculated that the increase in iron stores may play a role in the production of ROS, 
such as hydroxyl radicals, thus inducing tissue damage (Lipinski, 2011) identified by 
increased peroxidation of lipids, protein modification, and DNA damage (Förstermann, 
2008). If continued for a longer duration, iron-induced oxidative stress may lead to T2DM 
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(Swaminathan et al., 2007). This mechanism could explain why high dietary haem iron 
intake has been related to the risk of T2DM, and diseases, such as gestational diabetes 
(Qiu et al., 2011) (Bowers et al., 2011), MetS (de Oliveira Otto et al., 2012), cardiovascular 
disease (Fang et al., 2014) (stroke (Kaluza et al., 2013), acute myocardial infarction 
(Kaluza et al., 2014) and coronary heart disease (Hunnicutt et al., 2014)) and oesophagus 
(Ward et al., 2012) gastric (Jakszyn et al., 2012), colorectal (Qiao and Feng, 2013), breast 
(Kabat et al., 2010), lung (Tasevska et al., 2009), and endometrial cancer (Genkinger et 
al., 2012). 
 
 
4. BODY IRON STATUS AND SERUM OSTEOCALCIN LEVELS 
 
We have observed, for the first time, that body iron status, measured as SF and sTfR 
levels, is inversely associated with total and uncarboxylated OC in an elderly 
Mediterranean population at high cardiovascular risk. This relationship was 
independent of potentially confounding variables such as lifestyle and biomarkers of 
glucose metabolism, inflammation and oxidative stress. Since OC has been related not 
only to bone metabolism but also to IR and sensitivity, our results would help to explain 
one of the possible mechanisms relating iron metabolism with glucose homeostasis. 
 
We have also reported the general, lifestyle, energy intake, and biochemical 
characteristics and risk factors for T2DM (MetS and its components, IR, β-cell function, 
obesity, inflammation) in IFG versus normal glucose metabolism (NGM) subjects in a 
Mediterranean population at high cardiovascular risk. As expected, IFG subjects had a 
significantly larger waist circumference, fasting glucose, fasting insulin, and IR, and lower 
β-cell function, HDL-cholesterol, and adiponectin levels, which indicates a greater risk of 
developing T2DM. Also, total and uncarboxylated OC were lower in IFG subjects than in 
NGM subjects, and both these biomarkers have recently been related to the risk of T2DM 
(Ngarmukos et al., 2012) (Díaz-López et al., 2013). Our findings therefore support the 
extra-skeletal roles of OC involved in the regulation of energy, glucose, and fat 
metabolism (Lee et al., 2007) (Neve et al., 2013). It has been observed that mice lacking 
OC show lower β-cell proliferation, glucose intolerance and IR, and that UOC mediates 
the metabolic functions of this hormone (Lee et al., 2007). Also, OC knockout mice have 
UNIVERSITAT ROVIRA I VIRGILI 
IRON EXCESS AND RISK OF TYPE 2 DIABETES MELLITUS IN A PROSPECTIVE COHORT OF MEDITERRANEAN POPULATION 
José Cándido Fernández Cao 
Discussion 
  
195 
 
lower levels of serum adiponectin, which suggests a potential role for OC in insulin 
sensitivity and secretion. Studies in humans seem to be consistent with previous findings 
in animal models. In an elderly Mediterranean population at high cardiovascular risk, 
high total or uncarboxylated OC serum concentrations were directly associated with 
HOMA-β and inversely associated with IR determined by HOMA-IR (Bulló et al., 2012), 
thus suggesting a possible role of bone in the development of T2DM. 
 
Iron overload can damage important organs such as liver, pancreas and heart (Whittaker 
et al., 1996). Many lines of research also indicate that it affects bone tissue, causing both 
osteopenia and osteoporosis (Weinberg, 2006) and a high prevalence of fractures 
(Vogiatzi et al., 2009a). For example, in a sample of 38 untreated HFE-related 
haemochromatotic patients, 79% were osteopenic and 34% were osteoporotic. 
Interestingly, recent in vitro studies have shown that ferritin itself can directly inhibit 
osteogenesis in a dose-responsive manner through its ferroxidase activity (Zarjou et al., 
2010). Iron has also been shown to have a detrimental effect on the differentiation, 
proliferation and activity of osteoblasts (Yamasaki and Hagiwara, 2009). Moreover, iron 
exposure on human osteoblast-like cells reduced the expression of genes involved in 
bone matrix formation or osteoblast differentiation such as COL1AI, Runx2 or OC (Yang 
et al., 2011) (Doyard et al., 2012). It has been suggested that this deleterious effect is 
probably due to iron overload-associated oxidative stress (Zhao et al., 2012). High SF 
levels, reflecting high iron stores, may therefore inhibit OC synthesis through down-
regulation of osteoblasts. This would be consistent with our findings, in which we 
observed an inverse association between SF and total OC. However, we found no 
relationship between SF and UOC following adjustment for potentially confounding 
variables such as lifestyle and biomarkers of glucose metabolism, inflammation and 
oxidative stress. OC synthesis, but not the subsequent carboxylation, probably depends 
on ferritin levels. Moreover, we found these results both in the whole sample and in NGM 
and IFG subjects. Surprisingly, however, the association found in IFG subjects 
disappeared in the full adjustment model, after the introduction of fasting plasma glucose 
and insulin and other variables. This suggests that the relationship between SF and OC 
depends on glucose metabolism in IFG subjects. The elevated glucose levels and, 
consequently, the characteristic high insulin concentration found in IFG subjects 
probably influence the regulation of OC homeostasis. In earlier study, Bulló et al., 
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reported that fasting insulin increased OC values (β = 0.97, P = 0.028) (Bulló et al., 2012). 
Curiously, Fulzele et al. suggested the existence of a novel bone-pancreas feedback loop 
through which insulin signalling in the osteoblast promotes osteoblast differentiation, 
and simultaneously stimulates OC production by suppressing the Runx2 inhibitor 
Twist2, which in turn regulates pancreatic insulin secretion and insulin sensitivity (see 
figure 15) (Fulzele et al., 2010). High insulin levels may therefore reduce the deleterious 
effect of iron excess on the synthesis of OC. 
 
Figure 15. Bone-pancreas feedback loop model. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           Adapted from (Fulzele et al., 2010) 
 
We also found that higher levels of sTfR, which are indicative of low iron status, were 
inversely associated with serum total and uncarboxylated OC. Recent experimental 
studies have shown that osteogenesis is optimal in a certain range of iron concentration, 
i.e. while mild low iron promoted osteoblast activity, both, severely low iron and iron 
overload may inhibit osteoblast activity (Zhao et al., 2012), and therefore, OC synthesis. 
Studies in animal models have consistently found that serum OC concentration was 
significantly lower in rats fed an iron-deficient diet than in rats fed a control diet, and 
given free access to the experimental diets (Katsumata et al., 2006) (Katsumata et al., 
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2009). ID in humans as severe as in these studies conducted on rats is probably rare. 
However, even in humans a consistently low iron intake and/or severe ID may alter 
osteoblast activity and therefore also serum OC concentrations. Our data support the 
hypothesis regarding the detrimental effect of ID and iron overload on serum total and 
uncarboxylated OC concentration. On other hand, we observed no relationship between 
sTfR/ferritin ratio and serum total or uncarboxylated OC concentration. However, as 
expected, we did observe a negative tendency in the association between this ratio and 
HOMA-IR. 
 
In summary, we have described an inverse association between SF and sTfR with total 
and/or uncarboxylated OC in elderly Mediterranean subjects at high cardiovascular risk. 
These findings suggest that both high body iron stores and ID may contribute to the 
alteration of glucose metabolism through the inhibition of OC. Further research is 
required in order to understand the precise mechanisms by which iron status induces 
T2DM. 
 
 
5. BODY IRON STATUS AND TYPE 2 DIABETES MELLITUS 
 
In this prospective nested case-control study conducted on an elderly Mediterranean 
population at high cardiovascular risk, we confirmed a direct association between high 
body iron stores, measured as SF and sTfR/ferritin ratio, and the incidence of T2DM. This 
association was found after adjusting for established risk factors, such as hs-CRP, fasting 
glucose and other MetS components. These findings provide data from a different 
population – from southern Europe – to add to those previously studied. In addition, we 
found no association between sTfR levels and the risk of developing T2DM. 
 
Our results showed significantly higher levels of ferritin (127.59 ± 2.53 vs. 105.22 ± 
2.53mg/L, P = 0.037) and lower sTfR/ferritin ratios (9.9 ± 2.80 vs. 12.03 ± 2.80) with 
borderline significance (P = 0.057) in subjects with incident T2DM than in those with 
non-incident T2DM. However, we found no difference in sTfR levels. When we analysed 
the relationship using adjusted conditional logistic regression models, we found that the 
SF values >257mg/L in males and >139mg/L in females were associated with a high risk 
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of T2DM. According to the WHO (>200mg/L in males and >150mg/L in females) (World 
Health Organization, 2011a), these SF values, which are typical of iron overload status, 
are similar to those found in the studies of Norfolk (Forouhi et al., 2007a) and Potsdam 
(Montonen et al., 2012) of the EPIC cohort and the ARIC study (Jehn et al., 2007) 
conducted in the general population. 
 
Serum ferritin 
 
This association between SF and T2DM observed in our prospective study in a southern 
Europe population is consistent with previous prospective studies conducted with U.S. 
(Jiang et al., 2004b) (Le et al., 2008) (Rajpathak et al., 2009b), Chinese (Sun et al., 2013) 
and northern European (Forouhi et al., 2007b) (Salomaa et al., 2010) (Montonen et al., 
2012) (Aregbesola et al., 2013) populations. As in our study, these studies showed that 
subjects in the highest quantile of ferritin had between a 50 % (Aregbesola et al., 2013) 
and more than three times (Forouhi et al., 2007b) higher risk of developing T2DM than 
the lowest quantile. Our results were maintained after we adjusted for classic risk factors 
such as inflammation, fasting glucose and, for the first time, MetS components since MetS, 
and its components, especially an elevated level of fasting glucose (Zeng et al., 2011), 
have been strongly associated with the development of T2DM. Previous prospective 
studies adjusted their models using some classic risk factors, including inflammation 
(Jiang et al., 2004b) (Forouhi et al., 2007b) (Le et al., 2008) (Rajpathak et al., 2009b) 
(Salomaa et al., 2010) (Montonen et al., 2012) (Aregbesola et al., 2013) (Sun et al., 2013). 
However, association, after adjustment for fasting glucose and other MetS components, 
has not previously been observed. Only the ARIC study (Jehn et al., 2007), conducted with 
U.S. subjects aged between 45 and 64 observed this association until the MetS 
components were introduced into the model. Another study, conducted with cohorts 
from the Finnish FINRISK and Health 2000 (Salomaa et al., 2010) studies comprising men 
and women aged >25, encountered increased SF levels related to the incidence of T2DM 
even after adjustment for glucose but not after adjustment for other MetS components. 
 
Moreover, in our study, through the different proportional hazard models, SF and fasting 
glucose were significantly associated with the risk of T2DM, which suggests that both 
variables are risk factors for this disease. This is in agreement with the current consensus 
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that glucose is the main risk factor for T2DM, and that SF may have an aetiological role 
in the development of this pathology. 
 
sTfR 
 
We found no association between sTfR levels and the risk of T2DM. However, in the DPP 
(Rajpathak et al., 2009b) cohort of obese subjects with impaired basal glucose, an 
association was found not only between SF and T2DM, but also between sTfR and T2DM. 
This latter relationship was contrary to our expectations, i.e. higher levels of sTfR, which 
are indicative of low iron stores, were associated with a greater risk of T2DM. More 
recently, the Finnish KIHD cohort (Aregbesola et al., 2013), conducted with middle-aged 
men, also observed that ID and excess iron (using sTfR as a biomarker) increased the risk 
of T2DM. A recent review concluded that extreme conditions of ID, as well as iron 
overload, are associated with a higher risk of CVD (Lapice et al., 2013). The hypothesis is 
therefore that ID may also increase the incidence of T2DM. Note also that sTfR levels 
were much higher in cohorts in which an association was observed between sTfR and 
T2DM, e.g. the DPP study (Rajpathak et al., 2009b) (median 4th quartile 4.4mg/L; mean 
of the overall sample 3.4mg/L) and the KIHD study (Aregbesola et al., 2013) (0.6–
8.2mg/L) compared with our study (0.69–2.65mg/L) and the EPIC Potsdam study 
(Montonen et al., 2012) (mean of the overall sample 1.13mg/L). However, iron stores 
measured by SF were similar in these four cohort studies. sTfR levels are also reported 
to be affected by mechanisms other than those related to iron metabolism (such as 
insulin sensitivity and obesity) and could be causally linked to T2DM (Speeckaert et al., 
2010). Not only would lower iron storage therefore lead to higher sTfR levels but, as 
suggested by Rajpathak et al. (Rajpathak et al., 2009b) sTfR would be a biomarker of 
another factor causally related to the risk of T2DM. 
 
sTfR/ferritin ratio 
 
As in previous studies (Salonen et al., 1998) (Jiang et al., 2004b) (Montonen et al., 2012) 
(Aregbesola et al., 2013), we observed a significant association between higher 
sTfR/ferritin ratios and a greater risk of T2DM. As stated earlier, the sTfR/ferritin ratio 
seems to be a good biomarker of iron deposits since it is sensitive both to elevated and  
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decreased levels of iron (Skikne, 2008). However, since we found no association between 
sTfR and T2DM, the association observed between the sTfR/ferritin ratio and T2DM 
could be due exclusively to SF concentrations. Further support for this hypothesis comes 
from the observation of a strong partial correlation, adjusted for gender, age and BMI, 
between SF and the sTfR/ferritin ratio (r = -0.974), and by the not-so-strong correlation 
between sTfR and the sTfR/ferritin ratio (r = 0.542). 
 
At baseline, lifestyle, biochemical, and risk factors for T2DM (MetS and its components, 
IR, obesity, and inflammation) have been described in incident diabetics and non-
incident diabetics in a Mediterranean population at high cardiovascular risk. Of the 
incident diabetics, 83.7% had abdominal obesity, 62.7% had MetS, 96.7% had 
hypertension and 35.3% had IR. In addition, cases had greater waist circumference and 
higher levels of fasting glucose, fasting insulin, triglycerides and IR than non-incident 
diabetics. Despite these differences at baseline, and after adjusting for these and other 
risk factors in the proportional hazard models, we found an association between ferritin 
and the sTfR/ferritin ratio with T2DM. 
 
Our results and those of previous studies (Salonen et al., 1998) (Jiang et al., 2004b) 
(Forouhi et al., 2007b) (Jehn et al., 2007) (Le et al., 2008) (Rajpathak et al., 2009b) 
(Salomaa et al., 2010) (Montonen et al., 2012) (Aregbesola et al., 2013) (Sun et al., 2013) 
suggest that the association between ferritin and T2DM is probably due to excess levels 
of iron, even though ferritin, as well as to reflecting body iron status, increases with 
inflammation. This is support in our study because hs-CRP levels were similar in incident 
and non-incident diabetic subjects, while SF was significantly higher in incident diabetic 
subjects. We also measured hs-CRP concentrations to control for this effect in 
multivariate analyses of the relationship between excess iron and the onset of T2DM. 
Moreover, previous studies that analysed the relationship between ferritin and T2DM 
after adjustments for one (Jiang et al., 2004b) (Rajpathak et al., 2009b) (Montonen et al., 
2012) or more inflammatory markers (Forouhi et al., 2007b) reported similar findings 
to ours. All these data support the hypothesis that elevated iron status acts 
independently of the level of inflammation in the development of T2DM.  
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The essential role of ferritin in the organism lies in the storage of iron, since iron is a 
strong pro-oxidant agent that catalyses the generation of powerful ROS such as hydroxyl 
radicals, thus increasing oxidative stress (Schulze and Hu, 2005) (Drews et al., 2010). A 
proposed underlying mechanism is that certain ‘trigger’ molecules associated with 
certain pathologies may open up the structure of the ferritin molecule, thus provoking 
the liberation of the stored iron (Watt, 2011). This, in turn, could favour the risk 
associated with oxidative stress and its consequences. Oxidative stress could herefore be 
the mechanism by which iron excess is associated with a higher incidence of T2DM. 
Specifically, through its oxidative properties (Schulze and Hu, 2005) (Drews et al., 2010), 
body iron is suggested to play a role in IR (Syrovatka et al., 2009) and β-cell dysfunction 
(Kolberg et al., 2009) two key events in the clinical development of T2DM (Swaminathan 
et al., 2007). In mouse models of haemochromatosis, excess iron in the islets induces 
oxidative stress that leads to islet cell apoptosis, thus leading to a decrease in insulin 
secretory capacity (Cooksey et al., 2004). In addition, the peroxidation of lipids, 
especially free fatty acids, induced by increased iron stores in muscle reduces insulin 
sensitivity (Felber et al., 1987) (DeFronzo, 1988). Another mechanism that could lead to 
the development of T2DM is iron deposition in the liver, which could induce 
hyperinsulinaemia by impeding the liver’s capacity for insulin extraction, thus resulting 
in impaired suppression of hepatic glucose production (Niederau et al., 1984) 
(Ferrannini, 2000). 
 
Evidence from cross-sectional studies suggests that higher levels of SF are associated 
with increased IR (Pham et al., 2013). We have also observed this relationship in the 
present study (β = 0.001; P = 0.020), i.e. for each mg/L of SF, there was an increase of 
0.001 in HOMA-IR. Moreover, ferritin was correlated with HOMA-IR in the overall study 
sample, as well as in incident and non-incident diabetic subjects. This suggests that the 
relationship with HOMA-IR may occur in the entire general population. The mechanisms 
underlying this relationship have not yet been identified, though there is speculation that 
the pro-oxidant role of iron may activate a series of stress avenues related to the family 
of serine/threonine kinases, thus finally disrupting the insulin signalling process (Rains 
and Jain, 2011). IR may therefore be an intermediate link in the relationship between 
high iron deposits and the risk of developing T2DM. 
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6. STRENGTHS AND LIMITATIONS 
 
Given that this study was conducted in a population with various CVD risk factors, we 
should highlight the danger of extrapolating these results to the general population. 
However, this feature of the sample led to a higher incidence of T2DM than would be 
expected in a healthy population. We would otherwise have needed an extremely large 
sample to ensure a significant number of T2DM cases. As with cohort studies, there is no 
assurance that some control subjects would not develop T2DM after the follow-up 
period. Also, given the observational nature of our studies, we cannot completely 
establish a cause-effect relationship between independent variables and the risk of 
developing T2DM. 
 
One of the strengths of this study was that the diagnosis of T2DM was not self-reported 
but verified by a second analytical test, in accordance with ADA criteria (American 
Diabetes Association, 2013), enabling new incident cases to be identified more reliably 
and accurately. 
 
Also, the dietetic variables used in the analysis were obtained from a semiquantitative 
FFQ (Appendix III) that had been validated in the same population in order to reduce 
the possibility of error (Fernández-Ballart et al., 2010). Finally, the prospective nested 
case-control study design used to assess the relationship between body iron stores and 
the risk of T2DM enabled better control of confounding factors such as gender, age 
ranges and BMI because each case in the incident T2DM group was broadly matched for 
these variables with two control individuals without T2DM. 
 
In summary, our results support the deleterious effect of iron excess on the risk of T2DM 
independently of known risk factors. Previous prospective studies had found association 
between elevated haem iron intake and a greater risk of developing T2DM in U.S., and 
Chinese populations. We confirm these results, and extend the evidence to another 
population – a European population from the Mediterranean region. Moreover, as in 
studies of U.S., Chinese and northern European populations, we also observed, for the 
first time in a southern European population from the Mediterranean area, a greater risk 
of T2DM in those subjects with elevated body iron status.
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In a prospective eight-year follow-up study of an adult Mediterranean population at high 
cardiovascular risk, we observed that: 
 
1. At baseline, incident diabetics consume more haem iron and less fruit and coffee 
than non-incident diabetics. BMI, waist circumference and the consumption of 
tobacco are also higher in incident subjects. No significant differences in obesity, 
hypertension, hypercholesterolaemia, and hypertiglyceridaemia are found between 
the groups. 
 
2. The incidence of T2DM is higher in the upper tertile of haem iron intake than in the 
lower tertile. 
 
3. High dietary haem iron intake increases the risk of developing T2DM by 30%, when 
other factors associated with this relationship such as socio-demographic, 
anthropometric, lifestyle, and dietary factors, are taken into account. In addition, 
alcohol consumption increases the risk of T2DM by 2%, while coffee consumption 
decreases the risk by 7%. 
 
4. A controversial association between iron status and serum osteocalcin (OC) is 
observed. While low iron status, measured as soluble transferrin receptor (sTfR), is 
inversely associated with serum concentrations of total and uncarboxylated OC, in 
adjusted models high iron status, measured as serum ferritin (SF), is inversely 
associated with total OC in normal glucose metabolism subjects but not in impaired 
fasting glucose subjects. 
 
5. At baseline, incident diabetics have a worse lipid profile and higher levels of iron, 
inflammation, fasting glucose, insulin, insulin resistance and metabolic syndrome 
(MetS) than non-incident diabetics. 
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6. High body iron status, measured as SF and the sTfR/ferritin ratio, increases the risk 
of T2DM more than threefold, when other factors associated with this relationship, 
such as socio-demographic, anthropometric, lifestyle, and dietary variables, 
inflammation and MetS components (including high glucose levels) are taken into 
account. However, the relationship between sTfR and the risk of T2DM is not evident 
in this population. 
 
The relationship we observed between excess iron and the risk of T2DM in the 
Mediterranean population supports the previous findings in U.S., Chinese and northern 
European populations. Identifying risk factors such as excess iron could help to prevent 
and control this disease, which has increased worldwide. 
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Metabolism Clinical and Experimental 
 
Abstract 
Introduction: High body iron stores (B-IronS), measured as ferritin levels, have been 
associated with an increased risk of type 2 diabetes mellitus (T2DM). However, studies 
evaluating the relationship between levels of soluble transferrin receptor (sTfR), 
biomarker inversely related with B-IronS, and risk of T2DM are scarce and inconclusive. 
Further, sTfR concentrations have been observed to be significantly higher in obese than 
in non-obese. Thereby, the aim of the present study was to assess the relationship 
between levels of sTfR and the incidence of T2DM in obese and non-obese, separately. 
Methods: A prospective nested case-control study of 153 cases of newly diagnosed 
diabetic subjects, 73 obese and 80 non-obese, and 306 individually matched-controls, 
138 obese and 166 non-obese, who did not develop T2DM during a median 6-year follow-
up (interquartile range: 3.9-6.5) was conducted using data from the PREDIMED 
(PREvention with MEDiterranean Diet) cohort (http://www.controlled-
trials.com/ISRCTN35739639). Subjects are Caucasian, aged 55-80 years, and at high 
cardiovascular risk. Cases and controls were matched for age (≤67 vs. >67 years), gender, 
dietary intervention group, and BMI (≤27 vs. >27kg/m2). 
Results: Positive correlations were observed between sTfR concentrations and waist 
circumference (r = 0.143, P = 0.002) or BMI (r = 0.113, P = 0.016) in the whole sample, 
and in obese individuals (r=0.210, P = 0.002) (r = 0.169, P = 0.015), respectively. Further, 
sTfR concentrations were inversely and directly associated with risk of T2DM in obese 
(OR =0.50; 95% CI: 0.25-0.99) and non-obese (OR=2.09; 95% CI: 1.01-4.32), respectively. 
Conclusions: Opposite associations were observed between sTfR levels and risk of 
T2DM based on the presence or absence of obesity in a population at high cardiovascular 
risk. While in non-obese elevated sTfR levels were associated with a decreased risk of 
T2DM, in obese the risk increased, suggesting that adiposity may alter the relationship 
between sTfR and T2DM incidence. 
 
Clinical trial registration number: ISRCTN35739639 
 
Keywords: Soluble transferrin receptor, body iron stores, type 2 diabetes, obesity, 
nested case-control, PREDIMED.   
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Iron excess and the risk of gestational diabetes mellitus: A 
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Obstetrics and Gynecology 
 
Abstract 
Objective- The aim of this systematic review and meta-analysis of observational studies 
was to evaluate the association of high concentrations of hemoglobin and/or ferritin and 
the risk of gestational diabetes mellitus (GDM). 
Data sources-The selected studies were identified through a systematic review of 
scientific literature published in The Cochrane Library and PubMed/MEDLINE databases 
from inception to October 8, 2014, in addition to citation tracking and hand-searches. 
Methods of study selection- The present systematic review and meta-analysis was 
recorded in PROSPERO (2013:CRD42013005717). The search strategy of original 
articles was performed combining several terms for hemoglobin, ferritin, pregnancy and 
GDM. To identify associations between hemoglobin and/or ferritin levels with the risk of 
GDM, OR and 95% CI of the selected studies were used. Summary estimates were 
calculated by combining inverse-variance-weighted study-specific estimates using 
random-effects models. 
Tabulation, integration, and results- 2032 abstracts were initially found during the 
search. Of these, two with both hemoglobin and ferritin data, six with hemoglobin data 
and one with ferritin data, were included. After conducting a meta-analysis of eight 
studies we observed that elevated hemoglobin levels were associated with an increased 
risk of GDM, 1.53 (95% CI: 1.15-2.04). A meta-analysis of three studies showed that 
elevated ferritin levels were associated with an increased risk of GDM, 2.08 (95% CI: 
1.38-3.14). Low and undetectable heterogeneity was observed in hemoglobin (I2= 40.7%, 
P = 0.107) and ferritin (I2 = 0.0%, P = 0.692) meta-analysis, respectively. Nor publication 
bias was seen. 
Conclusion- In this systematic review and meta-analysis of observational studies we 
found that high hemoglobin and/or ferritin levels were associated with an increased risk 
of GDM. 
 
Keywords Hemoglobin · Ferritin · Body iron stores · Pregnancy · Gestational diabetes · 
Systematic review · Meta-analysis. 
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Increased iron levels and lipid peroxidation in a Mediterranean 
population of Spain 
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European Journal of Clinical Investigation 
 
Abstract 
 
Background: Many chronic diseases are adversely affected by elevated iron levels. It has 
been speculated that this relationship is mediated by increased oxidative stress, due to 
the ability of iron to generate reactive oxygen species. The aim of this study was to assess 
the relationship between elevated iron levels and lipid peroxidation in Caucasian adults 
residing in the northeastern Mediterranean region of Spain. 
Materials and methods: This cross sectional case-control study included 300 subjects: 
150 adults displaying elevated iron levels (cases) selected from a representative sample 
of our general population and 150 age and sex matched adults exhibiting normal iron 
levels (controls). Dietary assessment (3-day food records), iron biomarkers (serum iron, 
ferritin, and transferrin saturation) and lipid profile were determined. Elevated iron 
levels were defined by high serum ferritin (SF >110μg/L in women and >200μg/L in 
men) and/or transferrin saturation (TS) >45%. Oxidized low-density lipoprotein 
(oxLDL) plasma levels were measured and oxLDL/LDL-cholesterol ratio was calculated 
to estimate lipid peroxidation. Multiple linear regression models were applied. 
Results: Individuals with elevated serum iron levels showed increased oxLDL/LDL ratio, 
but not oxLDL levels, compared to control subjects (20.92 ± 4.89U/mmol vs. 
19.72±3.573U/mmol, P = 0.028). These results were further confirmed by the regression 
models adjusted for demographic characteristics, diet, lipid profile and inflammation. 
Importantly, higher serum levels of triglycerides, LDL-cholesterol and lower intake of 
Vitamin E increased lipid peroxidation.   
Conclusions: In our general population, we have observed that higher circulating levels 
of iron, measured by SF and/or TS, increased lipid peroxidation (measured by 
oxLDL/LDL ratio). 
 
Keywords: Elevated iron levels; oxidative stress; lipid peroxidation; oxidized low-
density lipoprotein; oxLDL/LDL-cholesterol ratio.
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Institution: Ministry of Education, Culture and Sport, Government of Spain. 
Scholarchip/Grant: FPU MOBILITY AID. 
Date: 28 of December 2014 
Period: From 1 February 2015 to 03 May 2015. 
 
 
Institution: Ministry of Education, Culture and Sport, Government of Spain. 
Scholarchip/Grant: Grant of the Formation of the University Staff (FPU Grants).  
Date: 28 of December 2012 
Period: From 1 March 2013 to 31 August 2016. 
 
 
Institution: Rovira i Virgili University and Foundation Caixa Tarragona. 
Scholarchip/Grant: Martí Franquès URV-FCT scholarship programme.  
Date: June 2012 
Period: From 1 September 2012 to 1 March 2013. 
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